project_id string | case_id string | case_submitter_id string | selected_normal_wgs string | source_center string | state string | a260_a280_ratio string | normal_tumor_genotype_snp_match string | ribosomal_rna_28s_16s_ratio string | rna_integrity_number string | age_at_index string | days_to_birth string | days_to_death string | ethnicity string | gender string | race string | vital_status string | year_of_birth string | year_of_death string | age_at_diagnosis string | ajcc_clinical_m string | ajcc_pathologic_n string | ajcc_pathologic_stage string | ajcc_pathologic_t string | classification_of_tumor string | days_to_diagnosis string | icd_10_code string | last_known_disease_status string | morphology string | primary_diagnosis string | prior_malignancy string | prior_treatment string | progression_or_recurrence string | site_of_resection_or_biopsy string | synchronous_malignancy string | tissue_or_organ_of_origin string | tumor_grade string | year_of_diagnosis string | treatment_or_therapy string | alcohol_history string | is_ffpe string | composition string | days_to_collection string | days_to_sample_procurement string | initial_weight string | pathology_report_uuid string | portion_submitter_id string | percent_lymphocyte_infiltration string | percent_monocyte_infiltration string | percent_necrosis string | percent_neutrophil_infiltration string | percent_normal_cells string | percent_stromal_cells string | percent_tumor_cells string | percent_tumor_nuclei string | text string | embedding_shape list | embedding unknown | analyte_type string | days_to_last_follow_up string | weight string | sample_id string | sample_submitter_id string | portion_id string | slide_id string | slide_submitter_id string | section_location string | concentration string | spectrophotometer_method string | oct_embedded string | preservation_method string | no_matched_normal_low_pass_wgs string | no_matched_normal_targeted_sequencing string | no_matched_normal_wgs string | no_matched_normal_wxs string | selected_normal_low_pass_wgs string | selected_normal_targeted_sequencing string | selected_normal_wxs string | creation_datetime string | portion_number string | specimen_type string | ajcc_pathologic_m string | ajcc_staging_system_edition string | intermediate_dimension string | longest_dimension string | shortest_dimension string | cigarettes_per_day string | pack_years_smoked string | years_smoked string | analyte_type_id string | figo_stage string | analyte_id string | analyte_submitter_id string | aliquot_id string | aliquot_submitter_id string | sample_type string | sample_type_id string | tissue_type string | tumor_descriptor string | ajcc_clinical_t string | ann_arbor_b_symptoms string | ann_arbor_clinical_stage string | ann_arbor_extranodal_involvement string | aliquot_quantity string | aliquot_volume string | experimental_protocol_type string | ajcc_clinical_n string | ajcc_clinical_stage string | primary_gleason_grade string | secondary_gleason_grade string | igcccg_stage string | analyte_volume string | masaoka_stage string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TCGA-BLCA | b8f3d552-2d4b-4dd8-b0e8-6a38e1baa2f3 | TCGA-UY-A78P | true | 23 | released | 1.9 | Yes | 1.95 | 7.3 | 78 | -28719 | null | not hispanic or latino | female | white | Alive | null | null | 28719 | null | N0 | Stage II | T2 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | null | no | Not Reported | false | Not Reported | null | 0 | null | 89019149-B6D2-4540-9BFE-BACCA9F5DA14 | null | null | null | null | null | null | null | null | null | project id: TCGA-BLCA; case submitter id: TCGA-UY-A78P; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.95; rna integrity number: 7.3; age at index: 78; days to birth: -28719; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; age at diagnosis: 28719; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2380.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; specimen type: Solid Tissue; | [
1024
] | "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" | null | 2380.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | Solid Tissue | MX | 6th | null | null | null | 0.821917808219178 | 15.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | fe33e5e0-a54d-481a-897c-e32b4708da69 | TCGA-UY-A8OB | null | 23 | released | 1.84 | Yes | 1.57 | 7.6 | 63 | -23360 | null | hispanic or latino | male | white | Alive | null | null | 23360 | null | N1 | Stage IV | T3a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | null | null | Not Reported | false | Not Reported | null | 0 | null | 1D6D35DC-D4B8-4186-9EA4-97F53314D01B | null | null | 0.0 | 0.0 | 0.0 | null | 0.0 | null | null | project id: TCGA-BLCA; case submitter id: TCGA-UY-A8OB; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.57; rna integrity number: 7.6; age at index: 63; days to birth: -23360; ethnicity: hispanic or latino; gender: male; race: white; vital status: Alive; age at diagnosis: 23360; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2109.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent stromal cells: 0.0; | [
1024
] | "YcunvjzLuz4dnlu+h2oDPX68Fj5sOdU+ZfwJvv/LSz6Q+em9xhgCvuf31D5DNYA7XvotPajHP759z3i+5ulrPp+Jfr0mBXu7jx4tvkmMWz7Y/+u9VQ/xPkjROD6/U6W99oGavq5T0b2iU5E+sRlwPs7j7j36FjM9g6LHPTcWNj60tnK+Qx+Mvkdh8LyhBtQ+rn1vvnpYNr5PjeU9GVyxO8M6zD3JU6E+rO/pPbsedr7L4uG+i2kjPcLs0jwVIC6+o8VfPhraCL6zC4y9eI70vWT/rr01zZ++jN0nPXsFvr1qewa9WCODvmk1yD483T8/N6BbPbp3B70e8Mq9/nzvPnAaAb4XfoA+yniVvnK8ir5UJ5Q+ePsyvhkr4L02MG0+lIOKPsmtgT6DNCq+Ro6UPJJUSL1txZg98MonvrZhtz3yIMg9hDQkvs4NAj5zQTW+i99zvhItgL4OYIi9H3+yvnCWyT6Zf6C+4jQyPmQliD6MzAY+vR9SveeqX7vpBYK9v1M8vCoWTr6NOZ8+FrvHPS7luT7sGfE82Nl6vX0uRrsHn8o9hTfcvdS9Mz0ogl69XOxEvu7KGL527Rw+ZyPtPiTyYjrouQM9TJVWvSR0Gj41yRs+gO8EvSJ66b62hmY9zcgVPn1cJz8vfSy+hNiFvlFF9Lt0Kh2+A9kBP0YkIj0DywK/0BLVvMIdSr4myHu+3LbcPDwgIz5UF4y+jkKVPrw8gL/8rRy+kgKCvheQfTyxUu48jPaZPf854T2vmMU+q0wwvSoExj7EEZS+MA1BvtrPjb4qro4+cGKFvorHJz1h7N897VDYvv9QhTx5kd2+lC+sPuX03ztMbTU94cmzPhBlPLyuTpw8/MzCPQ9wZD2pGaS+6TsOOl6hGz5gBWK+BNIIPqTjJb3W3ie+dqGIvmDWiD7tTdi8uCx9Pgn4BL0KsPG9I4ixPZs4g7yWdgE/7quavdPDDD/Q9KC+bR6wOq/baL2CDys7DbcKvtk5Lr+/OCQ9UojwPeUcPr4jZog+bcKZPofCxL1nt9o9SmKivTALBb5FJki9CTDfOzSqHb7bTOC+2CHrvhTgNb6xpYg8+nqxPnl9RT1wHK++top9vdMZJb7aGlu+cCr4vqVpOz7E5dI+0d1HPg5lHD0LD5y+spu1vh+Gnz0+FVi+/ZQZPgcOEb9YAo095FtVvihYL76s1I68xx0CvhQCor5c1gs/vnQaPad96j0oOQW+udycvoe1kTytwZy+L58Mvhwqg72SZOG9NewpPnlIYz61lJI9JzWBPmemYr3T3YW+8X8ovZ84UT12OAo+qW2LvSZEqL5s3w0+hcUEPQ7qxz1todU8C1K5Pr9eQr5XXLfAOViwve7tFD8OemI+vG1uvgRfbL6MV0e+nPI8PoxPybsUHBm9KyW5PeHPbr7f2rQ9q7CIO1Dhtj2pDz6+gBRMPkswhz0O7+S9VT98vXZlQz4EpS4/zPhKvuvpCj00PXk+6HXJvdM477q7HAU+DKUEvenoxj2eS6u7/UqhvrtLE76x+Ze+fVXCvtbpk72iTvC74tctvvkwH70y8a69x++IPandpT6FvWk+C6LSOfYTpb3HCBM9rsCsPorzmT5fj6w+pC0DPj2VrT1pfco+JGrVvmpsJ75ABxk+bGCiPemH7T1zM0e++Pt6PVsNlr5WyCc9mZcvvjIr2j0ykBM7RleCvgmTyD7eBVm+phA2vpmyQj59H+q5whH5PheYvb4aAB4+UC2PPiOphD4SswW+jEEMPo5lbb71J5U95lrnPFIBkT5iBPU9ZdDPvT/URz6/Kig9637OvZdaCb8fY6C+fccUvtsmkb45Zs0+n/c3PvTY073oi9g8uhzbPpTgMz5+z849+jGePnhohj4fnC8+1erKPth6kD1SL6C+ZXoUPDGqpjwWe1U+EFG6vVtxlL4a4im9YR1/PSqq5b3uD5c+R6uePXPDDr5loSq+WXupvbrSOj6+wKG9HEOOPtwRcr69Cxq/UQTevXa9j76nfhU+Y7b5vkMTKD7DWIW9MP8iPsOWJj9w+pi++EMwPS82aL2v9Og+fvDzvT7nKT4n54g+nAwFvqKWYT74LkU+1qGIvt/eSz25WsQ981tFvgE1Jr8yuhc9cpL9u4j1sDwG0JK9CjTyvU/iuL58LJ0+gAOhPgu21z1Glhg9SkJivsdgwD46X2W+5bI9vbwzI73x19s53eLvvR3M4z7YBKw9QCROPjK/Aj4gg4s9T17cPUE1T76Cij48dCIEv+mrUj2UBjy/CCwjPgpI0r65Ugc/7GOTvis7jb2bdB69b8zpvU/uur6fhYy+NXH0PD7Ky77mEVA+b7ROvtC17rzhrL497riFPYGCDT7amSS9ofqhvqIdvD7/s6A/QESIPA3akr03sl++Vhj9vhMeJbvSfiY9d1WQPpFmeDsIWdu+BXGZvjyMG77HQ6c+vg8UPoIpJT5yzTM+9WFoPeZHL725Ws49ruHsvv1WDL68uci+fhDsPT4TNb6+Fp08gfWQvVjI8j3UfRE9Cx0xvhVXLr7TpOa9gvbhvPU0kD7kq4A+90IPPj4f9DtjzUs+Dqa6voEp4zxmVni+zdpWPiRFdb6lUIQ+0BNbPjzcfD4XPW8+BpogPp9FhD4h5II+oloLvbsbBT5Joga+XGEmPdKkTT6VNyO+s9+YPte2Dj6CHsS+wksBPRNzhj6DzaI9rTIMPp0Nqb5SbZk8tHZiPumkBL78DcM9utSBPcyU+j2Rzby9rvF8vVMorT2MKnq+oPHlvMljgL1DQrA9zsvGvqCyPL6A3Ay+8z6QPLF9bT79bpy9llpcvWj7hr3niKE+kRCOPQhUmrzTNBg/IDEGvlHK773yvUc+o+2Lvt2faD52GuQ7vfOUvpiOUT0s3P29SprrPV3rFL7dtAw9gLNmvthO9D5lOn6+EkV4PrbXp77zd3S99SbCvQkBlzz90ru+IxZmPhQgWTzWYUS+6TigPpl0lz5I3wW/rTskvh/G6L1EyQW+dleWPvo5w733OKI++ImWvH4lsDztfV6+yXtGPgzJIr4QTAo+2HMjvBXO07y7ubk915o0PSRDLT7GW0O/Fe6tPeHBo71q04i+TiRPPm9CSr5iNaC+EGcFvjURgr3hg4c+m1yGvltfij63xIS9DsK6PZD9WL6qVvS9QDanPACsBD2HUPU9ZWXTvdWH8b3AL2a+e0umvt8ytL3LMqu+6fckvskByz3h8xE+0O2+vT0zH74rboG+rzesPllnKzwaDDy+FGSwPkF3Ab8XtRE+4XJovlPAyr6256u+Y1M3PkLNhD9se9q9/06lPnJvgD3xP7a9Py2JvhOLYD7enZy9n1+MPmMCgb644Lu+MY7vOoMtxDz2GUY/VjDUvVSpob7LLvI+qNG4PW1AC77HXaQ9cDa3Ph819b3Z7YM+f8hcvqtEVj5RVdu9NsZaPoqqyj6C8nA8SxE7vaFEwLyrPo2+K7rMvjL6hL3ZmWW9yvkjvbYNi72C9oW+A9I0PvtTuz1NxrW+C1qrPp4zMD5qlEa+bI1CvvMrhb7ksJW+QDevvJD50z12g9q+sm26vmseJD7LDhg+9FC8Plzbzz5gb1k96QDuvSoik74AVIk+IzQkvneelb6Y5Tc9pcxvPNBPF75tnHi+lQ0HPkvUaT7wYb2+kZk4PowRpL5XGDo+E9jSPQQsDb4XnkI+RylFPqddB77YBoW9s1IKPRyZxz2bYeS+N/EJvgxLTr7Fs0y+tVYOvsjYjr7wKZk+voSHPNz9eT5x9JU9WfMIv1Zf4r2C4qy+YTMsPQxmhL6uta49QA/dvoU2zz3erdA+NWTuPra9U76ZeEe+gQeLvv+ga77YS8E+Q2RrPhFBl73ZBRW+bNZ9PXviyz0ONZy+MEScPVLi4D5jJ6u9JDV9uzleuzx/lMk9vUPYvQFNAD5tot++ExeyPUWepr2IxEI+wgCzvjowED3vpFg+A+xIPvxc8D5KGZk+4rMsvX9W677ihzq+aOMOvn6QDT5tX229GabAPw0pnj4yzMw+Uoc9Psl9fb4JaPo+CioMP15xwT1lhws+Yc+LPnBKwT4LCvy9Ek3iO7UgKT9U6q++P3GgvU8Lrb9F3Wy9WKAfPRuLEz9ohy8/q+RVvh5Pqb55ZDi+b9Uuvp9XC752ANc9RSQOP/mYRb6VUzg+qMNSPsaiTr2mVZ0+U6RnPsCxa74WT+o9Erq3vKLJi75llHA8W3v/vG2V5T2CIMW+s2gyvjEmPz40kl++E8ZoPnKLoj6ZqY++PFCGvj5zKj4KjJU9mmuUvpOkAz/wXoo62OVmPpFuhj5VTai+ZBPEvSPvZL5ZSvO9TxJSvlH2bL7lek0+oENwvqJFWD0khsM94TalvqH2KT64SR4+I8USvZh7AT4/ZJ4+Df0mvbo4Sb4LmSi+A3mkva5SCD3RVQS+f7LCvh+JHD92cxI/ZyicPhPTGL4cGMY9Yt52PvCvKT6GbJg9g5DVvgSJFb7kR2o+Lzu/vkUmED0dDJA+vBPaOZH/fT2vEpe9gF6WPbrCJT5OENq9zRGHPup0Nb7WJNu9yD66vkw57zz/vtG+019yvLFasT1758C+0HgJPH44ab4j76A+YygOPu6+Qr55INs92/JSvgrQfL7Y+/Y9/0I9vaFUur5Wtag7NNMbPoqzKz57zBq7R/l2PfnKw71wKq4+Lw+ZPoyWF74oWgM/xf16vf484b1eQK2+Jj+VvnJtv75zfbq+qYyEvkfpUr7GQ8m9AsUxvfr6PL5Iv7C9Oya4PeZ60j6rVJW+uhCKPVDoDj2l9jK9+hgfPpt2WL4OeFW+IW5nPlOeh73Myhg9xgJKPi5KD76Gh7Y9uV5mvjJtmj2SSuA+IqSLvmtGIj5nrEY+RXq4PF6K5T7zCxY9zubzvrUcxT7pvpU9P8SuvrT2JL4qOpi9IThmvYYeED6ju6s9mZPwPfV6Iz29QQQ+TgI4PjSBVD1Plk++5uaJPMJV2zyiMko9U1z0vIgRQ74kwm28L6a6PY+zAD9qxFq8xwm+PGQj6L1Agz++//1MPYx5Kr58G6e9sOCyvrqk2L2xF4m+EminvFSsIT5FUi0+JKlhv0eF7L1VN/+9IbBePsPovz35xjA8AgOPvhm9lr3nyzU+4Z2svQG1hb4r81Q+KxeePuhTCr6L9dS97u6qPQ6HbT2SBq29ET9PPkr3eT6Bf5C+MANtPlN8mT78HEa9VwyBviL+er4knaQ8ZuoKP1cysbs3vEo9THmJPhBwOb4TqUu+szafPWzqxr56Dm++ck/8vtYwrj66pnu9m/5HPhqNpT2T5m28hZgKviRS0L6fJ5K9rDxdvtvwKT7EFSg+Rq5hvcRboL7Q780+vTekPo9r5r1eyk0+7cpSPq86qbzXmtW+SJiAvsekzD2rEmu+BJoiPTumXj7m6J296xwePQU63z3hq4M9rPUMvCEw7T033+i+ng1Vvg==" | null | 2109.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.36986301369863 | 25.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | fa2410b1-4f69-446d-99ee-a10a00034c42 | TCGA-UY-A8OD | null | 23 | released | 1.92 | Yes | 1.42 | 7.9 | 68 | -24588 | null | not hispanic or latino | female | black or african american | Alive | null | null | 24588 | null | N0 | Stage II | T2b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | null | no | Not Reported | false | Not Reported | null | 0 | 40.0 | B74B0DFB-0A6B-4E4C-A843-50130DE79C1A | TCGA-UY-A8OD-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-UY-A8OD; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.42; rna integrity number: 7.9; age at index: 68; days to birth: -24588; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; age at diagnosis: 24588; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3432.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-UY-A8OD-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 3432.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 45f5af14-060a-49a3-b51d-25ab8a88feb7 | TCGA-UY-A9PA | null | 23 | released | 1.86 | Yes | 1.73 | 8.7 | 48 | -17520 | null | not hispanic or latino | male | white | Alive | null | null | 17520 | null | N0 | Stage III | T3a | not reported | 0 | C67.2 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Lateral wall of bladder | No | Lateral wall of bladder | Not Reported | null | no | Not Reported | false | Not Reported | null | 0 | 50.0 | 73CA1D6C-0158-4324-9D82-4442254EF8A4 | TCGA-UY-A9PA-01A-11 | 2.0 | 1.0 | 0.0 | 3.0 | 3.0 | 17.0 | 80.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-UY-A9PA; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.73; rna integrity number: 8.7; age at index: 48; days to birth: -17520; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; age at diagnosis: 17520; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1072.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-UY-A9PA-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 3.0; percent stromal cells: 17.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1072.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | f90cff19-1c16-4514-8bc1-169539d01fca | TCGA-UY-A9PB | null | 23 | released | 1.87 | Yes | 1.67 | 8.6 | 49 | -17885 | null | not hispanic or latino | male | white | Alive | null | null | 17885 | null | N0 | Stage III | T3a | not reported | 0 | C67.2 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Lateral wall of bladder | No | Lateral wall of bladder | Not Reported | null | no | Not Reported | false | Not Reported | null | 0 | 90.0 | 1CCAA482-BC52-4F00-89E4-31D0D9BBEAF9 | TCGA-UY-A9PB-01A-11 | 2.0 | 2.0 | 1.0 | 5.0 | 0.0 | 24.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-UY-A9PB; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 8.6; age at index: 49; days to birth: -17885; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; age at diagnosis: 17885; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 899.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-UY-A9PB-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 2.0; percent necrosis: 1.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 24.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 899.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.36986301369863 | 25.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 9ef9e328-ac74-4c8a-9990-347b87cf7764 | TCGA-UY-A9PD | null | 23 | released | 1.9 | Yes | 1.83 | 8.8 | 80 | -29565 | null | not hispanic or latino | male | white | Alive | null | null | 29565 | null | N0 | Stage III | T3a | not reported | 0 | C67.3 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Anterior wall of bladder | No | Anterior wall of bladder | Not Reported | null | no | Not Reported | false | Not Reported | null | 0 | 160.0 | 0698B674-4D6D-4FEF-8129-F66DF28A45F9 | TCGA-UY-A9PD-01A-11 | 2.0 | 1.0 | 0.0 | 5.0 | 0.0 | 25.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-UY-A9PD; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.83; rna integrity number: 8.8; age at index: 80; days to birth: -29565; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; age at diagnosis: 29565; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 542.0; icd 10 code: C67.3; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Anterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Anterior wall of bladder; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-UY-A9PD-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 542.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | fed69898-a229-4b81-bbd9-cdcb164dae7b | TCGA-UY-A9PE | null | 23 | released | 1.87 | Yes | 1.61 | 7.9 | 86 | -31755 | null | not hispanic or latino | male | white | Alive | null | null | 31755 | null | N2 | Stage IV | T2b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | null | null | Not Reported | false | Not Reported | null | 0 | 80.0 | 4B7A7988-B259-4630-86A6-522EAFAFF078 | TCGA-UY-A9PE-01A-11 | 2.0 | 1.0 | 2.0 | 5.0 | 0.0 | 23.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-UY-A9PE; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.61; rna integrity number: 7.9; age at index: 86; days to birth: -31755; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; age at diagnosis: 31755; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 189.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; alcohol history: Not Reported; cigarettes per day: 2.4657534246575343; pack years smoked: 45.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-UY-A9PE-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 23.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 189.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | 2.4657534246575343 | 45.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 3bd918a8-3b92-4042-b4a1-f9dfcd6fe405 | TCGA-UY-A9PF | null | 23 | released | 1.88 | Yes | 1.94 | 8.1 | 77 | -28470 | null | not hispanic or latino | male | white | Alive | null | null | 28470 | null | N2 | Stage IV | T3a | not reported | 0 | C67.2 | not reported | 8130/3 | Papillary transitional cell carcinoma | no | No | not reported | Lateral wall of bladder | No | Lateral wall of bladder | Not Reported | null | null | Not Reported | false | Not Reported | null | 0 | 90.0 | 9521187B-B7A8-48F8-860A-57A28664BD26 | TCGA-UY-A9PF-01A-11 | 2.0 | 1.0 | 0.0 | 4.0 | 0.0 | 25.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-UY-A9PF; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.94; rna integrity number: 8.1; age at index: 77; days to birth: -28470; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; age at diagnosis: 28470; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 117.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; alcohol history: Not Reported; cigarettes per day: 0.273972602739726; pack years smoked: 5.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-UY-A9PF-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 117.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | 0.273972602739726 | 5.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | cd10dc46-356a-420b-b3f5-9e4ed4e7ecab | TCGA-UY-A9PH | null | 23 | released | 1.93 | Yes | 1.74 | 8.2 | 73 | -26654 | null | not hispanic or latino | male | white | Alive | null | null | 26654 | null | N0 | Stage II | T2b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | Yes | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | null | no | Not Reported | false | Not Reported | null | 0 | 70.0 | 0F1A84D7-7EB5-4FDD-BB99-FC4DBB712814 | TCGA-UY-A9PH-01A-11 | 2.0 | 1.0 | 0.0 | 5.0 | 0.0 | 20.0 | 80.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-UY-A9PH; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.93; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.74; rna integrity number: 8.2; age at index: 73; days to birth: -26654; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; age at diagnosis: 26654; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1561.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-UY-A9PH-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1561.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 90bf49b7-6710-4665-82df-30ecc22c59a3 | TCGA-XF-A8HB | null | 23 | released | 1.88 | Yes | 1.46 | 9.0 | 50 | -18544 | null | hispanic or latino | female | not reported | Alive | 1956 | null | 18544 | null | N0 | Stage II | T2b | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2731 | 0 | 740.0 | AEEB69FF-8CC6-4E22-AD71-A55B11595314 | TCGA-XF-A8HB-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A8HB; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.46; rna integrity number: 9.0; age at index: 50; days to birth: -18544; ethnicity: hispanic or latino; gender: female; race: not reported; vital status: Alive; year of birth: 1956; age at diagnosis: 18544; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1370.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 2731; days to sample procurement: 0; initial weight: 740.0; portion submitter id: TCGA-XF-A8HB-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1370.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.095890410958904 | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 17ee3278-dc2a-4021-a903-e4ed11e3218b | TCGA-XF-A8HC | null | 23 | released | 1.81 | Yes | 1.75 | 7.4 | 79 | -28996 | 200 | not hispanic or latino | male | asian | Dead | 1926 | 2005 | 28996 | null | N2 | Stage IV | T3a | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2005 | no | Not Reported | false | Not Reported | 3146 | 0 | 640.0 | A2FF709D-B1C0-4287-BB27-0F96F81BA2CD | TCGA-XF-A8HC-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A8HC; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.75; rna integrity number: 7.4; age at index: 79; days to birth: -28996; days to death: 200; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Dead; year of birth: 1926; year of death: 2005; age at diagnosis: 28996; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3146; days to sample procurement: 0; initial weight: 640.0; portion submitter id: TCGA-XF-A8HC-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | dfc67e7b-3986-4129-ae02-4d8f57e776e3 | TCGA-XF-A8HD | null | 23 | released | 1.84 | Yes | 1.26 | 7.2 | 77 | -28305 | null | not hispanic or latino | male | white | Alive | 1929 | null | 28305 | null | N0 | Stage III | T3a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2820 | 0 | 760.0 | CB491DC7-F20F-496F-A416-AA32105D32D7 | TCGA-XF-A8HD-01A-11 | 2.0 | 0.0 | 19.0 | 0.0 | 0.0 | 0.0 | 81.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A8HD; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.26; rna integrity number: 7.2; age at index: 77; days to birth: -28305; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1929; age at diagnosis: 28305; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2964.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.6575342465753424; pack years smoked: 12.0; is ffpe: false; composition: Not Reported; days to collection: 2820; days to sample procurement: 0; initial weight: 760.0; portion submitter id: TCGA-XF-A8HD-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 19.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 81.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 2964.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 0.6575342465753424 | 12.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 841b4582-a268-4a55-a9a2-47c7e5c3b69f | TCGA-XF-A8HE | true | 23 | released | 1.94 | Yes | 1.84 | 8.3 | 47 | -17212 | null | not hispanic or latino | male | white | Alive | 1957 | null | 17212 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2004 | no | Not Reported | false | Not Reported | 3457 | 0 | 810.0 | AC201676-ED94-488A-BCC3-A9302FDF1D48 | TCGA-XF-A8HE-01A-11 | 2.0 | 0.0 | 4.0 | 4.0 | 0.0 | 0.0 | 96.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A8HE; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.84; rna integrity number: 8.3; age at index: 47; days to birth: -17212; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 17212; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3817.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3457; days to sample procurement: 0; initial weight: 810.0; portion submitter id: TCGA-XF-A8HE-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 4.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 96.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 3817.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 8573e114-ac20-4113-a942-01f2d1562a7b | TCGA-XF-A8HF | null | 23 | released | 1.81 | Yes | 1.22 | 7.2 | 80 | -29288 | 2954 | not hispanic or latino | male | white | Dead | 1924 | null | 29288 | null | N0 | Stage III | T3a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2004 | no | Not Reported | false | Not Reported | 3418 | 0 | 150.0 | 1276CC52-8D49-40E9-A365-3E065E1B77EA | TCGA-XF-A8HF-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 50.0 | 50.0 | 60.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A8HF; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.22; rna integrity number: 7.2; age at index: 80; days to birth: -29288; days to death: 2954; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1924; age at diagnosis: 29288; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1709.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.0547945205479452; pack years smoked: 1.0; is ffpe: false; composition: Not Reported; days to collection: 3418; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-XF-A8HF-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; | [
1024
] | "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" | null | 1709.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 6th | null | null | null | 0.0547945205479452 | 1.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | b9b61cf9-8711-4c3a-8511-659070cfe36b | TCGA-XF-A8HG | null | 23 | released | 1.85 | Yes | 1.47 | 7.6 | 69 | -25421 | 467 | not hispanic or latino | male | white | Dead | 1936 | 2006 | 25421 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2005 | null | Not Reported | false | Not Reported | 2900 | 0 | 550.0 | BBBBC7D7-4994-4B78-9C65-22B4E8C61261 | TCGA-XF-A8HG-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 80.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A8HG; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.47; rna integrity number: 7.6; age at index: 69; days to birth: -25421; days to death: 467; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1936; year of death: 2006; age at diagnosis: 25421; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; cigarettes per day: 0.4383561643835616; pack years smoked: 8.0; is ffpe: false; composition: Not Reported; days to collection: 2900; days to sample procurement: 0; initial weight: 550.0; portion submitter id: TCGA-XF-A8HG-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 0.4383561643835616 | 8.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 02964d82-cc94-4286-a66f-03567101950c | TCGA-XF-A8HH | true | 23 | released | 1.84 | Yes | 1.32 | 7.2 | 61 | -22393 | 57 | not hispanic or latino | female | white | Dead | 1943 | 2004 | 22393 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2004 | no | Not Reported | false | Not Reported | 3312 | 0 | 420.0 | 33C8B2EA-980D-4CDC-B8A9-B8583E04BCCA | TCGA-XF-A8HH-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 10.0 | 70.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A8HH; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.32; rna integrity number: 7.2; age at index: 61; days to birth: -22393; days to death: 57; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1943; year of death: 2004; age at diagnosis: 22393; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3312; days to sample procurement: 0; initial weight: 420.0; portion submitter id: TCGA-XF-A8HH-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 10.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | eed3908f-f1bd-4254-bca8-bc1a7427e95c | TCGA-XF-A8HI | null | 23 | released | 1.85 | Yes | 1.59 | 9.0 | 57 | -21059 | 544 | not hispanic or latino | female | white | Dead | 1948 | 2006 | 21059 | null | N2 | Stage IV | T2b | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2005 | null | Not Reported | false | Not Reported | 3153 | 0 | 270.0 | 737E5709-0C1B-488C-B915-84F26A4B86D8 | TCGA-XF-A8HI-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 90.0 | 95.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A8HI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 9.0; age at index: 57; days to birth: -21059; days to death: 544; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1948; year of death: 2006; age at diagnosis: 21059; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2005; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3153; days to sample procurement: 0; initial weight: 270.0; portion submitter id: TCGA-XF-A8HI-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0; | [
1024
] | "PwOtvoEosj7kW1y+qlYZPYdEMz4tE9w+mE0XviVZID4z2/K9wqAKvnL12j7WGFy6oIY7PcAiXb6I23C+ByBcPrn1F7xxp7g8jkArvmhkYT4sXPG9/7b+PlepLj4L3GK9q9+avnOqzL2emo8+UCB3Ptcwpj0QIqc9D1XPPfwTPD4zF5G+Q8Wgvnponruw4tc+L2qBviZ/O77UcA8+QLYnPDWGtz1JO6I+3VURPg8bZr63Ydy+jSaRPfZinzszflC+bpZhPmNm1L27zJ29o+3KvfKpfr2295++/tydPa97cr241xS9Dalzvj0a1D7pHUI/gdRRvOHFsrzVlu69L436PhlmN74pIXQ+e4OnvudUmL5G1Xg+B/4yvuamBb6QNII+w1mHPpqGmj7J9im+56c/vJawjb1Syt49pDsrvlVI8j3AeLk9vKQkvrH/AT75TzK+DUONvgEflb6rdxS9GQLEvoC91j56frW+2S4ZPtnvmz4jzjg+9naquq+DoDwNyL291hT7vK6DWL415pA+QAPaPZht3j4n5BE9D0iJvYBtkby4AQ4+kZwLvsuniz00Y7u9FWlCvn8gJb6oywU+9rbfPs+IVjwJjgU9YZdGvWy66D3xIDY+FkBnvRxL9b5Q2FY9z9wgPogOKz/+jCK+1+KKvpEfkrvIxVi+jBn9PrJWkj3vzgS/8ohrvWMHMr6Ogoa+OoxmPVJ+Nz4iGIm+7U6hPq03eL/sABS+41OIvgPGBj2/5ic9bjfRPThfAD611+M+hUxivMHqyT5YX5O+k9hRvmFBib6E3Hs+cjuPviQyQT0l0nk9Z1L0vksRwLznDOO+uCKwPr7w/rz/N348u9WqPoiDY7wycTm8wGS3PZH58T2uxKi+lu4hvK/PNj5vDnK+Z6cvPgl78Lw7CE2+7WWGvmYAbz4a+Aa9RIyIPpQQ8rxo8QW+9wOBPVXLib27CwA/N0nXvXgtCj9UGpi+/UUCuv4qWr2RRem87zYHvtUMNb/g/xQ9wD6TPfoaT74QVIM+dCyuPjoIjb28xrw9iKe2vSR4GL6P7qi9y7zhu+gxDb5QLt++7CT3vsRBE75/LI88B3KkPn/kjz3pgKm+vgO6vdZyKr6ogFe+aOLrvrb2Bj5b69c+I1oxPplRIDxUpoq+9jLIvjUP2T2jWmS+MQkLPl90Gb99e7Y9+mRCvnLVEr5/Jjg7tqYKvtBrrr4ig/k+FyzrPO209j0yZh2+LZaFvnNiLz3y4rO+dE8XvhhisL0Tdcu9YCdCPooQVj6dqI09YcyJPrdcP70w6FS+dK3+vEwRGD1FwdE97d6hvWYZr777MNo99VPKPHIA5j0Anka9ev3EPke0VL54WrPAQ3arvWeMDT9kaWY+4bBqvvO4er57/Ey+uC43Pl/qQrwSWaO8E5a7PfHvXr4Rlcw9GQdovH+/nz09yme+mm5dPgipjz27SAG+c06Xve3UaD6sVSg/X/g3vlfMJD3zb3g+8R76vbovMj0uZQE+DcVjvCcd1z2WiAY9nt+Pvn5REb7lJp6+M5/HvmL8qr0CgTe98pgRviobgL3mPrm9IbxjPc9bsT7iEGU+DWAwPeeqwr1XsUQ98+ezPoWpjD6Perg+Pq80Pk6AiT3nTMI+FwPVvkBiNr5ztAg+lPGBPW/L0z3Bi0m+rJGkPRoMkr6Ai1s9aD5Svg3V7D3LzaE8efOTvkubwz6WOmm+CW8+vh31SD741Z88jnHyPmHMw76WKfk98MaHPtJKlz4eHR++GwVPPnQeUr7agqo9AXVSPOYpjD7s1sE9e4YEvr/GTz4Mrqs9+hqDvbbXGr/bVI6+PwsNvviijL5Fy9Y+lyMzPsEyyL3xUGQ9sufQPhdiST7hZ/E9GaamPq7niT5jU0A+UpfAPi96ZD1hpcC+WvC0O1fdBTx0FGQ+GjHHvTT8lL6qC868/9kaPclwyb3TT6Y+dJ+mPaBlxL1u7jK+GHarvd9qSj4hieq9B5uSPvKkZ77ygSC/gY3ivV1ujb7hQ9g9RecAv3QgSD6x+LK9PtIjPvwzKT+1OIW+oeVnPRUWtbxd/uk+NskJvls5LT6Uc5A++qAEvpn6YD6HxSs+psOHvsOPqT2HZQs+eYZQvqTvJ7+mAlY9Lj5uvP2gRrt7MGC9zOoLvhuP6L5Fl40+mdydPp2t1T2XTDw9b+p5vlzluT4E7HC+AMcDvQ5Ufb204N08HZ8Zvr7w7j6ku7889ItdPgGINz7IuTY9TqARPj7Obr5ztmO6WPv6vnVSaD2pOjW/P8kgPqglzr4Wcfw+rpuIvmWzmL2k11i9SwYVvsHtuL72gIy+cjuYPXgi0b4ucFU+I/V0vmXzYLzA3dM9ggSEPWdrCD7apoK9H9uRvp3dqD7At54/Im3FPAq1kb0+J3C+Zb/5voV7bzz1xwg9F+epPtT3ozzbo72+1cqlvhui/b0Nra0+8v4BPk8jHz4gqQ0+0nWFPc0UGzwgCqw9XdvrvppuJL71VcO+l8ewPTZBT76fQAU8EFayvAICCj4HL5Q6HGUwvrdMEr4INbW9sf0zvfVgnD4Z4Ig+Mu8ePq0DMD3ZFjM+yKPDvoAS0LzgMna+Qo9tPqk7j74kcoc+Nx9gPuCcjT7kQnA+vp8KPlUIej5D55E+N0gnvWMJ3T3QHQm+e3tjPZeZUD5vEDi+n2OoPhcoAj46sLy+RAgPPWxXiD5rNKU9J9npPfmdpr5XuU49ao5IPi0OAL5iHJU9dwrrPeKy2D0Fe7m9J7lBvYht0T2NSjC+BT4ovaXB7LzQp9s9GYS/vpguHr7jdy2+yCINPOklcz7Snra9yAU0vd7T+LxSZ5w+hdUvPbXwS7zDpBI/NK3yvfqABb4molc+LYGMvoQ5Zj5yGTc8wteJvtKkxjxUGwC+SX6hPbp/ib1icNk7eGd0vslT+D547W++b2eXPrbPo74nOyG9Lzj4vbEg2jxkbMy+5I11PmdjfT1wvUK+Ns+mPhrtoj4QdA6/LGssvlHMu71tQDe+nu2GPuDWxr0NbKw+LEUSvY3eyjx7Xlm+8HAjPvzfQ740ezM+pXyCvBrTpb0rbpI9yeAePRB2ED5+30q/Vh65PVXt6r3t2IO+SKI6PqRvOL5bYpq+V830vbCf/r2Fw4o+y+Fkvrn5gz6M6dW90vrcPe2RU77b0y6+3ziGOiwUMz1zXBM+OS3DveD2272Bbj6+RZmkviG25b3lzpi+nus4vq378j0ev0Q+wUYSvk+LFb4bZpC+ZY/QPu3xDj0sQ0e+kpy7PnoPBr9+Wx4+j4Z7vrRy4L5FD7++UvxGPicqgz/rtcO9RP2RPmxCLj1Ol3G94YWUvjjwST5PkzO9jOqSPvVqiL7VSbO+x3WPPBUKxzt1bU8/pa25vYavm77AuAI/e3KhPRPYNb7qWaE9MWHDPnJU8b2W+pM+u81MvmHGST6ALdK9RqNbPlu60T5BtYw7NTosvUb/lzyuVaG+WaHKvrWwdb0Nyd+9OawdvR9Tlb3V3o6+2L9OPgiTEz7qnsy+vouaPmbENj5aDnS+PxRdvp9egr75PLG+ApefPBv7uT0iyuW+10bLvgOmJz5knCc+TCayPtRczD4+zOc8bXMWvskYob7uqYc+CAU7vhuzjL5gPVg92CSkuqa8ML6AnFW+bSYCPiucXD55o7e+C6wkPrZes74xTlY+KDq0PdiNKL5Lyyg+rQNaPibf4b0Dd9+9CD8WPcUJhT3UK/a+cTUQvoQURb51vnG+N+gYvu3nir4B86Q+Zq4BvZtuhz68MSg9evUTvyg6vb2sBce+c6J3PSIEib53SMQ9cNDmvpG/FT74/dM+jPjsPup+bb4Wp0m+YctcvqKGb76Qp8o+OIp0PpDRnr0d0fW9+tplPdKVrj1b95e+qepiPeOB1D60WJW9ELsevFGTBj2ZSeI9wdLhvX5oGD7W/Na+suS8PTT6wr1Rk0w+7C65vpdLJTsVJlI+TDotPl5vCz9A+LY+T8mxvEbI5L4j7Ce+qxfYvQyuHz6EKY+9lx2/PwvsoD5n78w+NOwvPph7lL7BovI+PUcTP5Troj0g/0U+em2LPhWD0z5ExKS9q+MfvAomKD+nrqq+1Ka1vd0Mr79BFWC9CeJXPV6EFD/kZjQ/5H9Ovi+uuL5eU1q+410xvkBFC77acfE9YiQTP0TBPb4fGjA+KRNMPggqKr037aQ+LSFqPlwXg748chQ+w2chvRu/ir6auQA9SzD4vJnf6D1YqLq+lvMVvlwgMj4vu4G+hWaAPnMopz7kTJ6+nayLvhTkAT6JTYc9fySZvrVwED/wUKi6M154PjuIhj64N5C+oOLJvXrcab64MBK+gBdhvqxfg74C9VM+BJp4vi4/BD0Pmdg91xCovuWEKz7P+CM+tKCEvQxcyj3IOKQ+q0+VvS8qV76oSxS+zPTOvSDWET3k3Sm+CqLUvq/uHj8TdxA/KJeGPr8gIL5KiWk9aY+DPvpYKD7IXpY9Ta3qvj25AL51GII+dvO8vkLkRT2n5pU+xM/iu+F3mD3rpVi9cOr/PataRT5b/va9+fF9PmpWNL5ID5C9WJ69vl2W/jt3Psm+lO30Olvcnj2WFqy+Lbk3vPgngL7P/ag+/6brPZQeUr4EifA99dguvk8cnb5Lsfk9RYrdvM+MpL5pWCk7J0krPg1FIj4ABOu8hqGGPeSD2L1eXqA+G/ylPvH9M77RxgM/7ryUvSBEmL1xTa++hmalvka00L72JbW+Lt9/vp7idr6C1Qy+zzzSvFANJL6xhz29KF6sPYMA4z5qVJu+5gYDPZiXXjzbYPC8pqYzPmckb75TVC6+0AGAPp6Lk71V7qk9M0Y5PqhOGr7QmSE9E2pDvi6crj0Oqt8+eTGWvoAnQT4nukw+D+zjulwj4T6ksRY9qIDrvnQizj6qKqI9S6aovqaIFr59vfC9HIQzvbBOBz4kxsM9+NIDPszqJDw33B4+Y89JPp/03jwlwUK+ujURveARYjzLaIw9eMb0vOQ4Gb4ihyW8SCllPecVBz++V5I5kd8JPROpzL0apkW+hyVNPbhbPL7BHr69RU21vqFlzr3k/nu+jgzivHtvLz5bLEA+Kxhdv0JeCb6M4qK9sdBIPiO8Gj7zhtc7QUOGvrZ9Ubx7O1g+Tsq1vUR/gb4+AlQ+ab6bPjGGtr0xxfW92mztPe7sbT31Pp293tpfPpYFjD60Joy+zJRrPioLlD7wAja9S1ODvhQrYL7n5U09KE8OP0ZX0LxoIME813mIPlw3Wr4u80e+Dh7GPR2+yr40WHG+i8ECv4iCoj4NvH69jkcpPvXGGT5HWgE84RXsvVMAz77w0BG94T5XvmfyOT6cJDo+ySQAvRdYqL4J6MQ+aGK5Pg/f873G6WU+9Y9iPhDyZLwjeN6+1clOvk6p9j15pVS+QuuMPNl7aT49cLi9l1jqPHplAD6a1Bk9qLsBu4r/Cz4xCfK+G9dGvg==" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 80fd5a84-4d82-49ab-ba78-9636f1989fca | TCGA-XF-A9SG | null | 23 | released | 1.82 | Yes | 1.37 | 7.1 | 81 | -29825 | null | hispanic or latino | male | not reported | Alive | 1925 | null | 29825 | null | N0 | Stage II | T2a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2834 | 0 | 660.0 | FD5739DB-DC2E-4291-ADBD-12C12EFCACCF | TCGA-XF-A9SG-01A-12 | 2.0 | 1.0 | 0.0 | 3.0 | 0.0 | 10.0 | 90.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SG; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.37; rna integrity number: 7.1; age at index: 81; days to birth: -29825; ethnicity: hispanic or latino; gender: male; race: not reported; vital status: Alive; year of birth: 1925; age at diagnosis: 29825; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1479.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2834; days to sample procurement: 0; initial weight: 660.0; portion submitter id: TCGA-XF-A9SG-01A-12; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | 1479.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | b838a4db-ef0a-4d88-a220-bf57e31e0b3c | TCGA-XF-A9SH | null | 23 | released | 1.88 | Yes | 1.5 | 7.5 | 65 | -24060 | 1971 | not hispanic or latino | female | asian | Dead | 1940 | 2010 | 24060 | null | N0 | Stage II | T2b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2005 | yes | Not Reported | false | Not Reported | 3256 | 0 | 200.0 | E84E385B-B56A-48AC-AD5B-EA7BE9E69CDE | TCGA-XF-A9SH-01A-11 | 2.0 | 1.0 | 0.0 | 4.0 | 0.0 | 15.0 | 85.0 | 85.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SH; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 7.5; age at index: 65; days to birth: -24060; days to death: 1971; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Dead; year of birth: 1940; year of death: 2010; age at diagnosis: 24060; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3256; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-XF-A9SH-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; | [
1024
] | "O1G0vhtUqT4T5G2+/JY1PWaaLz7KJt8+N8IdvkNtJj5OTvK91JUMvqDo2z5thv47GA4LPc95Wb7w1Ge+JnlSProUIr02E0k8MX4wvht2Yz7H7+i91w/3PgRXMz55xFW9BSmcvo9V770oM5k+nu2BPoWewT3x9pk9IoCyPWnjVT7NXY6+skWhvluSx7tAIuQ+czhzvgxwNb4xryQ+8UD+u7DFAT6uR5o+GEAWPsc/Wb6nw+G+Nh1HPexPhbxoRUS+QiNwPvoPEL6PRr29eXmkvc7vdb2HU5u+m++QPfw6ib1RF2C8OJGMvuDAyz6Fo0c/s5EcuwdTk7yWrvi9L1D8Pi8kH76D42o+cw2ivj0Ukb4J+HM+Qs5Gvv6aB74BOWI+pDGUPs+GlD5ikCC+M5PNvOH+lL3cKeM9O70Wvkg1ED4o5qQ9Y9wbvivrCj7ODSy+qx2CvnlekL6J/HW9BhbHviXJ3z6pjLC+IM8vPiT4lD7Mekw+pwYOPKGbOzuLFau9/1p4vKaiXL4etJ0+QbbGPZuX4z6h4rE7vFUqvV8m1Lz9XxI+K3LVvb35Jz17Wqm9s4RTvkPEG7469w8+b/LpPglwkjx4TAM9NG0ivdos5D0se0U+grZcvXF9+L4xdko9n4MVPnL+Lz/LpTe+TdSKvhssY7yqO0W+JY0CPyHdkT3HAQu/wvOBvc+ATb4aEo+++kttPcPrNz6XLJi+obuhPiKUeL+IU/+97FaNvjpwTj1Cy9U8JyjdPSTyBT7IwOk+jyauvLCz0D6eWp++z8lIvpxzjb66qHk+AyWQvhlHCz0Q2nQ9zcT7vqyD9LqsveO+EKq1Pk/w+LxBjNY8jGSqPv9bn7vcXna8PIWIPXLjxj29EKm+eaSxvDxUNj68pGe+9dQsPh+yD72k3EW+iWCGvuYkgD5ExFm85ciOPoi8ZL0z9gu+mbRMPb4GUL0r3/o+3CjFvS8VBz9XuqK+xv+HO/tkSr2Wt6K8Q3YWvnypN7+Gkdg89UutPeJ4Qr7hXXw+vY6jPhBmnr09aeU9HJCcvYdqDb61L6i91OoeuzzHDr73Vuu+/5b/vkvVCr6yV7W7j42cPvPtiT1CRbC+WLSVvaInIL7jCmC+v6vwvikwIT5kydw+6Vk1Pg5C/DwXGZO+G7jGvpV33T3rbmG+uMETPsYTHr/9pqM9Fydavtx/Kb6/tem7QbP7vasHt760ZgA/4XunPFyM9j1bjBy+ggKZvvCq3Tx6yqu+TuwfvhOlnr342a69uAlEPs5WYj73g6s9awmIPuztbb2kKma+x/8BvaW2UT1tp9k9UJWWvTiwtr55feQ9bTpBvB9g/T1QIfy87evKPiTdRL5HjLLAx72QvYvxFD/yUVs+BUlavnD/f77I+kK+R3hEPvLNLLzNUeK8gezJPZy5bb7/5NQ9k9BJuTP3sT2ntly+lM5ePqA4uT332Qm+C5eEvb9KQz5H5yw/0XNAvoRIST36bYc++QrevWSdDT2tVwI+HQXJvDOi2T2Mffs8eryRvod7C77W8Zi+E8TLvmv/nr1r0i+9KeMjvq8sKr0Zb9a9KI2APfattj5/xG4+SgBgPfE3zb2bE109ce+5PizpiD68abg+k2UaPpmmgD18VLU+ulbhvvwHT74+sxs+H5WfPeo/0j3pXke+SN2CPbjeoL4+aw49MidcvrxA+T0JXtI888aCvquavz5FMF2+IEwzvlZTTz4kH/s8lnP1PhTryL6LCQA+0XCEPlbglz51Mie+r0V9PtLJXr5H+8I97LKuPDv3hj4aCa49DB4CvidkVT5YKko9v5KdvQ2QHL9iepG+7uoLvgnTm743ctQ+5A9APo3J3b2X6zY9IlPUPpUkPz6NQfQ9rFGpPmtijT7mQ08+bFjNPpI4jD0FTbO+tRQCvPo4Cj0/UW4+I1Hhvbkhor6bORW9sVRMPUoAsb2I6qI+z4W5Pfhf7b1r5Cq+tA7JvQSwTD5izcW9JlqSPjLve76DFSC/7/r7vSUFoL7MnNo9RNwCv/AlUj6lu6e94FcwPm/GKT//VY++pBH1PHFuD7wMi/A+VHoavn9EKz4JUZA+TJ/zvetkdT7TODw+zWyJvpoyjD0uhAg+zkhEvlR3JL9Q2T89S6s5vKklZ7zXoqG9r14bvndJ5r6T05I+Rj6gPjPY7j1wA0k9V0xivtzmtz6QRGy+xcGHvTAtPL1HRNI7sIYKvnDz5z6j4+k8uKZKPnDoPT4J7Ug9+woOPmbCc75/bx47WNT5vlzpSj3uFDy/OF85PhRS2L4NXfQ+f0qNvu2Ppr3yIWy9HLEEvsDQtr7TD5q+5uVxPblk1L4o90c+lD9uvi0foLwW5vQ9zPCmPe2KEj5c5D29br2Tvu+xsT6OYKA/ji+LPCz+jb0E62m+9x4BvwZs0jvS0hM9x8K3PgRIqjy3m8O+kiGdvhH7zL2IRq0+NokNPuMMFD5wIw0+LTCBPSagjLzO7Lc9WTjmvta6Br7+L8e+jTLtPdEmRL4zz9o8lqVXvEcqFT4X9+o7cLhRvhujHL4tH7u9ytx9vWbClz4e1Yk+zRUhPmxZEz0uAkE+LI7Nvk6iAL1i3Wm+4zJ3PmM4k75eZ48+dvtVPpxhhD7wsng+PMjpPSYlfT49Y4Y+Qbluvc530D3+jha++nD+PKR/SD5r1i++EQqjPi9X7j3Dbby+qwLrPPsthD6C+5s92rsNPkF9r76WiGE9VvxPPlrP+r1/IL898bvRPftt4D17rqy982uKvcVV8z2A/l2+4rDXvHAIzbz7KLI9hejDvpoBIr74nwe+W3WNPMrSeD6r78K95+BbvU0cKL2uaZ0+PrmHPfRwR7wrwBM/CJ4Eviwh5L2PKVU+E1OKvqgOcj6VcFQ7BXGZvn7GKj3sURK+3Jn3Pa15tb0UzAo7IqxxvvFN+z6rBm2+RpqVPoSxqr5WYGy9Y4/6vcJWtDxDzMy+6raDPoC1jj3NfUe+tvC0PmfToz5c2wq/6QQlvkno072Xkj++r4yWPqVHub3VHsM+AgAnveXEQTzNdGC+x50zPoTxSL7slUM+MS5OPIBqnL3H9bo9h8SOPdGoDD6ww0S/bnblPeej6r1X5X++QPtGPhWPQb6RsZm+/QftvelZyL003JA+C9VgvhvKgj51OsS9GQT/PQajP77bbya+Sk6sPCXDUD2C/is+eOK4vXRIwb2KUE2+zYmpvj6fA74i/Jq+FIY6vsaNAj6nAzg+Q6X4vfR5Ir5JeI++HZDTPqKRTz38bzu+X+22PqNkCL8vXSE+Yvl4vuqe4759cLq+dZM/PklUgj/nBcC9lPaGPspCMj1JVEi91O+RvkvnPD6hvpG93dKOPl3mhb4dxbm+I0mpPAInQTwH3Vk/rnmuvX4rqL4X5AQ/fbiJPch6LL53KLc9p4LGPllcAb7FPZI+xDxLvueoSz4WhLa9EQhrPgBk1j4YC/U7W75mvf002DvFvaa+8x7TvovtZr2GrM+913NFvdLLgb2+IpS+fvE1Pv1sEz7kkc++6JytPo3mLz6K2me+LcRkvitShL4b1q++CjcZPNqAxz1aI/G+3G3Qvr7YKT7jKCs+NrC7PmBzxz49qTI9OwgIvtmNor5Ju3s+xcsvvhuWnb4KeJw99HQEvAUyNr5upFK+wR8RPk/9Tz5dKr2+wzcmPpVVvL6viHI+tXixPSufLb4GYC4+gBFfPtHUsb08ZNS9KXA0PUeQtj3HDvC+hiAUvgUyV77eNGy+1RYjvu6QhL6sk6U+CZAdvQxCez5IpiA980QVv3mB173vDse+FJUqPUMkir7borA90knivqCk5D0QstU+LzP1Pj9YW74T6De+jLh3vm3ycb6ovMI+eFGCPgPSar1Gnue9ITScPTgVtj2UX6O+RBGfPR5M2j7YssW9eSWgvD43aD0uE949e/n0vSQbGT693di+sx6nPTShrL1l9Do+qC+9vvE6FTwU8VQ+hF0+Phb7DD8mfcE+9TopvN9d6r4abDm+UDHovV8cHD7ka429hYbEPynJqj7zgc8+bR41PrbunL6vJuY+/x4ZP8d3oj3jYzI+ILSDPq0p0j4xP7+9muWtumezJj+vuai+8xvWvYHhtL/6XCq9aF3SPD3rFz/7tDg/yTFAvjy6wL7hSke+0ZIuvgjyA74RaNE9EUMNP4ZkQL78azA+mcg/PsT/qbxsPKg+e6RwPij1iL5mIBc+zuUkvZBRjr5YXa88Ez/4vAb32T2OKNS+z/A+vihrOT7mP4S+CBJzPnoftT5hPpe+rzCHvrjOCT5NQYw99KCivqi5FT97iS68YsdoPsRhgz6x3ZG+gobpvTWiY76dJzO+igBqvkv4i77w3lY+wUhxvgdjJT09cfo9OiipvtNfJj7AuS8+kSMxvRAjBT6kxbQ+msWkvXM3V74sARy+D5PbvffqFj2h7S6+/izbvszmHz+GxxM/7Z6NPoQ4DL4Kuz094q6APpOvOj4s2Zg9R3jxvmKHAb4mo4s+XRGuvsr7YT1Ivps+gUM+uph2oD0aY229BhXAPYKCOT7xufS9mZKKPsBHKr40LKW9Gka3vttecDyk/9y+f2EBvBYulD3Rore+okaYvOtucb7tt6Y+KALfPYAISb5TYMg9DX00vsLon76rifM9NR7cvFYXr74MW828eGI3PlImHj7jfa+8C4yEPWcP373AeKc+hFGpPmnyWr61PQc/yPWXvVJpkL1Korq+qL+XvvvF076aArS+MpWMvgQXcr591hW+/RZYvbPFG77Wbw+9VrChPaMh5D5vbqe+J5AaPUmgFz3TLQW9q6RAPv0hVL4hukC+aEN2PnKUl73c0cU9Oo4kPkCLBb6q9kA9SmlWvtnR4T3Pzug+2Z6PvrqIOT7740I+4juOPEyz2z5ka1I9v/f2vofixj6Ibbw9CFaivnWGHr5iRQi+VOVTvTipCT6lV9U94eMCPldNZjwBTB8+s3c+PhctNz02E0W+D5j1vLYa8DwirI09+KO+vEZdI75n8Be8GxoEPfxsDD8CIH489iRzPGBm0r21I0m+rbW3PLFWNb6APsq9OCC0vuw55r2GdWm+vlESvb+9OD4Esjg+PH9dvzm9EL6sDcK9O95DPjSXAj58diq8kaGRvml0Fb1rSlQ+Aj6QvW1qbr5ka0Y+Qu6iPrip271S9e29p5TQPZumoT1474m9HRVgPvwShD5PpZG+SilwPo5Uij5K6Ve9pM6BvrhzYL7hQVg9u30NP3ztT7wNjdY8fYiPPuO+Vr5eI0O+ut3UPYQ1xb7Ie4S+kaH6vmLSqD7O5lq9G38gPmV4Cz6lOx48Vmn9vZd9z756CQi96Nx6vrduND7Bhzk+mP5BvTXvrL5dw8c+cLy8PrhMBr4IiHQ+CxFlPl1chbywfNW+VJtdvsfd3z31+m6+3hyJPAW3dT7jM6u9h9pdPeKOBD4cfEE9OkeXvKrKCT7TsOy+ZgpAvg==" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 6b0c8e8d-8aba-413d-85ed-631653f00ca9 | TCGA-XF-A9SI | null | 23 | released | 1.87 | Yes | 1.67 | 8.8 | 73 | -26719 | null | not hispanic or latino | female | asian | Alive | 1933 | null | 26719 | null | N0 | Stage II | T2b | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2855 | 0 | 950.0 | BB424BA5-5E43-410B-B27C-EFBBDE18DA00 | TCGA-XF-A9SI-01A-11 | 2.0 | 1.0 | 0.0 | 4.0 | 0.0 | 20.0 | 80.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SI; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 8.8; age at index: 73; days to birth: -26719; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1933; age at diagnosis: 26719; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2423.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2855; days to sample procurement: 0; initial weight: 950.0; portion submitter id: TCGA-XF-A9SI-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; | [
1024
] | "OfSrvkkttT50NGC+uDX0PCsgMT6Tdt4+vL8OvoNrPD6qYva9gucAvict2D656/w52w0HPYaNSr6F31m+JrJfPgNMBb0g+p48sNNDvlsjXz5Z8AW+69b/PqcCLD4OYlG9cVqpvk/I6r2sHZ4+Zx99PuEZzj3N4I89P7+kPcgLWD69voa+oKacvvUvyLzZA+A+joBsvlaQPr5mBxo+JTT/uXsFBD7OVaI+7C8DPig6Wb4LBui+P/lZPdnp1TqsP0O+DNBfPo8s/r2zLq+9+4aivUlnmb3ckZy+jqZ/PW9Cr70ov6e8YimOvlbD1T5o/UU/4a3qOnJf6LtS7gi+2nP6PjWhHr4LlYQ+W/mcvsVan77Us4I+xFtIvrdf9L1IlW4+LcuJPhazjz4DVC6+oh1OvHKec72ITOM9DIQgvkKK5z1aqZ09UdwevsukAz4T5Bi+DvCIvpORjL6YdE29a1LGvs1p2j5uwq6+jzonPmBvjT4NiE4+xwLAOjqTgTsgx7u9kn5KvGH+Tb6GDKE+ycnDPZMk5D6MmmY8IZplvYZpeLz7Ixk+pYThvcCIjz1IXs+969RfvuzSKb5IIP89kz7hPoogLjzw0i89L/xJvfBO6T0lQj0+IZsivdwW+74yCkY9HBwgPi2cKz9Zhjm+/iOGvqVOo7zSyUC+pdUBP4miUz1UmQe/LyORvRd1Tr6NLIC+qlOCPfSlJj4s7Za+BmKqPj0lfL9vhvq9KRuRvh8tIT26Zus8C8TaPYbl+D26/eg+9GTIvDMayj5nMqC+8FZWvmfgjL79AnY+nB6LvuF6Pj0pr3E9PGP1vkOEZrxA8OO+XbixPpGhcbzyQZ48r/yfPh9WGLsh9oK61pejPfDluT1d1aS+5BtzOii+Sj7kSWu+NGYpPlzP5Lwxcja+IYCKvgWpgT6XAAu9KWyTPpiyHL2E/PW9D4FcPUZUob10Nvs++73/vXwWCj/tFpq+sghKPGUzTb2E5y69TjkMvv3ONr/b38U8yo2/PaVHRb4ni3o+FIGhPpIegb07pOY9OOKnvfjc7r2ZdI29SHllu+iaDb7Kjui+SOX8vhdaCr6w8O07zH6gPjKsVD2aka++gAqxvT/ZML6UXmS+SPP1vmCsHT7Sj9g+c/U5PodLUT17PZm+MzHSvqrHtz3IuE6+56AaPkE0HL95D5k9jxM9vhZgO77Mb3W6eGgNvkYDuL44DAE/hqjJPPfz6z2JUgy+JguQvnnFlzzvt7K+oRoTvhC5qL0v/9O9dKg+PnH5Wz5aS389LDWCPkZUFL1t8me+/zXmvN6XQz3lBNU9ifCHva3nq74hswQ+cSE0OyUE3T0sdCW9JwzLPjDVQ76QxLLAf/Znva7+DD8trFc+hs5Wvt4hZ750+Dy+PSFFPl18nbwvcfe8+HCfPeZ3Z76P7q49JvuOt3PeoD3pJFe+kv5oPrEarz1BnQa+qU11vS1sST6/JS8/6bU7vqs0Hz3jk4M+fzvSvW3vWDxrdwM+3A2ZvGjV3T2zzNI7+tSZvjEbHL5BiJi+FUHIvoHQuL2ydAq9+24yvngGhryUP7a9H7JNPVcurT5Bjmk+plAFPfDKxr0jabA81smwPvXTkz4B2rQ+kJAePsoKnj10CrY+f1vgvg2jSb7u0hI+0k3EPb97+D2IEEO+qeaYPYS5l77oGzc94ENivuBL7D2upuI8bceCvmStxz5/IGK+OFtIvjHsTz4nfJM8uEzwPpTzyb5/E/A97liJPhdLkT42hxa+IWJyPhdQTL74ytI9FEIuPSFPiz7lcLk9P+j1vbEZQj7jNbQ9LEqzvYGfE7/7ZZa+1dolvq5Gmb4xj9I++otLPjTj673w5Qw9NvzGPmtOTz4foOs9kxOePtKaiz6s+EY+RIzNPnkAnT3XN7q+WS5Huu+vOT1ID3Q+RsnRvac+k76LQKa8cX5uPRu3lr1io6U+x1+1PcRXAb6Nnxu+OczHvRbVSz64wqq9RO+PPiLscb7OVhy/Vhv3vRRWkb7lbdY9ydoCv33YNT79DZC9HlwpPnkWJj+z94i+sxUvPUy5rLzbE/A+W6EGvnZHMj4gqJQ+e48EviBEbD4XM1A+d6iNvv3loT0rtwo+03xFvoEkJr8EMCE9dCFLvFaV+bv8r7W9/5UNvu8Y376nVZU+DoyaPlsA2D0P2oA9lCxivmARuD76vG++wRIivT3OSb05aAK8dWH7vZ0f7T57dB89X61PPq5INj67v0U9XEgWPpjyar6nOU87S7ACv+1umz3fDTy/uOVAPmYe1L7MVvc+Qp+Wvsi0mb03ojq9F/MQvkkAur7wbpC+I3SEPUsHzL6jtjw+AplovhDF4byR3a899FFFPX/A+T0QmIa9vQ+hvpKesD58HZ8/TBkvPOjib72kfGa+kPD3vsQXijtkkXU9V22uPsjEtzx9lMu+D6WWviX01L18IrE+FVsBPpzJFT7ETzU+hSuJPTh/trtCu9o9RHfkvhFXFL42qMC+wqjbPfQgQL4qqPU86APXvEoaDT5VVau7V0pVvk0kF75mTrC9oitfvb1ilj6dhYs+LuUYPvtEBj25ODA+AkfQvhd767wiM2++qMNqPiZGj77bm4c+QOJbPn4niD5w92I+r5z8PRURiT5iuoU+K6tEveYX4j1XxPm9IvyDPYJXPj5QZCG+NTCbPmLlAD7hsr2+5uckPf5ndz6ZTUs9q7nzPfvusb5uvAw9hcVYPo0pCb5zAac9P7inPYWQ9z0nScK9JbQ9vXm86D33pGq+eE0EvWyxBr3FpKU9PPPBvvvmIr5VPBi+dhvGPJeQXT6pmva9xjy1vMxA9LxALpk+b7RhPfHzK7wUiRU/suUAvu5o7L2KrlY+cQWMvtXPdj7IDIK7WOGdviwFMz2G+v29S0YDPvAFuL1x1sS7gVB+vvg89z6vjHO+xYyWPkjCqr4Hr4G94NcFvtowpzxgg8e+6EtjPvssJz0lMWe+FO6lPldvpz7ppQ2/gPY3vrHp0L37njG+Wb2bPqG4uL3NqbE+Y2j1vIKHjDzJ+1O+wyI1PrrVM76eMEU+NmarvNQcnL2pObU9sxdSPfVa6z3+9Ei/GYLNPUhovL1cnoG+BARLPgYkMb4oy5O+VVXMvUrd4b3trow+5Jdivn1Dhj7LFN29pZniPaxiPb4G6BC+oGgEOyHaeD3C6CY+zq7EvSFjxL3o6je+VWOmvo8g572gp5W+JKEpvo5rBj4/Pjo+4kvRvcobJb7hRI6+0r7OPlVh0zwzXi++CD2+PnidB7+PByE+QEuAvpoN2r4pBby+8r07Pi0vgz/grLm91EWLPuq/gj0RgIK9CmuJvgrgPD7ZDFG9hLCHPrPIfb4yMbi+i0PCPKBByjyzVlQ/363EvZzInb4PrP0+gXahPcuIKb6eRpQ9E2bJPgLlBL6GxJQ+GulXvv3CNT4yrJu9qb5nPrIH3T7bH/Q7RFMPvSAxFrwbYp2+vULMvsp4XL1lo+C9N3YivWK6nb0yAY6+bDE9Pr3uCj51lMi+myapPvfSJD6MS16+Ujlivp/zdr4wybK+msQiPGNXvT2AC+m+a9rRvv+9ND471x4+2D24Po8mvz723RM9HeH1vfPJor4cqHM+YyccvlAVm74zq4A9grwXPIEPQ77n3Fq+aSoUPvuyZD5pi7G+HmQgPg+Msr7BV2w+XEuUPeIUAr6xZzk+bfdkPrdJzL2Fo8e9ZwRVPbZumD2Ji+u+xBD1vfhtQr7fXWW+cyQmvnpbg77utqs+5cj5vFeVgj4iKy89UjEVvxNHwL0747++xmIMPUmRjb4DSsQ9XLPnvrHw1D1XLtg+YBbqPrZoaL5FlDa+sbJ+vnX5gL6Uq8Y+g012PoUGjL1U5OS9Zv2MPftttj0466C+MUOrPU7t2j6v4Me9Q59ovMyORD3LvN09Jkf1vT+cDj5xdd++GCyhPY8Wsb0A1Dc+jVW4vnkwnDyMNEs+ZoMjPk9JCD8AXKk+jQbOvM6D+r5lSC++iEv1vWODHD6c/Fm9hA3DP5linD4lCdc+p5VAPqSUjr4aGO8+WOcTP83doj3cVRc+aQGKPnu01j4BVam9KdxtPEfRJj+5Squ+vpy0vQhdtL/pzf68F85LPc8SFj938Dg/gpk4vrwPw74gBlG+fg0tvpbDF77GBLY9tSUOPwVtNr46CUo+HEA2Pn+fHr2VWKc+aFt4PsVRg75+Ygc+n8NivTP/hL51LQw92gUJvTte9T320M2+SdcqvpnIOT5E2nS+/UJ9PoS0tD5gZZi+06KJvt/V9j2jF6c9zZWivkhWFT+SY+C7AQhtPvDigD6oxJq+uNrSvX+PXL5UkBK+yiNcvoGBhb5MJ1A+OQKIvgW26Tzgmfc9ORqpvgoHMD49wB4+SVQ5vX6O4j0vkK4+D29svfniTL5CCx++qafBvQCGTD3hvS++HzTgvpCxHT9+hRA/mJiLPqDLIr7puJQ9rgmCPhD7Mj5V74U9l1T0vsQS6b1htIQ+mjmxvkYRPD2dUKU+fruavFzVkD3KxnG92MGsPe1DKj5aFdy9BN+CPqBZSr5C8Zy91lW1vpeIjzoUgcy+cqwLvKMQcj2nxba+F6NgvITfb75PHqw+gNbjPSZ3W77KOeE9PlslvtLTi74xJBU+1E8ZvRqErL5dZl88+zVEPgMKKj6ZzUS8BReBPcCv8L14/qI+SHSoPlldSr7KSAU/sq+tvQ/Axb3UT7m+swagvlwhzr635LS+JUSHvktPdb7CtAy+vqNXvdgHMb4fs9+8hhi4PQcz2j5e66i+z1AYPZsUjjw+Vfe89bItPpZIVL4NJSq+H0B9Pq+BiL3soZ09LkUlPlfkCb5ay009zzg+vvD9xj0EYN8+OoyXvtlKRz7pQ04+DL0ePNIq4z6FEeg83Y78vngUyD7UOZg9d5GgvjMqLL5OaAm+amxkvRboAD4r08U9bVAMPmaFIj2wOxg+LVhLPhpaGz1p60K+QK62vO8XZz1VAJE9TRysvGumI754X7+8NtjiPLtOBT+gCFw7pDD9un7O9b3fHjy+FAkfPZthI75WoNy9C6q2vk2k3L1LZHa+p/EUvQUiPj6S/0U+dx1cvxPCFb44HMm9zmJPPtZx7T14PI+89R+RvrvtnbwrGkI+Nb2FvTP3cL66GVA+3MSvPjNO173ce+69maLbPYbTnz0r5oi9rAxhPkI8ij4kRZW+lIdnPiu9iT75hla9KzuKvt73Yb6j5UU9XIcOPz4fFLpNfFE85TaQPvXLUL5z00O+D2PkPSfg0b5QJGm+wZEDv5gKsD6q26G9bu8RPuVhEj6IAUM84lkEvvU90L4WyTq9VOB1vgY3ND5zyTg+ENJTvXdoqb6Mj8I+sLWrPjwD/r2lP2c+RJdqPkwzQryHvsy+c+5Kvr0W7T0XLl++So0iPMJIiT7aVJG9PyIKPYbtuz03qDA96T7jvE+dBT4wxfi+my9Jvg==" | null | 2423.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | b319798a-3f35-4902-8ecf-5be529d99312 | TCGA-XF-A9SJ | null | 23 | released | 1.9 | Yes | 1.6 | 7.0 | 83 | -30362 | 98 | not hispanic or latino | male | white | Dead | 1921 | 2004 | 30362 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2004 | no | Not Reported | false | Not Reported | 3298 | 0 | 510.0 | 0093D096-4A35-4543-9FDB-838AE59F0833 | TCGA-XF-A9SJ-01A-11 | 3.0 | 1.0 | 0.0 | 5.0 | 0.0 | 25.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SJ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 7.0; age at index: 83; days to birth: -30362; days to death: 98; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1921; year of death: 2004; age at diagnosis: 30362; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.0136986301369864; pack years smoked: 55.0; is ffpe: false; composition: Not Reported; days to collection: 3298; days to sample procurement: 0; initial weight: 510.0; portion submitter id: TCGA-XF-A9SJ-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 3.0136986301369864 | 55.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 03f588d6-832e-47d8-a9c4-af6640a1a635 | TCGA-XF-A9SK | null | 23 | released | 1.89 | Yes | 1.26 | 8.0 | 65 | -24019 | 486 | not hispanic or latino | male | white | Dead | 1939 | 2005 | 24019 | null | N1 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2004 | null | Not Reported | false | Not Reported | 3598 | 0 | 470.0 | 473BCE6C-7925-4E58-9257-B94046C707AC | TCGA-XF-A9SK-01A-11 | 4.0 | 1.0 | 0.0 | 5.0 | 0.0 | 30.0 | 70.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SK; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.26; rna integrity number: 8.0; age at index: 65; days to birth: -24019; days to death: 486; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1939; year of death: 2005; age at diagnosis: 24019; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to collection: 3598; days to sample procurement: 0; initial weight: 470.0; portion submitter id: TCGA-XF-A9SK-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.643835616438356 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 51fdb034-5d05-427b-b6b8-b6eecd65d976 | TCGA-XF-A9SL | null | 23 | released | 1.84 | Yes | 1.43 | 7.9 | 69 | -25460 | 2020 | not hispanic or latino | male | white | Dead | 1935 | 2009 | 25460 | null | N2 | Stage IV | T3a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2004 | no | Not Reported | false | Not Reported | 3423 | 0 | 650.0 | D8FA25D2-8119-47BA-8ECD-A2EA6E56E7B3 | TCGA-XF-A9SL-01A-11 | 10.0 | 2.0 | 0.0 | 5.0 | 0.0 | 40.0 | 60.0 | 60.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SL; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.43; rna integrity number: 7.9; age at index: 69; days to birth: -25460; days to death: 2020; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1935; year of death: 2009; age at diagnosis: 25460; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.0136986301369864; pack years smoked: 55.0; is ffpe: false; composition: Not Reported; days to collection: 3423; days to sample procurement: 0; initial weight: 650.0; portion submitter id: TCGA-XF-A9SL-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; | [
1024
] | "ac64vh0hrD4dFkC+v2gdPSkkKD53Rtc+JmUivhG4Mj7VNNm9gxsXvnRZyD6jM/c86HIdPQHjQ74XpFW+8b9KPhS5XL32ny09nowkvrjbYT5soAm+mmTpPgA2Oz5d/JG9GquRvs72sb3iPIs+n4SCPobesz0BGZI9QoPzPcROMD7pE5C+I+eXvjj6IDqHTtc+VOp/vgBWL74e+hs+h4uEPL6J6D39i5w+kefyPd4Ke77/n9u+v5WpPfNuB7st/EK+qkJuPhw1DL6BMdy9of3QvRhtkr0h5KK+hTmIPbSIZ70kNeO8U/qAvnmwxT5T6T4/I+eau/7hEb2d8fG9FfftPpA6Ib6D9Wg+UE6avmDbjr7lnoU+Lqs0vg8JEL4qhGo+e/6CPkEVjT5wzCK+rgE0PO0md72QuZg9eAwqvisCBT4GBNE9f2kCvuGBAT6GcB6+6sCCvgtglL7iiUC93GG7vg0t0j5tSbO++9QuPu8ImD62aDc+ZS7fvBsWBrqprLi9lHCfvJVeQb4Ggpk+TBzuPS/v2j5ETsw8DhaEvYn0CLxpMwc+lEHhvT8Ujz22ncK9xIFTvrCEDr75qgU+cf3ZPmIlXzx11Yo95k4KvSezqD0XwS0+roEyvSW7476TpjA90OAYPjP6KD9iWTC+hESKvoFBfjxqCES++1L+PgDOij0kQAe/QO9AvRA+Lr50o4i+oeYoPX1FKT5614q+1RuUPij1dr96OBe+zFqIvs5OLj2P+dk8zPrePeBb5z0EPNE+vqVCvEpVzD4DMYm+ghI2vnd+kr5ep44+Qq+Evpo9Tj0h8mw9jqz1vr9k67tQe+K+C1GuPjIjBr09beo8NaKoProe27v7bN+5ZRy7PaOh/z0XGaW+H6p5vEXSIj4KgUi+0ZUdPsoJLL3cSSi+ToyLviWrgz6rNWO87eh+Poj0C72oKge+uFlmPWMacb2+qwE/T3bCvRCPDD8iBZi+8tPGPEdUOL363Fi8T0EcvuP0Mb/ftxA941O2PXNqL75/AYc+NrKsPrUKsL1vbqQ9Fd2UvVwVGr7l56W9LvSCvC1lBb4Astq+I1H0vgACKL4Fu/Q6uX+lPv8WmD0xCKu+IzWfvdz5Ir6fjly+oOTqvkwXAj6Satc+S1NFPl5exTzpy42+oQXAvk8Nuj1l6FC+4u8NPhDuFL+Ty5g9x2ZJvvICDL4gecS8c7sGvsqBtb6TPAM/9exyPOFOBT5MFgi+y6eGvkPvaTxvFLC+w4sSvvLvrb3s66G94tI6PsOsTD5EgKA9Y4SGPqRmEL0fFm++R9AhvSejfz00D/09yxiXvSFKrr7dROA9MIYCPdF53z0VOJC8PkG5PimMU75+L7TA/x+FvS7pDD9PtUY+r+NZvv3Jib5wqjC+sN0gPh+RbrwdaxG9h6muPSp5Wb73T7091v/Qu0erwj0XvF++oyFhPgAItz2gngq+Pn6XvcwbPT6bLSM/uKNHvpwyFzxkD3Y+6hrcvbdkOD37oOM9iRfqu9di8j1i0go9jgaQvrVG/b1dqJi+GYDKvsM4Lr0moRW9skQqvvzLnL3S4Z+92qtnPfL1pz7l42w+xCpSPa6T0r3GuTQ9AHm2PhtUjj6Zcaw+dNwcPt3/pD0GQL8+lKXIvsY3Lb4Gvvk9NOeCPYM8BD7cai6+w8iQPeoRmL5ABCk91GlNvvUo2T0rmLI8GjV/vmRcxj5dTEq+yMVBvuSEKj4z1sI8OpbzPoImwb53ZQc+YBGQPnXxlD7OBCq+ez49Pv30Wr6Xq5I9u7bHPIIRjT5NhKw9zJf/vbtzZT7CP7s9iT6jvblvHL8WCo2+njwbvtXfk77zX9s+q1NEPhcG4b0iU/k8dRDVPqAWTT5EJOI9+hujPvYbhD5OJDk+wOi9PnxTZj3NB7i+SCImPNFx4jo4SGE+1MWxvRinjr5v3MW8vR03PXdJ5r3OgJ4+k5OuPUDNyr3weTi+eFizvd2qQz6GPOi9b56QPv/eXr7Zwxy/9AndvTB/kL42FdA9H3D9vus9VD6tZq69pH4XPmmiLD+Vo4m+E1AJPcOgubyR1/A+Ro4UvsFNGD4/95I+Sdnzvas3gj4oNzQ+QO6Kvl0qZT32ngU+xicjvoVEJr+hxUc9DwFbO6D2+Ls/N5a9bygSvn4D375DI4o+Mb6hPi/X9z0DDEo9g6ZsvhsQrj4TM2S+urIOvTmxCL0kJEY9oXkNvgr25z6fwg49bBFXPmBNJD4DqYs9S4/7PW7xZL53TOC49jUBv5CCPD1gKDS/iJBBPlln0L7rs/I+K7h2vhWewL0RGzG9Rz3xvaKbsL4fhY++VXqTPdSU0b6rXkU+eV5ovqgv6LwafbU9zcHBPcFF+j0C6Tq9sDOOvm61qj467pw/8UqePL0jvL1acni+BZP9vtiSIbvrcfo8ZEyoPpa7mjzPCcG+D7OnvrKJ971QTKs+0lDtPZzJGD5U3wI+4sdePdCWnryGX4Q9I+fivsTzEL4xGsS+ZEn0PU+1O74yxIw8/MUHvWnjCj4Mxoo8U3AyvsAGIr5AYdm9CuS+vALRlj75NJE+kKgTPtLLST1i3i8+q0DBvgySnLwm33a+jKhrPuKEhr4VCnw+iMBRPuxsiT4aaXY+wUDyPfapbj6fkYA+fpn/vPqM7z3wNxC+dZY9PZAAQj5Ney++Y5+YPnTzBT5GYLy+2njLPFKFhD4255w9gzD3PYzQq74nuTk9roBbPqEx6r2rWpE9lh7PPd6wsD3wy+C9YQO2vQQw5D0m01q+lEEcvToIZTs/n7s9yhq9vj4qOb5wQh6+aWPAPKAWiD6mIci98pdQvYFJZb38laA+1FyQPaba8bysoxA/+l0YvlY+2r3koE8+LwyJvkBuYD4LpcO76BuIvoeXjzwAYOa9ccSlPV0q371/zx28ps9yvnzj9D6+2Xe+UiKMPgP1p75wEZq9Kiz/vf+mmjzMJsS+G41iPk0PGT08OEu+2emrPqZkmz6YjAm/9gswvlbK1b2X2ja+jM6KPk2tur1Pbas+SIQbvTKdYTzCf06+rk0lPvvoQ75xGTA+h9OFvJ6DQL3Iqbo9AJcEPTm1Iz6hQEe/k/ebPUjI7b1hwH2+xyw4Ph3QR74vGKC+WcC9veiq3b3+U4E+B01gvmVpgT4d+Ny987HsPVm3Vr7kth++rA3OOzl5RD3Ghx4+LZSavb/O2r0LBTy+1dOcvnkC4L0eYZ6+FpVCvkh10D3MOkA+/jEIvqzdE768BIy+j+/EPjLyVT0ItjW+aN2xPrArBb8PhQg+b5xzvnSw3r4DIbe+wDlBPjZ3hD8x1LS9cBCUPh1yOz3fD4+9C7GNvpSqUD5Meku9WaWQPgYVhb6Pvay+arkGPAD+jzzsEkw/yKvqvUAopr5Oc/4+Pd+tPXcHGb7y4qE9B2u8PrJLs70wtYg+fGk3vimOUz4LktG9UTdePq/2xz65kI28I+L/vLzRmDu6naq+n9+7vvjDnr1jZrm9X3BcvSwBYb1oUoq+uoA+Pp83Hj67xMy+0dmaPpbaRT6Tr3e+4r5LvoSwi76KuKa+JvdEPEdt0z19H+W+7bfJvvotPT7kXCA+zQrCPshbyD7+pUw93m8Tvua0nb4QcJE+QcE0vrbqlL7siaU93LK9umnsI77etG2+m1cKPpN8Lj4RbrC+j4MqPi3DsL4NQEk+UrLFPS0uG766bRo+KrlPPhUm3r10BfS9MKwFPfi38j0H++m+tPEGvsTtZb5LVna+jHMOvrROi77bF5s+7X0Hvd7NgD5lizs9/s0Sv2BqlL3HULe+niqBPRnti755Lqw9eyHcvkBO7D3ZitI+1FzmPqdgWL4+IEm+bLVevoqbXr69ncI+MOZrPhVlcb1EkOy9VoGDPV1w9j0Tbpq+LKV9PS2A2j5255G9H2ifun3cVD17RtI9ajn2vZcgBz79PdC+phnePdq8tr17bkE+Dzm7vgxSdzyds0E+FNNCPunUAj8/yck+nq4ivS/g6b6RFTW+cUbvvT9lHD6LVMi9MXTAP7rdqD5e5co+fWgqPtWbi74R1vA+wxIQP3vUsz1AbiA+8nWDPtIh0j6Jr7u99CuWuSjzJT/cLKu+QYDKvTKIqr/1Rlu9TttRPTwmGD8xyzE/X+hdvuPIsL5Gc06+X3MSvn14/L35/u89UNkTP7TzKr6Bskc+p0g6Pmf3n7zXcZg+6jt3PgCMhb6clhM+4iRNvR1Ieb4iXts8+9gwvUVF3j3i0r2+1hAXvptDKT6QAXa+03KFPu2rqz56Hpm+4TGIvhwP+j1mJpQ9+bKdvm2uDz95DA+8kl5rPsz3gD5tLY6+mXHXvV5MWL6KGA2+SW5mvk6aer4qS2I+8LN5vuJeCz1GrsM9dYabvreCLz47lhU+ua5Svfw5uz2qG5s+Wc1fve9QYL68wxa++CzrvfTBdT1grxu+6mLJvrvUGz+r+gI/AwSOPv+5Dr7KAmM92AmAPv/8Dz5wE5M9bhDnvumH873fong+C8G4vndKeT3n+Yk+OVPOO8ujhT2CApO96+WvPcdCQD4n8+u9ePZ3PsgUK74ISrW9xfq3vlowizwTWMe+IPG+vO8sjj3ssLe+9zXLuykibr6XcZg+Qo70PU+jRL7L4Hc9REsqvloomb6ml/w9RbGnvDDNpb41ttK8QmwhPuVTID6+dRq9Oq0wPRoUsr0D0ac+eSmwPhXyNr5cVgI/LbWwvU8Rrr2/Hqy+1RGgvvRBzr4iCbe+6O18vmj3br5YzNG9TPpCvT/5GL4cela9DPKgPYP35j4zVZ2+bQDSPAsYGj15/QG9Bq06PszSa75g5zq+HZJ1PurMnL1j2Ik9EX0yPnsjGb5Gcms9PEJmvlg6qT3zQeA+bBqOvt84LT5WBC0+4WE/vAWx2j6ubzk9yL3zvpnzyz5BF6A9o+WjvjyIHr7+U7G9RMIvvfBhGD7CR7c93RkQPtLn1zu3KSA+dHVAPnUe+jwb4EK+k/nLuoYkCjza0oU9kkkCvYfzLb4h0sy7lClOPbU2CD8zYP06MWBrPCfUtL0anze+Rw1LPSkiS77957+904uvvjVO2b1n7Xq++cM8vXE+Ez5c8DA+BTFXv0nZ7b3mTca9sqNZPgnUET5kycU7jNyGvqfuLrwAQEo+aVjCvfMOfb41kGk+3CCPPv+Wwr1/5ti9+nS2PY3ZeT1F35y9nDJVPtstjj4Hp5C+EaljPsfwgz5DxVu9/JGHvqaXYL6BCXE9o3MKP4Trnbyv4h49fEqDPtwUSL5lcUC+RW/WPVrGyb7dMnC+X1sDv3Gasj4QUQG9QKIsPmPIFj4P0V67Tl/IvYn32L4PJ8W80wJWvu9iJj7Hejg+uwqFvKQVnL7r2L8+rD+vPh0i1L1zRWE+z3xQPlxtyryOCdu+KzR3vlduAj7/4GG+Dzp2PEiZXj4mFby9GDgWPS5f1T0CUGI9Fp2zvGuW3j3OvOa+0DhPvg==" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 3.0136986301369864 | 55.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | b027f4e2-f260-4d60-a1f4-444bc49c4a0b | TCGA-XF-A9SM | null | 23 | released | 1.89 | Yes | 1.64 | 8.3 | 76 | -27826 | null | not hispanic or latino | male | white | Alive | 1928 | null | 27826 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2004 | no | Not Reported | false | Not Reported | 3364 | 0 | 710.0 | 77D2B628-13A0-486E-866E-C10DDF141B2B | TCGA-XF-A9SM-01A-11 | 4.0 | 1.0 | 0.0 | 4.0 | 0.0 | 25.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.64; rna integrity number: 8.3; age at index: 76; days to birth: -27826; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1928; age at diagnosis: 27826; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1048.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.6575342465753424; pack years smoked: 12.0; is ffpe: false; composition: Not Reported; days to collection: 3364; days to sample procurement: 0; initial weight: 710.0; portion submitter id: TCGA-XF-A9SM-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 1048.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 0.6575342465753424 | 12.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 76388364-eb01-4b16-a2b9-0b6c05b4b386 | TCGA-XF-A9SP | null | 23 | released | 1.86 | Yes | 1.28 | 7.5 | 59 | -21776 | 454 | not hispanic or latino | male | white | Dead | 1945 | 2005 | 21776 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2004 | no | Not Reported | false | Not Reported | 3382 | 0 | 430.0 | E5DD1503-9CED-449F-8312-3BD96D9ED951 | TCGA-XF-A9SP-01A-11 | 2.0 | 1.0 | 0.0 | 6.0 | 0.0 | 30.0 | 70.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SP; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.28; rna integrity number: 7.5; age at index: 59; days to birth: -21776; days to death: 454; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1945; year of death: 2005; age at diagnosis: 21776; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.6164383561643834; pack years smoked: 66.0; is ffpe: false; composition: Not Reported; days to collection: 3382; days to sample procurement: 0; initial weight: 430.0; portion submitter id: TCGA-XF-A9SP-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 6.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 3.6164383561643834 | 66.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 33708951-0a0d-4ad0-b472-23151c9f76f6 | TCGA-XF-A9ST | null | 23 | released | 1.89 | Yes | 1.88 | 8.7 | 68 | -25080 | 128 | not hispanic or latino | male | white | Dead | 1937 | 2005 | 25080 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2005 | no | Not Reported | false | Not Reported | 2992 | 0 | 900.0 | DD442B47-AE60-4492-AE4A-0BCD1AC15A0C | TCGA-XF-A9ST-01A-11 | 2.0 | 1.0 | 0.0 | 4.0 | 0.0 | 25.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9ST; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.88; rna integrity number: 8.7; age at index: 68; days to birth: -25080; days to death: 128; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1937; year of death: 2005; age at diagnosis: 25080; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.287671232876712; pack years smoked: 60.0; is ffpe: false; composition: Not Reported; days to collection: 2992; days to sample procurement: 0; initial weight: 900.0; portion submitter id: TCGA-XF-A9ST-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 3.287671232876712 | 60.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 42bcf1a7-2f3a-4ed8-a41d-cdd67e65b928 | TCGA-XF-A9SU | null | 23 | released | 1.86 | Yes | 1.7 | 7.1 | 74 | -27068 | 182 | not hispanic or latino | female | white | Dead | 1932 | 2006 | 27068 | null | N1 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | yes | Not Reported | false | Not Reported | 2887 | 0 | 860.0 | B2C3CDC0-DC42-4971-9203-30B712F89553 | TCGA-XF-A9SU-01A-31 | 2.0 | 1.0 | 0.0 | 5.0 | 0.0 | 30.0 | 70.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SU; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 7.1; age at index: 74; days to birth: -27068; days to death: 182; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1932; year of death: 2006; age at diagnosis: 27068; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to collection: 2887; days to sample procurement: 0; initial weight: 860.0; portion submitter id: TCGA-XF-A9SU-01A-31; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.643835616438356 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | cdfd86db-15e2-4d38-a717-2207e8de2d8f | TCGA-XF-A9SV | null | 23 | released | 1.83 | Yes | 1.94 | 8.2 | 82 | -30265 | 388 | not hispanic or latino | male | white | Dead | 1924 | 2007 | 30265 | null | N2 | Stage IV | T4a | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2006 | null | Not Reported | false | Not Reported | 2848 | 0 | 740.0 | 5C45E09E-9B8A-4CD4-92CC-873CF78D2524 | TCGA-XF-A9SV-01A-21 | 3.0 | 1.0 | 2.0 | 5.0 | 0.0 | 28.0 | 70.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SV; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.94; rna integrity number: 8.2; age at index: 82; days to birth: -30265; days to death: 388; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1924; year of death: 2007; age at diagnosis: 30265; ajcc pathologic m: M1; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 2848; days to sample procurement: 0; initial weight: 740.0; portion submitter id: TCGA-XF-A9SV-01A-21; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 28.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M1 | 6th | null | null | null | 1.095890410958904 | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | f5e03536-26e1-480d-a7bb-010eb8210cd6 | TCGA-XF-A9SW | true | 23 | released | 1.83 | Yes | 1.37 | 7.2 | 85 | -31049 | 362 | not hispanic or latino | male | white | Dead | 1921 | 2006 | 31049 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2721 | 0 | 480.0 | FC0E8C4B-EC30-47FA-8582-5AE007A9F697 | TCGA-XF-A9SW-01A-11 | 3.0 | 2.0 | 0.0 | 5.0 | 0.0 | 30.0 | 70.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SW; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.37; rna integrity number: 7.2; age at index: 85; days to birth: -31049; days to death: 362; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1921; year of death: 2006; age at diagnosis: 31049; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2721; days to sample procurement: 0; initial weight: 480.0; portion submitter id: TCGA-XF-A9SW-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "ri24vmYZrD7simK+XiRAPcAmOz408Os+2w4CvleMHj42WwG+BCUXvkeu1T513pY80zjmPI/4Zr4qBVG+l4VyPsk8s7xvpbI9ZLnjvRhjVz4y4uG9pFHvPrknQz5szIO9+ElkvnS2ob01BGY+fmx7Pq61VT3PZmg99hLPPUlMZD5ny4G+MH+dvmoKDL0ftMA+lAlYvqLoWL4cxv09OL+MvBJHCz5PI5g+sN7qPSRGgr7vV8S+UjqVPcp5Hb3pbSK+mvhaPmQTzr3N8469MrygvYYHqb1kepu+6eMoPRFI8Lwnnh29dL6Rvvutvj4vljg/FkrXvP+dibqL0AO+6GHZPonIIr4hj10+FjSQvgujhL5YI48+tnQxvr3LFb6odTw+1WpwPrZykT6L9Cq+fNHlvAp+mL3VDM49go8sviLLBD6DrLI9JKIJvpQjpD1ouCC+LT9xvqgJjr5xqh+9JNe+vsL84T6rgM2+BwAxPj8eij65TVo+MCTuPPJqSjx1JJG9o2mSvHhgWL44kpM+21r6PSu17z4K28s8j80wvZVvUrpd/g8+JEMYvv8R9T2BG6e92b5Hvil12L3Gvyg+3bXmPlnpDT0PPZo93idcvRbqkz07FEM+qHaWvfCF7b7ZMYU9O00mPtoJGT9wCTS+UDx6vm2iTbyDJGO+IyrvPrl07T13/gW/wMUfvbAOLb55QYe+MliDPZ0dLT4Nfp++wYeSPlP5cL+lQTW+szKXvicCjD2rT/U7sWYTPifs9T1uztw+BACbvOpJxT5r146+zthHvt/pbr5izJI+szCHvqrFLT2f1zE9LHHtvrboZr3ehuO+Ow3FPkW20LwscDu7XTaXPtoRFbyG5ja8SlCCPUT6BD4iUJa+0YXAu+fJKT4sH1O+kAo4Psf6Tb3qdzC+rM+XvtAQZD7h07i8y699Pgoqa73RehW+Op6fPD1t5LyeTwE/Ex+9vaXfBz/lEou+YD27O6rCibxI7y29e1MFvqp3Kb9uBn89nDHIPVeFBL6vGYs+//moPkRebr1g96o9Uc4+vU2b6r3XT7+9YsJOvZfmF74WtfG+VqkDvzmEQr5Xy628deOSPnls+DzasKC+gougvVKrL74LIyq+D6TiviIgAD4NLNA+B0hCPoBo/TwK04e+8Ri/vsc80z3eNz++Q1fnPdnGEb+iE6Y9AvaCvsrgCL7MoSa796jlvRnvr74e4Ac/MFdQPeHOCD4i7xO+uEpjvrEcgD0LDq2+GI8Qvq6LT71cQqy98aNTPtCHXT4VsMo9CZ1/Pi3177y/SDe+s5dwvVywKj0eE4A9bXQpveZYub7ihzQ9hTPWPLQFMz5b6w69PY6/PtM9cr6UpLjAiDlGvbMICz/kZSs+j4FZvitreL4TCyi+KpAHPuHrTzxTi8G8xwdhPfwIXr5ZR8w9BezTvM5A4j0iAkm+qVR3Pmy+yz29rAK+WCgtvbDzUz7tFyU/eLgZvlCLSD1dcWY+2igBvnw9eT0P0w4+nCVNvYB+2j0xh9o8vEKOvhXfKb62IIi+dHDDviQwl714ysa8Z2MrviFjnr3zHYC92M39PCTZsz7nunA+w3k0PTu4C75J6z89ffWUPteLkT4jf5g+eFgQPvElSj05abY+oFnevguSRL5nMQg+R11CPVOpBD4xiSW+UoWNPTvHrb7myOY7i2Iqvioe1D2LmTw9+Nt1vl7GyD7FaV++eFwQvsfIID52syM9qRvmPquCt75ZNyw++c2BPqKUiD5S9DS+4bNjPnVoVb5p03k9DRkMPVhtiz4XarA9BbQEvqE6XD5a2cM98ECRvV9DFr9bm4a+3hL8va3/ib52F9k+4nw/Pqwg571koVc8vy/IPo8/Bz6XMa099J2XPuU9fj7kRhw+nwusPlI9jj3hzKa+ZD2gOowvP7t8qYc+idbjvRyilr7vP0y9wqAkPcW95r0mYZQ+i+KlPUCI9r2C+Ra+etYFvu+LYj6Xk5y9Ycx9PlO5YL4I9hK/J53hvWb4ZL5pZ7Y999b1vowhND7Go6a9PBsPPhzkHD+jx2m+7VVjPaHeXL2dme8+4eUMvqmJFT4Gnow+irTlvfKCej4m6zo+aTN5vlROnj3ykMQ9Mg9GvikfGr87QlU9M48CPElhvjz/47e9JboDvmfz5b4CO5A+9IGfPreJlj094yw92NmGvjYkpT7auWS+upZZvahtOr0wuyU9PuDfvfIU3z4YJZM88yg3PgcaYz7g5vk8bp/4PaoPTb691ju99loFv73gqj0umDa/oCYvPsBtx74TGOY+w1uOvpKpnr3+9Gq91qIfvo/jpL7Un4m+9vp1PT7z0b5NCyw+JNNavvrXmb1D5Pk9Mm6jPSUhCz5w6Zo6DUiRvvsrnT7FDJ8/zfUXPZIle707fG2+UCfXvs+e3DxK7xQ9ajnRPmT67btgGbO+IsC5vkYjvL3yHKo+ssJQPnWzAD4cfuQ94T/wPL26jrzSm2c9qQbjvrrQIL5awMG+8S4LPkaUO770R9g8LSA0vL3MGj4L6nQ789cpvkyu6r03L6i9cuehvBeMmj75sIg+rLk1PheupD2OjS8+AGbKvts6zjvi9Ve+5sJsPtjtiL6/bGg+UI1IPmuSdj5JEYs+8zAMPnUeXj712pY+ryWIvSkMlT2zFMS97RzkPc/QHj5y1UG+JoOlPl5gkT0mpr++3ISkvDt+dD4348w9jzgoPhZ7xb7IExw9d0d4Pq+BAL7KYWo9z5B0PbfeqT2TjQu+y8OWvUzNzT1pSTW+GPmKvV16Ij0dgL89JEK3vljPRL5hQhS+Uz+VPfyEhD6pNrK9ncehvR9EJL3LvaA+Ro/OPVMBq7wB/hE//iwivl0qwr2s+Vc+9mWAvmgOaz5unl87q0iUvrQ41Tx1orS9ED7DPb2t1r1H8hG7UgdZvitX+D5pkU++CPeLPio6uL799pC9CB0Tvor45zyc7r2+U6F/PrxzNT3qshC+zeaiPn68qT44zQ+/GBoXvmrLAr7EhCe+AQGdPsW9Bb4QzaY+aIw9vZJqa7zHaUa+HBpDPmuHfL6mczU+yOyNvFb2Mb0nl6s97mShvDOV8T1nh1K/i9CaPah9CL7TS36+NFZXPq5OTr7e+qG+W/6mvfblBL7lw2o+/mROvtCgdT4E8OC9IZz5PQcwKr6UzQu+nbwmvPz+0TvpRTo+SWBkvaJ0vb1y0Va+3culvkCp0738OIy+gEIrvuVw3T3KkUI+FWOzvfnOI77/EI2+hP65PhzKuD0PYU6+eUS7Pg1uBb/fEho+E/uXvnKR3L5yfLC+nslhPu7vhT/u2Zy95eOPPtdnOj32cG+9gBGOvo0sgz4gF+m9F1OKPnGncb6G2bO+BoZdPW7bs7tOAUQ/ZLycvYlPr77h1e4+KDy2Pc0T+b2ommk9eteiPv+B/r3TVIk++5RFvtPhMD6EYsC9x6QhPmCn1T6WRHy7SVw4vUqyyDz5MKC+FgjZvklfgr0nRbu96PGAvGMM3b1Qy3G+25JhPpAeHT5XSsq+erWRPjfjMT4QvmS+VjR3vrjAU74N6sC+d4DBPBBHyD0L4um+MIy2vv4LBT57jCI+mfirPn9avT7itgg9mrUEvs52mb66d2U+iJEpvp3Nj76VaNo9g7OOvP0+JL4XSlu+SRAHPhzDET60A52+g+H1PSQuyL7TzDA+NIQAPr9rHr7+MgQ+koZaPrrv172USNm9qxSMPBrPkz0dzuq++/bmvdIPIr6SB36+7X8jvudlkb7tx5U+UjPzu0uofT7C+SM938AGv6WfBL2zGt6+x6GyPSYfcr6loKs9ZMDfvjqSDD6p+NM+CuvvPgCLGL4z6D++kH5xvnc0eL6VOsA+xqeKPl4Pt73EmAe+Ba0bPSdvCz7Mi52+AeahPQ4n1z6w5q+9lD3mvEagbj2Z5eM9t9wTvuz2ID6z6Mu+n7MJPlrlyL0PgDE+6qOxvoiPKDxvwy4+tNBKPsSe8z7q57w+AXfxvK9p5L7uogm++/vGvXpJQj4k9Ai+SPe/P9W0wD7ZmOg+eoYkPrzkgr5+TQQ/H+kPP+qutj14ZjY+DWJlPhT9yD4vXTa9Uv9XPAj6Gj8FI5++j9iRvbhApb+5epa9bwIRPVd8Gz8xhys/n1FfvqkLor4t0mC+wt8tvpmBA77rSu49XuUVPwWnPL7UJS8+ufpjPrjwsrzWk4U+7BhdPu9HZ76JbhM+Si0dvUGWkb6HM7C7Gvk4vdfw3j1PU72+GMwcvnHTST7hjHm+RpWCPuvipD4P74m+cVSGvrEUGj7Mw8U9W2mavrQ9AT/WTDi9b9BcPh5eZj7K0qW+cqi7vZ9eUL6PKfi9LPlVvkG4f76vXWI+epeGvoAIIj3FcMo9+m2jvi8pHT4OyQE+GEwSvTlv/j1Tl5A+mb7evNnnX76ZLQ6+6vIEvvl3jD2ZijC+zVfnvkvlGD9cAP8+AmiSPjteLb547Do9K5t5PgCsEj5+3R09b+LYvr8qCr6VjoM+axeqvv7HSz1Me54+EcJGPJBkgj0dbpG9IofNPd2BRD4IOwW+mVRxPtfNPb4QGli94fSwvt1FhTx0aK2+Xax6vc8Eej1v6qi+2fiUvCCsgL4uOJw+IIHNPRVxJb6+7vM9YDs3vvpejL4B4ts96DSwuy4wpL50srw70FjjPRg3ED5MWeO8C9ovPSzh+r1a0aQ+PRmlPhb+WL7IUwk/JvuTveQDw7wNPrG+wlGVvvK8zb4idKu+w46HvqW5cb4KFr+9VTg0vUQQJL5xkne99dw0PV2ZvD6pTKK+6zMNPTsyBDj7Qy+9UR41PgThbL7Rxj2+BCGMPn/UjL1NLN49P/RJPmahMr4d/DA87lE6vpT02T2RZ9U++f6fvi2wHj7KOlk+1RQ/PUxc2z56/po9VNPtvsPixT5JNmM9HgqzvkOUAL76YwC+gE07veh+FD6E6qY9rdD6PXjufLzRiAs+j3VNPh0KwTzRh02+Ur8/vUAJT7wHApQ9MEr7uxD8Fr5yAvy8BB+0Pc05DT+6/oU8ITXRPCwmp73T3jG+BIYPPalYO77IVU69A32ovtyikb2lsIe+OzvfvFP1Fj7lOjw++FNZv5+OJ76gYeq9rrR0Pty5DD48f0c7M4N8voPOMrwLhmc+vTDgvQ9Yjb4RtIc+UpyaPhs5m72mNgW+bzmgPTs+KT37t9W9grwwPtnHYD6g7J2+iCN+Pqirfj4sKki9Pmt4vpLmZL4WegY+hSoIP2BdoLwrF887V+WHPiHTZ77Xl2++38/jPcxpxr7Nboq+lB38vjeJmD5ARAy9ypIbPhnRKz7uGdQ86HObvRBA3L5pdVE7/9tjvhzKTD5zeiE+bUJVvdBxn74tGbc+/COhPlvKDr6WFD8+nTtlPhloebzNj+6+WzBqvrqb4T3CDVa+fTHtPJ/SeT4MOIW9b2ljPckw5D0vsUU9jMj4OmJcCj5PJuO+14tIvg==" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | a648d9bf-cf37-41fc-9515-e8f5ac85fcd4 | TCGA-XF-A9SX | null | 23 | released | 1.88 | Yes | 1.25 | 7.2 | 63 | -23349 | 719 | not hispanic or latino | female | white | Dead | 1943 | 2007 | 23349 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | null | Not Reported | false | Not Reported | 2702 | 0 | 770.0 | FFF56041-E252-4438-BD4A-C7FD5295A061 | TCGA-XF-A9SX-01A-21 | 90.0 | 0.0 | 0.0 | 0.0 | 10.0 | 40.0 | 50.0 | 60.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SX; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.25; rna integrity number: 7.2; age at index: 63; days to birth: -23349; days to death: 719; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1943; year of death: 2007; age at diagnosis: 23349; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 2702; days to sample procurement: 0; initial weight: 770.0; portion submitter id: TCGA-XF-A9SX-01A-21; percent lymphocyte infiltration: 90.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 40.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 2.191780821917808 | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 8a83f744-8469-41ef-a4cd-e983f849383f | TCGA-XF-A9SY | null | 23 | released | 1.89 | Yes | 1.85 | 8.6 | 60 | -22212 | null | not hispanic or latino | female | white | Alive | 1946 | null | 22212 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2006 | null | Not Reported | false | Not Reported | 2734 | 0 | 360.0 | FACDA2AA-EE41-4EF5-8599-E72249E4B715 | TCGA-XF-A9SY-01A-21 | 2.0 | 1.0 | 15.0 | 4.0 | 0.0 | 15.0 | 70.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SY; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.85; rna integrity number: 8.6; age at index: 60; days to birth: -22212; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 22212; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 640.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 2734; days to sample procurement: 0; initial weight: 360.0; portion submitter id: TCGA-XF-A9SY-01A-21; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 15.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 640.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 2.191780821917808 | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | dc321b92-7275-48c9-adeb-7670db3195ef | TCGA-XF-A9SZ | null | 23 | released | 1.88 | Yes | 1.77 | 8.6 | 79 | -29100 | 859 | not hispanic or latino | male | white | Dead | 1928 | 2009 | 29100 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2007 | null | Not Reported | false | Not Reported | 2352 | 0 | 1080.0 | BBDDB909-1AE0-4F10-948A-DAA989CF87D2 | TCGA-XF-A9SZ-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 20.0 | 70.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9SZ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.77; rna integrity number: 8.6; age at index: 79; days to birth: -29100; days to death: 859; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1928; year of death: 2009; age at diagnosis: 29100; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to collection: 2352; days to sample procurement: 0; initial weight: 1080.0; portion submitter id: TCGA-XF-A9SZ-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 5th | null | null | null | 1.643835616438356 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 5f5c1775-a908-483d-8a77-b902c5b7570e | TCGA-XF-A9T0 | null | 23 | released | 1.88 | Yes | 1.67 | 7.9 | 68 | -25190 | null | not hispanic or latino | male | white | Alive | 1939 | null | 25190 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2323 | 0 | 770.0 | BD4F0E43-3FE5-4059-875E-70E998BEF60F | TCGA-XF-A9T0-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 15.0 | 15.0 | 70.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9T0; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 7.9; age at index: 68; days to birth: -25190; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1939; age at diagnosis: 25190; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 799.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2323; days to sample procurement: 0; initial weight: 770.0; portion submitter id: TCGA-XF-A9T0-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 15.0; percent stromal cells: 15.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 799.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | aa6b44ab-14b1-4b5d-8679-ba958b546afa | TCGA-XF-A9T2 | true | 23 | released | 1.88 | Yes | 1.66 | 8.9 | 54 | -19945 | 575 | not hispanic or latino | male | white | Dead | 1953 | 2008 | 19945 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2288 | 0 | 460.0 | 71F04D3B-0CA3-4CB3-9E94-E082F37C4097 | TCGA-XF-A9T2-01A-11 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 65.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9T2; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.66; rna integrity number: 8.9; age at index: 54; days to birth: -19945; days to death: 575; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1953; year of death: 2008; age at diagnosis: 19945; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2288; days to sample procurement: 0; initial weight: 460.0; portion submitter id: TCGA-XF-A9T2-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 65.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 5th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 5f7c3b2d-9a5b-470f-bd12-9c7787a543f0 | TCGA-XF-A9T3 | null | 23 | released | 1.72 | Yes | 1.68 | 7.7 | 69 | -25532 | null | not hispanic or latino | female | white | Alive | 1939 | null | 25532 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2008 | not reported | Not Reported | false | Not Reported | 2140 | 0 | 130.0 | F782DE7F-4DE3-476D-BDF6-549CD871EE9C | TCGA-XF-A9T3-01A-11 | 4.0 | 0.0 | 0.0 | 0.0 | 35.0 | 0.0 | 65.0 | 65.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9T3; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.72; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.68; rna integrity number: 7.7; age at index: 69; days to birth: -25532; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1939; age at diagnosis: 25532; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 68.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; cigarettes per day: 2.8493150684931505; pack years smoked: 52.0; is ffpe: false; composition: Not Reported; days to collection: 2140; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-XF-A9T3-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 35.0; percent stromal cells: 0.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0; | [
1024
] | "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" | null | 68.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 4th | null | null | null | 2.8493150684931505 | 52.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | f9a03eaa-a228-429c-99c5-8e877379db0f | TCGA-XF-A9T4 | null | 23 | released | 1.88 | Yes | 1.84 | 9.6 | 48 | -17728 | 495 | not hispanic or latino | male | white | Dead | 1960 | 2009 | 17728 | null | N1 | Stage IV | T2b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2008 | null | Not Reported | false | Not Reported | 2146 | 0 | 740.0 | 82129FB4-5062-4878-931D-C09C336EAE4A | TCGA-XF-A9T4-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 80.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9T4; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.84; rna integrity number: 9.6; age at index: 48; days to birth: -17728; days to death: 495; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1960; year of death: 2009; age at diagnosis: 17728; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2146; days to sample procurement: 0; initial weight: 740.0; portion submitter id: TCGA-XF-A9T4-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | f9a7ab94-70df-4194-8102-66021d01dadd | TCGA-XF-A9T5 | true | 23 | released | 1.85 | Yes | 1.89 | 8.8 | 78 | -28578 | null | not hispanic or latino | female | white | Alive | 1930 | null | 28578 | null | N1 | Stage IV | T3a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2008 | yes | Not Reported | false | Not Reported | 2105 | 0 | 1050.0 | 23A2FC99-03F3-4A72-8F33-14ED56125E65 | TCGA-XF-A9T5-01A-11 | 3.0 | 0.0 | 0.0 | 0.0 | 10.0 | 0.0 | 90.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9T5; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.89; rna integrity number: 8.8; age at index: 78; days to birth: -28578; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1930; age at diagnosis: 28578; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2027.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2105; days to sample procurement: 0; initial weight: 1050.0; portion submitter id: TCGA-XF-A9T5-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 2027.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 6ee18b9a-3f45-491f-9535-502820cfcf46 | TCGA-XF-A9T6 | null | 23 | released | 1.86 | Yes | 1.89 | 9.2 | 88 | -32207 | null | not hispanic or latino | female | white | Alive | 1920 | null | 32207 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2008 | not reported | Not Reported | false | Not Reported | 2044 | 0 | 620.0 | 84E24E42-02F8-471F-B8A4-B50D89056CA2 | TCGA-XF-A9T6-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9T6; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.89; rna integrity number: 9.2; age at index: 88; days to birth: -32207; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1920; age at diagnosis: 32207; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 64.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2044; days to sample procurement: 0; initial weight: 620.0; portion submitter id: TCGA-XF-A9T6-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 64.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 317e1db6-df93-4793-a4df-2fa234d8a81a | TCGA-XF-A9T8 | null | 23 | released | 1.89 | Yes | 1.79 | 7.2 | 64 | -23403 | 418 | not hispanic or latino | male | white | Dead | 1944 | 2009 | 23403 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2008 | not reported | Not Reported | false | Not Reported | 1972 | 0 | 1140.0 | 7F4BAF33-CF00-4B19-914A-5AA8CFB3D797 | TCGA-XF-A9T8-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 20.0 | 60.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-A9T8; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.79; rna integrity number: 7.2; age at index: 64; days to birth: -23403; days to death: 418; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1944; year of death: 2009; age at diagnosis: 23403; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 4th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; is ffpe: false; composition: Not Reported; days to collection: 1972; days to sample procurement: 0; initial weight: 1140.0; portion submitter id: TCGA-XF-A9T8-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 20.0; percent tumor cells: 60.0; percent tumor nuclei: 70.0; | [
1024
] | "rfq4vsvtqz7lL2i++x7xPFbfGz5KDu0+yd4xvvu5Hj5iqNS9jGMevmPJ1T5/vRA8YqUyPaLbTr4/+VG+vmRFPu7hq70dcNg7048bvnq4YT6GHeG9jhwAP6TYTj4nsEq9KIOevn+r+b3Qs4c+Uql3PmYf5z1494w9pPTdPelgUT5/2oi+DrKbvnrxCjwEouE+Zit3vvYOWL70cDI+cD1fPEzPAD5p/5w+wuMhPoF3cb4viue+dXOUPaIloLiYFEO+tM18Pp+NEr6fccm9Jv/FvbiVtL30WqC+/SJ/PRSMob1jeF68rieIvsfTwD5KrUY/l2cNPPn/xby/6sq9Aj8AP+W5OL53QXc+jr2hvuZIi77lzog+Rj1Jvul58L3KWm4+f0yNPgPZiT4UJiC+/mutO8cwgL0wIc49sPAhvhTYDj6imaw9EpsIvkfDFD70hxK+nLmIvkRii75KC4C9aCe1vjGBzD4SzrW+FqsyPh3glz6j0Vg+SrGUvPqvwrxDua694973vN9hVr7Zcps++RLfPU4a2j7TRWK88ZBVveJ6z7wDLw8+3TrfvfcSQDwp4rS9/llSvmLuDr7FiRo+gaz1Phik5TzNkkg9M7fRvKyn1T1SPkY+wxp7vX0D8L5lmQA8vMYHPpr7Nj8F+R2+XUKavngaqLv1Rzq+PFb0PvlnmT2TDA2/G8k5vV+2V770RIa+tPBXPWqfND4nxIu+z0egPjuDfL9SyxC+GjqXvtvvdj26t6w83de1PVQCBz6Ozts+uusYvI1izz41Fpi+2VI9vqhSj741TXk+GRWTvtkbLD3du6Y9RsX4vkmoDrylMta+k2ayPj3Gr7yfDPs82cuqPpgh9btkeGA7fXGrPdhHAT6eyJm+au8EvOWjIz5OOle+rM0sPggb+LyB+jC+MUSBvkJIgj5iIoy8XBGKPsmPIb1DYhS+K2ggPapNS72UJf0+f3zGvXGADT9Ki62+9CBYPOZI9byp0Jo7UH8ZviaEL78D/LI8nvHNPVMKRL749oE+GYCqPsaI2b1oPQc+/H66vYvoBL4/5bi9z+biu30AB75efeS+XM4Bv6BXC75KvHK6+R2nPk4rfT3EK7O+20CMvUJUE77DP2y+/pL/vitzLD4tGNM+22knPmOxBT1+hpe+ViTIvmpf1j1TyFm+kr8GPkvRGL/JaZc9tGpXvu0MHb5GXse8rEfzvQbgtr4KiwU/RrzMPLkDCD7btOC98BCfvrqMdjx5YKe+51znvfFiqL1vSb69fm03PlLKVz5acbI9+MOGPlqRdb1pW3G+F70pvfLtrj3Z0Q8+n7STvbSww76yvPk9pHoZu8UXzD0Gb7C853XFPvR0O74CprLA50+pvQjJDj+J3Ew+DqVLvtRRgL6BQiq+ceUlPtlshrzjPVa9fa/EPeJ3YL6W6sY9tE2pO8tbrD3d4Vm+IIVdPvRKzz1B0/+9Ar1evUraOD776So/gSFLvoVjSD0d2Xk+xF/evcEpqjynYfM9cwA2vS+D+j3TOvY8ogaZvi1y971Xt56+eATSvtoVVb0tCqu844QvvtETg73UC9y94TaDPe5qtD7cLGc+NDFZPSmU1L3JegQ934O9PhoGiD4EYb8+yaQWPiquhD3ut8U+r7zbvhDIU76cMBQ+pE/TPXqu6j13Aj6++gCIPUzTob7VWX08npVRvg4W2D0cK688Hlt9vg2CwD6GPW6+YF5Evt8JMT67dx49+/cAP+T8yb76Nwo+DO+CPgY+kz5GiBm+uGFuPnnkW74jb589+G4iPW/wlT4rtLY9icLsvQKMWT7Cu2Y9bV2vvatFI7+kdpy+fjARvuHaor6quNY+LT1MPqwjD74r+wc9qKHbPomkTD7pAQQ+xiKjPjDKjj4n0jo+zenaPhtUVj15fKy+cBqZvI4S/jxc33U+6D3KvT09nr6ia9q89iZYPed37b2k7Zw+XE+ZPexHB76+Djy+Ka2zvekKXz5m57C9F/2PPvyhb77yjh+/0wfyvSTim74Sn8Y9e/MEv5xnbD7Zg7e95+kZPj82Lj+ew5a+jZvbPC2vxLugOeg+tvURvvImED4meZI+t33QvaI1eT7fp0Q+7C+AvuE8dj0jTA0+s4EwvhTuIr9C3Cg9T3mfO1bqirxwpKS9sY8Wvi8E3744R5k+we2hPuGd2j0hnYM99O5vvoYwtj7dh4G+uCCbvRv2nLzyFvw8R9j3vUj86z52wWc82t1RPkRCLz4XgZA9M8TQPQC2gL6H6VI8H7kDvyd1vTwwNjq/XE8PPvYd077WaQI/l0CLvp9uub2SxXm9pL4FvsgNwL6PAKG+jaFRPSHH3r5OrUU+GtlhvnCgDb0Pbsw9GIbfPfxwET6FEUm97HagvseNtD6iLqA/wXahO4Monb1eQ3m+H88Avx44DjzV9aC7ZNSyPpyMfjzRar2+BlqhvuMF0r2BkaA+cUn6PR0/Mj6k+Rw+nJA2PRTo6bwbztE9oXXevp7d6L1opMu+NwQCPt8pVL5ZB8Q8oAPqvG79Fz6qO4K87aUlvmMxJ75SN+C9qPkkva4tnT7LeJQ+WnsLPmaZbT2oEzI+Xcm9vlu+w7y9ynu+dX12PlRsh75hm4s+IShMPkbajT6HGX0+7J3rPZRadD7UJ4E+7dmjvAtQ8j2wBxe+dbkoPXmQMz6tCR6+9qqUPgy9Az7R28a+/4ERPQXwfT7h5ZY9RB8DPoEzt75Qc2I9GcdaPv49tr30fL49pbLaPak09T2edMa9VUGwvZaIAj49HIK+FLhovbt4Izz6vpk9lLnEvuVYL76lWQ6+PS6LPBredz4UYci9eZ2OvQCNDL3HL6M+26yRPazCOr1aqhI/G+0YvhAWzb2BYVo+B36NvgqUZz5OMiK8BjycvuGuED08YRK+hfYGPjFY2b2HP7+7HrNkvkNWAT+s9nO+4aCbPvRsr74QN6+9S8P9vWiMujwXmcq+VUyAPk7NST11hFa++0q0PrYtqD6L9Aq/EoMbvgU+zb3wDi++ApKXPg6Q3L0I4L0+oOnovLFcCT0bql++MqI1PrMiXb7LeTs+Th6pPARqNb09Ar09fAqXPdVDHD6n7EC/PzPxPUQLCb6MZYC+hWhJPk3BSL78zZ++4QSPvWQGr706DZI+391WvisLgT5t4Oe9OWoPPhv8Wb4hNkC+9V+EPLSZOz3jJCQ+HODBveFd8b3NcVS+RmCkvvIL+L3syaC+C5JDvs/T3z0JeDE+NSvcvQ0cO7728YO+LzvOPg2QUz3XIj6+8vC4PsZ6CL9qVhs+yfaBvvCk2b6jesi+9u86PhdcgT+wNLC9DsyePhe6kj0QpHW9bpCMvofKMj7RgoW9LS+aPj6DjL72pbO+B35Au/QJqTwLblc/MZvZvWQ7ub6w/wM/ZYmnPV3JIL62vKc9UN+7Pptu2L0em5U+cx8rvnXAVz57ucC94lB2Pr1p2z5qYwM8+89+vVYHpLw+vK++XbDFvjZsdb2+KJy9jp9RvcPzSL13kYy+0jwgPitvGD7BIM2+KR+sPqq3ST5ETWu+xQxivg/YnL5q+7W+Lx4rvFa13D25qe++Vvjfvh42JT4CEBY+l/20PuWGxT6K5X49fYYLvtBapL5BAIk+XqEjvv+Upb4Agak9WBm+vKQaFr57sWO+TbwDPgHFTD5577O+nYMvPpoYvL68B2k+WT23PZZ8Mr5PBy8+XgNSPtkmtL1xXaO9iP4YPTho9T0eEPa+ZrkWvvN5Z77dEE6+BiYRvtdqi7600Zo+9ARTvUf/gz4ZtX09VkkYvz3skb2eS8C+i7uCPTXBkr5MvaI90iXcvrgdyz00lNo+4nj6PvggPr6Tkze+XSxpvqrRWb5gOb8+b/iAPs9+Yr0ZXPW9FAaSPWpauj3daJ6+nG2HPT8D3z4ju6u9oD7SOSXBPj0yMOo95KYKvqqDDT62H8m+r4WqPdaUzr2gPS4+K8u+vrdnjDwtiUg+nPJFPnMLDD81QcU+iJg7vdJB874yVy6+PJ3+vZdWJj4ATrK9Jt3GP89xrz6u2cU+fVsmPl+OmL5fpeU+DAYYP5GHij0eFgQ++MSQPvzw1T7ozLK9WgOWO4tjJD9vfrO+kXPpvfzitL/YpWO9yYAjPYlpFj9R1Ts/YhhBvolyvb64/ky+PnghvqxzAL7OEK49jQwMP3EhRb6eEU4+qWFUPjYysrwLP5g+3TZqPjwTgb6LzC4+1+EQvVWvgr6Kt6o89p83vVRsyz0A1di+oC9EvrzwIz7jhm2+L/+CPoMVtT5SIJ++mvCFvi+oDD4jKI89uDudvocTET8C3uC8zZRcPqy5bz5kYZu+tAvZvW+id74JhiC+dOJgvrjQf74G7Fg+en9pvjEUAz1/A9w9OcmkvkVzIj5OdyQ+k7TkvMtD/z3LeKI+BFeNvYMrPr6vzTG+DB/hvbM3JD1t7Se+5c7avhSpHT97hwo/uMWOPoH7Fb7/+EU9qLqJPtFFST47d7A9aGzmvrJN9b1id4Y+3w+zvu8PjD3d9ZY+FDggu1e7qT0MI5G9qO24PfaSRj7dIty9bP+EPmayN75kIt+9l86qvgGuGTy33te+b11DPG3DqD1U7rS+qPWhvDfsdr7kSJ8+zSMGPq3SRr5zTX49UFRHvuqxnL5vyvc99uQLvVZyt74Rd/a75Yg1PtPHLj7dkT291xo6PZ43nb31Vq8+rdynPpHPPb72UAo/pS6evcRRxb1Mp8C+SGqcvgJU0r5dwbm+mMSKvkRNZ74MhA++aPpMvZYpFb662Im81TqHPYcO6T6ehKi+HpL9PHMwzjzTrzG9E+BIPiIbW74v5je+Ekl6Pg36mb21/p49xTJFPnveA75O6Hw9S1lsvgQesD1MbeA+y62NvvQBNj7oSk4+tA2rPHv33D6qCmk9kPnzvrBQxD6/AZ0991OpvqpgF75k+AK+LZJ6vSgCFD7Q0sY9B9YBPnxxBTyazjE+sy5JPliMID3ubja+HavTu5joFT3s2aw9QvGEvFXHL76gJkW7EhNFPQaTCz9aU7W7Du/iPBF9bL3HoDy+H8gJO23kTb7R7LW9A/K1vp9qCL5KvV2+mlA/vVg7RT4bejs+he1gv1ln6r3jGsy9iztXPrthAD7w8VY7P7edvh/5bDr8aks+RjCYvY5ta74MI2k+7/eePrRS8L0Yrs6906PgPccCrj3aVoS9xnNhPiFfjz5m5YS+21ZkPkKUiT4vyWi9VT2FvmKoXL4yllQ9zRsPP/3OeLyTUFg96USPPtAPU76UAze+kYq6PZ5XyL4l5oa+9uv6vpwjrz4CGh294cE1PlyQAz5PQZu7kRj9vVfk2r5TwLK8IQZqvoj+MT7hZj4+Eohkvc9Mnb6u2ss+rE+qPm8AEL4rJXo+TyZpPnZkMr3Gete+FwJZvmAGAD4hSHe+Wn0CPYwRZT7BAae9v1puPYYOAj5i2uo8RugTvXmT2T2cCuC+8nVUvg==" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 4th | null | null | null | 0.821917808219178 | 15.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | c8388ac0-975d-4f1e-8324-8cabdc75738d | TCGA-XF-AAME | null | 23 | released | 2.0 | Yes | 1.52 | 7.1 | 64 | -23448 | 2828 | not hispanic or latino | female | white | Dead | 1942 | 2013 | 23448 | null | N0 | Stage II | T2b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | yes | Not Reported | false | Not Reported | 2877 | 0 | 250.0 | F59EB865-9B98-4A22-9237-513CADD28F65 | TCGA-XF-AAME-01A-12 | 10.0 | 0.0 | 0.0 | 0.0 | 0.0 | 35.0 | 65.0 | 65.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAME; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 2.0; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.52; rna integrity number: 7.1; age at index: 64; days to birth: -23448; days to death: 2828; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1942; year of death: 2013; age at diagnosis: 23448; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2877; days to sample procurement: 0; initial weight: 250.0; portion submitter id: TCGA-XF-AAME-01A-12; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 93fbe302-a2e0-4cf4-a638-312786f547c2 | TCGA-XF-AAMF | null | 23 | released | 1.8 | Yes | 1.61 | 7.8 | 68 | -25023 | 329 | not hispanic or latino | male | white | Dead | 1936 | 2004 | 25023 | null | N2 | Stage IV | T4 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2004 | null | Not Reported | false | Not Reported | 3362 | 0 | 830.0 | 1F998F05-1055-4BBB-B3CF-BF07C0066A26 | TCGA-XF-AAMF-01A-21 | 5.0 | 0.0 | 0.0 | 0.0 | 0.0 | 40.0 | 60.0 | 60.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMF; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.61; rna integrity number: 7.8; age at index: 68; days to birth: -25023; days to death: 329; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1936; year of death: 2004; age at diagnosis: 25023; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; alcohol history: Not Reported; cigarettes per day: 1.7534246575342465; pack years smoked: 32.0; is ffpe: false; composition: Not Reported; days to collection: 3362; days to sample procurement: 0; initial weight: 830.0; portion submitter id: TCGA-XF-AAMF-01A-21; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; | [
1024
] | "8UO7vuk+qD6/41i+AU0LPRv2HT5p/+E+gHIwvsacIT5fE9+9rVgBvvwT2D6jISc8M0NFPQjiRL5/X2G+kKlPPl/vnb04X4S55RozvhGobD5Pnf29NKn5PnBWQj4E3YG9Kp+YvgHx6r2X9Y8+NU1/Pk201D1ocoE9IRTSPTHOWj60QY2+ZqufvilGtbmX6uM+alN5vnwpQ74KszM+UvaWu9ayBj5lRZM+kvQTPl+Ycr4V2O++z0GQPb8We7yoXUm+PSl4Ppz2F76AZry9nivLvZbUrr1l8ae+b7OaPbnfl70bZFk5A9yBvk3zwz40dUU/j90VvOfDM72L+ty9Jqn4Pim0J77xqnM+zUaYvs6Qib5YLog+9BBOvqBL9L1vP2g+1UqOPlqAjD4wVB2+c2y8O8tidr132tk9XNwjvlcUFz7nk6Q9yikFvgZsCz4hWRi+iFaDvmZpl75p5429jJXAvoyJyz7AJLW+4fw0PhyPkz45XVY+reKEvGZuWry6gKm9+RYjvYK8Zb4qAJ0+ZO/fPR6d2z4NiK+8pXwxvVHUkbzm9iI+Eunovdjc8TxehbK9hz9ivmuhEb6PbBA+6YHkPulHoTwQOic9USA6vaMJtT3GB1E+VBhvvdQC677mdok8qFLIPVhyMz/ZMDq+QYGTvi/Dlzs8jDy+aFn5PsC8jD17hwm/Ly8PvQ3lSL7QWYa+tgzRPH7jLj6vfJK+bcOZPj9wer98ww2+K0aQvlUNXT0X5FM8S7vOPRQ8Bz6axNE+xEgnvKwe2D7bkJ++/DI3vurMib6XD4Q+lPOGvoBLhz3pgrU9HlX+vgm0djxUM92+8A2vPnswU7wnXuI8hYumPu0qIjsxXvu7C+mmPZqj9D11LJ6+1uz7vJ4LHD7SVk6+e1UoPmRvAL0zXTO+cdmPvkZqkT4irIu800WHPugJIr2lLwS+EbaBPdbnTr2e2QE/cNXdvYcRDj8kcam+EwbIPNvM17xJkCk8UD0rvhF1ML+Zjb88pK+VPb5dLL6XSX8+a1GePi5R272q8+M930OtvTzVH77JZKO94byAO8iD7L0izOO+s6gBv4P/G77rny275oqkPue7hD20ELm+WjykvXY7A77nwWK+pPDzvkoRJz6A1s4+Nu9CPhNUMz0Kl5O+o8G3vjjz7T0c41S+3skTPiSHFr/5RY49TSVYvqyVI76JY5a7LFUCvixlub41sQU/xdq2POYLAj7+BAO+XGWavhvA3zx+uae+VJHkvaK/o73Iu829XD0tPi7bWz5vJas9RdyGPp/YCb3wkXC+s1znvLV1aT0jSxs+fA6PvbSJvr7vQPA9hQNfuYLd2z3a7227baW/PvQcQL7ksbPAY0NwvXBSED/9sVQ+6ShTvi6lhr61MjW+jnEfPiQR0bztl0G9FxS8PbwdV74KvNg9Kwp7vMx7mz3O01a+pQ1aPlIN3D2h+wa+F1iEvSvyNT71MS4/y/JWvhvCQj32LHc+VLnCvUFqAD0a5vE9El6YvN36BT4ZPx49CnSMvr9lBr6FaJq+Qm7Hvv+WZ71q7Km8PDIxvuXreL2qmMe9b72XPXfjqT519W0+cK42PTh/rL1jlsE8yIS9Pt9chD4WAbY+cmoJPpmpnz06ssM+bJrdvijtVL47uhM+vVOpPaPI5D0NRTy+dNOLPVKNoL6Cyic8yNdUvqtjAz6xqJw8ryOFvuT5uj7IoHC+EZIrvvlBLz6mRPc8HioAP9v0x75jtRI+WdiFPsG5kT6u0SG+yUNjPsivXb6VmbA9aucpPWWSjT4a7KE9AqnxvdRxVj6Y71A9Sg3IvZb9I792EpC+utcEvnLXn74v+dA+Ic1JPtPS+r2FKfw8WJTePvjORz4jBvc9WlysPhNKjT60JjE+I2jQPv4Loz0dfKi+BcmtvBZx6zyuRnA+2mu0vTMalr4uuuy8RINWPeAi3r2INJI+NtOiPTmL+b2BBDm+jNekvZmhYT6bh8e9r8mOPnFRcb7x0x+/yF7xvRJxob7pPKw9WokCv5BFaT7S1pq9XJgPPopbKj94RJS+Cl3WPOj5xrtCBuc+qXAGvuPIHD4FDpQ+8wC9vXM5gT5gmUM+4rWEvqieKD15zes9wm1BviqVIb9jt0Q9HWCJu8kKML1/U2e9mb4ZvlDX5L4cOJg+IAOmPiSI/D1XWpw9wDxnvou7tT5C4Wy+0P+cvc4f97zWbeM8rnLvvVe+5j4DpwI9aoNMPrdXKj4J9Ic9qKfKPfctfL7Dvga6N20Fv6u46DyHqzi/YtALPtQn2L7qfPo++MqEvomWgr2u2Ha96SgMvpwUv74dmJW+0nNePcJz2L7RO0o+B9xnvtWdVb1mu8490WfVPbarDT5S1Rq9Dr2Nvjrorj7DEp4/artqPGjBr73jeHS+TFcBv/jxDjy2gd27PnSvPi5+5jyzWcK+5C2hvgZd0b0ClK8+mZkMPsVoJj799hM+QE17Pa62pbwu2b09Nh7Vvtpe3r1eVMq+PrsKPnn/Pr5X59A7jIHVvFNNGT4O8gs7wsQyvrDUH77GnAS+Cqk7vQ1ekT5p+pM+9REHPt57CT1EnjY+52rCvkaU3by18Ha+gyWCPiE4ir6D140+0VlUPtajij5MhX4+xT3LPYHAgj73AnY+oHEOva6m2D0JdRe+WMJQPT/MPT4bRxe+uNiYPk69/j2tlL2+oWnnPI/ofz4kap89RNMJPqcVsb6Ry4893hJLPvI3qL2V3rs98tX3PbX37j1RfMK9bS3AvXncCT7Mj3e+mBdJvd5l6zrihJc90xPHvoJPPr4ZZAu+tukcPL4MgT46kbm9Ts1wvXaWSL1x3aY+1uZ8PXnN/LwJkhM/a0YavtYa4b2iMkw+vgSBvnvkZj6X3XE4TaOgvghmED3nCwS+ClsGPq+rub1BdLe7HuVYvkgA9z7O+G++AU6aPlrKp74OpI+9L+YDvnTqDDxV772+vJOCPskwaT0BdEi+pvS0PrJ7nD4viQm/uCMbviPf1b0zPkq+Hm6ePt2k3L2co8Q+jV0CvbJaMj1GpmW+nysxPpybW767I0A+hHZHPHOddL0q5J49GOh0PUJiIT7JzT2/55HdPRQ7A77+Z3++mfpVPpxLV75pmqS+VzR8vTZnsb0Vroo+O/lbvofeeT65G/a9+Tz/PZjYUb7wFTe+iW0tPd/vLD0RHCk+v4KrvRhG5r2dGVe+Rcynvtgr7b1o76m+pKpKvpSTrT0pLDE+J4oIvgjAJb7Xc4K+7nvKPqKXej1dHUG+Ks7DPju5Cr93JBY+uCmAvqhv3L6UiMG+ZPhBPocIgj+phZ29G4qgPk9YiT0r8Fe9acqLvlHbND4ZvIy9HUyOPsoXiL5F0be+qndjvDzd/TyaIVo/W27ivXCatr6+3gM/UHqgPbQwJ75dyLo9O6W5Ph5Jzr1ixI8+JHE1vrUfVz5iAtm98P99Pmcezz5CCcw7glhsvVx5Drt2ea6+ex/BvjRIwr1EwLa9Do93vSDsN72IhY6+xJMWPltOHT60Bs6+RaCqPocxRz4/o26+tNRnvkgalb6hPaK+mR+VO+Hnwj2rVOe+O1XevhkjKj4wViE+yzq+PhnWxj57WVo9foETvro8mr6g6II+c0omvkC2p77IZI89jYquvALfJr6ohme+SA8DPi6nPD7s6Lu+OBIkPuEGwL6qsnA+VzHKPf2CJr7Ygx0+Qn9CPrrYqb1nlrG9LpMNPbA7AT4FjfG+384PvplKY74/CGW+7wsJvo7wi77GjJw+9YJKvWqEfj7rh1o9AXoWvw4+vL2zFcS+68FuPeMeib5NfJU9wkXfvjqMvD0X8c8+qLD1PhQuN75t0DC+6d90vpONUr7rgMA+s9+CPtloQb3kGu69aE+lPXw11z2nDJu+shGYPV7l3T4yq6u9bUCSu7QGUT0uMtc95+oMvuQcDD76aMi+TIGePUCq2L2JXzU+yjvAvi92mjwfv0M+/iZAPgwHDD9zSsU+QnOWvL9P2b7n0ju+L9ICvqZJED7vUsq9o5zJPx5cqz5FecQ+804tPl0rm75Motw+PyAXP436pj0uCBI+6gmTPkDu0j4F/tW9Xb5jPGWOJD8ntai+g6bNve3bs7/34SW91BjVPM9RGD9wpjk/owxCvmE3uL44QFu+JQMwvrpcAr6nXKY9hfoLP0LzK764jUQ+OwpEPmsxr7wBxpk+0shZPgKPg77xdhw+44tYvdG4gb4YuJ07AfZ5vdcw4T1sutC+leFGvhGsQj6Tl3S+0TV0PrxHtT6CkZm+BZN8vry8Dj7MiJE9gR6bvqI6Ez+WHMS85UBqPqqpgj67HZ++aEK4vclNWb7XpSW+/eZavuuygL7qB00+qnFzvrObST0rE9w9zimovuuPGz51kCY+oOa/vNDe3j0rf64+LRegvT4VO76ZMiK+D9TnvaVHGD01YBy+TXTWviZAGT80yw0/hS+YPhFxAb5Efmg9TMqFPjBWOT4jmKg9M+7jvjTGDL7R5Iw+AB6yvg84hD0b7pY+/MNUPESQmz0QSLO9odC1PUBJNj7QPtG9SFaGPqxaP77ImNm9TgWxvuiDPLusvs++C98OPBZLuT0Ul7O+xrZUvCrPdr7mHZs+PMP+PTpJQr6PPoo96/VSvpBEnb5aSAY+8VsfvZX3r76KiHK8sBEzPjCNEj4MH/G8VMY2PTAKir0v77I+Zu2vPqgXTr6rOAo/s3ObvY9krb1esb6+ARWPvly81b7j0re+7YaJvmpjZb6YMgO+yl4mvV8aG75wc/K88c+ePcQE4T5qFam+labTPKEGBz23MTG9hB4jPn5gYr4K9Ey+jAV4Po8KbL05Jrs9zpQ6PgCkAr6GzXI9901evpQ7uD2Bg+c+L+iKvjy9NT6fNUM+h4KYPJDd4j43AI89JpHuvvtNxT7RNM09mE6vvuN6HL5lLQO+NKsZvV4NGD7X+rQ9vw4APv9gVjzUKzY+tH06PncZSj2SCDy+ae2suzheJj3JVMQ9Sm69vCkiLb74PIy85Ts+PQM6Dj8rh4M7eMPOPOQljr0oATy+durRugeeU76bLJ69Lda3vuz5Ar5trGi+kw1dvV7hLD6YZyc+/y5cv9S+B77knsi9xO9RPiXx5D2ddwA70vKQvsrcfbxDjkU+ZhKovRLqeb6nbWM+igePPnEN371OC829aqS/PbEjlj0VZJa9m+BaPsaAiD44DIu+B8RjPl2mjT4YeIm9P1B9vkfwbr7eYkI9n/ATPy7YoDmC6TA9xWOMPrz0TL57Wz2+3+/CPRXBwL5bkYG+ckj4vusWqT5EwzW963NLPtxrHT7Vrye8pJbXvQ2w2b54lvi7wMR2vhMFJj6RHzQ+cQN+vY0alr4ycMg+iZ+2Pi7YAb6fDV4+xx1WPso4CL2xL9++nM5ivqjrEj4ijIC+d/UeO25ZXT6VqcS9zgaaPfrg9D3BMvI8+qzJvJ977D3Ftd2+Y3dOvg==" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.7534246575342465 | 32.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 390a29fe-2cfd-43c4-a247-69e692763e17 | TCGA-XF-AAMG | null | 23 | released | 1.78 | Yes | 1.17 | 7.4 | 49 | -18021 | null | hispanic or latino | male | white | Alive | 1955 | null | 18021 | null | N0 | Stage III | T4a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2004 | null | Not Reported | false | Not Reported | 3366 | 0 | 540.0 | 3B9E30D8-1671-465F-9425-951912C1ECF5 | TCGA-XF-AAMG-01A-11 | 5.0 | 0.0 | 5.0 | 0.0 | 0.0 | 30.0 | 65.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMG; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.78; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.17; rna integrity number: 7.4; age at index: 49; days to birth: -18021; ethnicity: hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1955; age at diagnosis: 18021; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3364.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2004; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3366; days to sample procurement: 0; initial weight: 540.0; portion submitter id: TCGA-XF-AAMG-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 65.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 3364.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 0ec37c2c-8d90-48c1-9cbc-69fe6473c980 | TCGA-XF-AAMH | null | 23 | released | 1.81 | Yes | 1.59 | 8.5 | 80 | -29547 | 344 | not hispanic or latino | male | white | Dead | 1925 | 2005 | 29547 | null | N1 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2005 | no | Not Reported | false | Not Reported | 3271 | 0 | 150.0 | 5262C4FA-045C-4F50-8C82-D5CA53A406F1 | TCGA-XF-AAMH-01A-11 | 0.0 | 0.0 | 10.0 | 0.0 | 0.0 | 25.0 | 65.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMH; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.59; rna integrity number: 8.5; age at index: 80; days to birth: -29547; days to death: 344; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1925; year of death: 2005; age at diagnosis: 29547; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2005; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 3271; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-XF-AAMH-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 65.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.095890410958904 | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 8f10e006-531a-49ac-b51b-df3fdcb20929 | TCGA-XF-AAMJ | null | 23 | released | 1.9 | Yes | 1.57 | 8.1 | 70 | -25838 | 1670 | not hispanic or latino | male | asian | Dead | 1936 | 2010 | 25838 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2006 | yes | Not Reported | false | Not Reported | 2914 | 0 | 480.0 | 40212BF3-FE4C-4B89-8583-76C73560DD2C | TCGA-XF-AAMJ-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 80.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMJ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.57; rna integrity number: 8.1; age at index: 70; days to birth: -25838; days to death: 1670; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Dead; year of birth: 1936; year of death: 2010; age at diagnosis: 25838; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2914; days to sample procurement: 0; initial weight: 480.0; portion submitter id: TCGA-XF-AAMJ-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 329d372c-c44e-4595-b8ac-474c5a1321a5 | TCGA-XF-AAML | null | 23 | released | 1.85 | Yes | 1.68 | 8.7 | 75 | -27422 | 232 | not hispanic or latino | male | white | Dead | 1932 | 2007 | 27422 | null | N0 | Stage II | T2b | not reported | 0 | C67.2 | not reported | 8130/3 | Papillary transitional cell carcinoma | yes | No | not reported | Lateral wall of bladder | Not Reported | Lateral wall of bladder | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2288 | 0 | 300.0 | 919C33FD-44F5-440A-8A7B-B8EBACBCCC55 | TCGA-XF-AAML-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 80.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAML; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.68; rna integrity number: 8.7; age at index: 75; days to birth: -27422; days to death: 232; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1932; year of death: 2007; age at diagnosis: 27422; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2288; days to sample procurement: 0; initial weight: 300.0; portion submitter id: TCGA-XF-AAML-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 82f4c181-e022-4799-9f7f-01abcdc3803e | TCGA-XF-AAMQ | null | 23 | released | 1.9 | Yes | 1.76 | 9.7 | 59 | -21660 | null | not hispanic or latino | female | white | Alive | 1947 | null | 21660 | null | N0 | Stage II | T2a | not reported | 0 | C67.2 | not reported | 8130/3 | Papillary transitional cell carcinoma | no | No | not reported | Lateral wall of bladder | No | Lateral wall of bladder | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2785 | 0 | 570.0 | 6A895DCD-0417-4FC1-AE0C-CB72BE55E889 | TCGA-XF-AAMQ-01A-11 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMQ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.76; rna integrity number: 9.7; age at index: 59; days to birth: -21660; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1947; age at diagnosis: 21660; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2177.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.6575342465753424; pack years smoked: 12.0; is ffpe: false; composition: Not Reported; days to collection: 2785; days to sample procurement: 0; initial weight: 570.0; portion submitter id: TCGA-XF-AAMQ-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 2177.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 0.6575342465753424 | 12.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 818f5a45-4deb-49e4-9a73-55ef4269de4c | TCGA-XF-AAMR | true | 23 | released | 1.87 | Yes | 1.83 | 8.5 | 48 | -17670 | null | not hispanic or latino | male | white | Alive | 1958 | null | 17670 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | null | Not Reported | false | Not Reported | 2686 | 0 | 750.0 | 907112FF-1E09-4BD1-97BE-01E9BAC0E4D9 | TCGA-XF-AAMR-01A-31 | 3.0 | 0.0 | 2.0 | 0.0 | 0.0 | 70.0 | 28.0 | 95.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMR; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; concentration: 0.15; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.83; rna integrity number: 8.5; age at index: 48; days to birth: -17670; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1958; age at diagnosis: 17670; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2790.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2686; days to sample procurement: 0; initial weight: 750.0; portion submitter id: TCGA-XF-AAMR-01A-31; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 70.0; percent tumor cells: 28.0; percent tumor nuclei: 95.0; | [
1024
] | "CvCmvngqoT7JrlC+L9lRPSiDNj4O4+Y+LGjyvf1mJj5Dju+9HAYbvuZpxz4sRhc9WUC9PFMLcL6QqEu+Hcx+PsRjh7wx/E49BXcIvqifTz6f++691LrmPocGRz7uelu9uSFuvn06g732R3k+ent1PgFqAT20aNc8aC/pPRMbTz4Ftm++64mbvhygUr0Horo+oQ9lvjPAbb5cz8E9lqSavC4vBD7JRqk+DuP7PW++Y75jws6+OGiSPcntkLvM4w2+x2xoPqVXor1sski9You2ve5cuL0T45e+yBtuPR/nqbyI/D+9T4KTvgnewj6xQTM/xhf7OlMYXzxHPxG+IFXEPuQ3F76V63c+PvaIvm5JgL6VlZc+rdQmvu6TAr4POl0+kRFqPsmdhD6zQTm+ct2nvOLJk70/zew9iIoivsSuvT2TwK09qTsPvrGfxD2fRi6++HmBvtSLjL6X1JS8Mea4vtrl5z54LcW+/NcePoNtaj5XgVA+4K1RPDWVtzynYI69ogQ7PI5rYb6iJZI+7qryPctO6z6lV7I8bNlnvdCixTrFQP09weUIvgobDj7U97W97rVIvkA7Dr7DziE+lBLoPuSR6jzeh7E9eu2AvTtByD2BODk+g2V8vcnl5L72r/08hKMuPkBIEj/0bzi+YnFzvqTTsrxsiVS+cND5PujRxz34sgK/63SAvXpQLb5UBIe+pI1ZPa7FET7km56+qzGYPsbhbb+evCy+Rf+OvvEYLj1YlFY7cncFPhIrwj2Ixdk++xuvvGyKuj7Hh5W+pMNcvg/7bb6H3JM+ePWCvj1FIz17TV09lODfvtprjL3dE+y+NF+0Pp8YlLufr+07tAScPpoaqjsFFU88u2idPUJT1D0tCJS+XhdpvAUyQT5e0ka+MjcxPsEEhb0PZAu+Z+mivotvXz7wAvK8NUl6PmPsSr1GSwy+GklOPXFOab1DtwM/FrjsvfZSCD8PjZO+jt6WOvCchLz2+oe9HFz5vcO5Lr9qD4Y9MUTKPZGUBL7t4Yc+maStPtC0E70t8pE9amEUvVlFq73qHr29m7EzvXlzJr7eU+++l23wvsmmTL7iA3i80/GdPgpRsTxQvJe+PsaMve4tKb7KNRi+sInqvgmW4z0BAMw+ZdI5Pjb8Dz22JYy+/U7CvkNOhD3UYzu+MZvfPU+pEL/XVbc9IHBxvgbeJ75mWs28KOoUvpb+q74HSAg/BHIsPXBEFT5DUia+9I1SvjsZMD0EMLG+absAvn3ber1cbc+9xuFePoYzhj7hXKM9bMiAPq9QWL36D1K+GkkuvTho2zyW0HI9xkf+vDXFq76c7Ys9W2YdPQIEJD4S5726/5itPhFScL4ClbjAsNEGvZPAAz8QBD0+QmFtvqE4bb7FXjG+frULPluoDj2jhBm93/U+PRUVZb6LD9M9w6P0vKIN9D0eryq+RdtoPi/A0j2yqdS9MfcsvZIWVD5iQyA/j/UIvj4eRz3PHmo+mhfnvYAWQT0s4xQ+6ip6veofwz3+wxs7e8aNvr4NNb40R3W+TsO8vjZLsb09pDe8Fakvvq+5ub2qOoe9eogsPQltsD5tyGM+9gclPXkxCb5otT49P66DPuAPoD7HWqE+QX0QPlq8Wj3RTLg+l07XvunJWb45Gwg+1eknPcVqED4hNRu+gIxcPXMhp74dxrM7mVYGvhs3+D2Ugxc97gGIvtIUyj5gRmu+uIzvvYU1IT5eGSo9q5HkPlROt75Dnjc+98GLPnUykz4CJC++0BhLPoa9LL5yqb899mU8PTjQhj4t6to9/nMEvj50RT7fIAs+TmelvaRADb+a4oy+2nj/vagVib4KVMk+geRMPgU2Eb4Vfq08VQi9PgDZAj6zWb89EHmePqwjYz7uwxg+Kd2lPgrsrD1Wn6O+xGldO7MDUDwG0n4+/jHBvbF+kb4HkbK8qgaLPQrg9b16Wos++lu+PZQ2Hr7QmAy+jmD+vWHjWz4KYoK9Hj+DPl0tUb5szRO/oo3QvaeFTb6K39I9HJL+vtH9Gj5gS5m9f4v1PZMcET8PvWm+1OM2PXr4l71mLvI+wcYHvvRFFT5yNIo+9DULvjYtbD7U7lQ+D2OIvgyksD232cI9BWs/vrlnGL+nAVI9B8O9uxEKHTyrtz+9J/MCvkJN275JA4g+YeSXPubYzz2fp5M8X+mDvs7WnD648mC+JgwovUDMQb1DyUM9HbizvVwD4j4bkwU9DhFjPvsrWj5S2fQ8TUIHPsS9Or4wmVW9N1MIv6kG0z0PBDi/708xPhC11b5Zf+Q+n9OVvmp6kb2i3mC9guQUvoYfrL52PoK+K+5iPRVQzr7AHSo+QftWvkMsiL24Qo09ZbJdPc+m2D3gY1e8FqGRvtJ2oD6UUZ0/bd2YPBCoBL2R4XK+3b3SvobnsTx/o1o9xCW5PrbWxLw5krK+Kc25voqT6r0eaqQ+JvlSPuKGBj4hlQU+HUmrPCAQbLyPyVQ9MPncvnSWMb4kncW+nIvlPeLRL76i4eQ8qhrVu3iYAD5KMX48uFE8vtJNAr67CKy9P3lDvO6zlz6a544+K+k9Pi7MoD14RiI+qifSvj/FIz2lyV++yHtfPuttdr7Gv2c+SEVJPoh4fT4e/2I+xCT9PcePZz7bVqI+a1Q+vZp2cD1qw8u9bErQPaoFFD6iZTS+/9GfPoZ3kT3lkMq+F1MTPClyYD6XG6o9AAwCPp1Gt74NGkE7maSHPnV5D769/nU9UElNPVyF0T06/d+9ToA1vajKED7Jwym+F+aovQmlgrztcrs9fl+tvoRfV74N0u29U/OGPYsmgj6lT7q9hvl8vfAeAb0C8ZU+PCy/PcpQdbyVPBI/rvolvlLN4b05SlU+7ft8vhbzaT7RimG8iTyXvmm79Ty3HZm9nWmQPVynx73qEw45FcJnvvnr6T5O80i+j8qCPpM4s76O4IC9NyQFvuRj9zx9h7e+44dhPtrtMz0bGSS+Qg2DPknwqD5bIw+/xnsTvht84L2k7xu+QwqbPrMl9r3/HaE+p44mvRPoaLsuvWW+G685PkM4er4/vy8+TaVnvR32Wb3iEsA99khAvbKeqD0fRVW/LBkFPXMxob27JoO+ofxDPi0KV77Jvpm+SFiUvXMbAr7jb3Y+XDlfvqqkcD49zs29TvXkPT98Ib4EBMW9SQQ4vZaS7rp+TiU+Or+IvRiexL3mnTq+OVCovg2ey70INY++31UovmPa9D1YB08+LhyQverXKb4aU4i+ROa2PpFJnD3PK0a+oQS3PhZwAb++Zh0+8JObvoUpyr5KVKm+8J1mPg3qhj9UWtS9ThWQPh2cmT0hqJC9SfyNvmNgkD5AreW9n12GPvm3ab6ygLW+vVe/PPIsi7zWJkE/elqUvXrspr7QkOs+lvrdPe5z+b2Q5is93GigPhL1A77eUYw+yc5Ovi5AKD7f7b+9hjwaPumt2D5Kgqy83JyGveW0ITxZmJu+WVbYvvKDkL0h6dW9pIctPOcc372V01C+ODZOPseCHj6VWbm+MhqUPjKsFD6ZCUK+P7xdviw3R76Jp7m+EhOrPHEIuT3rd+S+qgSuvkAY9j29xAU+zA2mPvuMuz71x7M8yzj5vRM0mL72r18+rM8uvii7kb6OM6U9v7qmvP8mDL7Kx06+9lkSPvxL+j1Xt5W+qxIFPvFct75Tfy4+FcEIPu0T873qQSs+SzJoPm3DBb7i1fq9ciq6PPs0dj17Yey+SOPuvbASJr56+Ge+utwbvlDXjb4qG5M+5bwWvD+weT6ufiU9UvEAv/+sFb3xw9y+G4+iPVOWZb7Kerc9WTXsvsGtFj5/098+s8HoPkA6I75hYjq+JwRpvn0Par5eVsQ+aqh+Prq+uL0rewq+xJoNPaQBCT5ejpO+K926PYwM1z5Atq+9ei8VvIJrgj1qo9U9/FkKvr6DKj7lBdm+ZoEePm3Qur0QET8+yrCqvoZ4UDwoCBo+Rwc8PsZr5D4pia4+R/Mjva9c6b6Zvey9w/DLvXoyTT4IiQi+DHK+P1A4wz4xL+4+obMgPnO4gr7LFwg/JM0QPyCjzj2XySM+AOx1PuokzD5I4nq9X7XkPMKzFz8Z8Zy+z5Mivb6cpL+11YK9izM+PManHj/lwCY/85tevotJo74/vUC+neAlvj9PB76XZOo9mjkWP33QUL7Khy4+3AJZPtU+yLyLbYo+Ejx3PjnWa74piSQ+vZBJvbbajL5EfDi8MkQeve0V+T1qlaO+Tp4QvtEcTT7/Bmm+YYx0Pi6hrj7mOIK+IVF/viRoFj70a8U9mEWMvtouBT+9vi+9UBtfPrVzcj5VhJq+bm+dvcmKRb4CTcS9p/ZNvg8KfL6R3Ww+PMCEvthmQT1dl9U9muuivhDOLz7Bh+89Y/eHvUZd1T36xpE+GY2VvPndZ77kDQS+dA0FvhDRkT0gq1O+qQbjvtXQFD8ylf4+SK6NPvcQMb5v2II9g71PPrXJFT7XrwA9PaDTvqkQBr7WkHQ+pO6mvkupWj2qdag+eGLeuuSdFj2zPCK9zcfIPe5nNj7EtRG+U9WBPu0XO74Wu5e9Mj2zvpcEPDyIVKC+cLh8vUjVFj0NEJ6+f8+XvCXDc77A6J8+op7kPRVxLb6Th/09HYBQvtLLhb7Cl849I33TvGvIpr4rYyQ9WoDtPfwJBj4y9eK88qTcPBao/L1Gm6M+TUqcPjl+OL4IYAc/1/RhvWkKMrxOXaa+8PCXvsghv76OrKy+MkF2vgrAZr5mlrG9Ngv2vM6EJ74322e9ApCPPU+SwD4ll5W+5ogoPZmcYrxNsRq9icc4PiD8eb4QCjS+z2CUPn+xmL38dac9NyxAPnJ0L75pL4C8N/guvqsD8z0FZ80+f2OkviYqHD4Tkks++QlkPcn83T6FNXI9DDHlvl0/zT5ZFHk9TQ22viOwFr57neO9RBYhvbalCj6SlZs9oV0DPrAkETzVbQc+jvNbPoxxAz2DAGG+hDQTvVH8rDs2Yok9/FLuPCxnDr7wzk+9k0OkPdFTBz8uEUW60up/PJcIxL3HuTa+bFgOPc8eQb7Ci1u914e8vppznr24+Y2+iePovDrcBz7le0s+6lxav6e7Gr7JT/m99RlmPuBBFz6T6K+8PCR3vjrkdjyajlI+DID2vXvdi74VdoA+ov2gPvEjg722oBW+7yd/Pa/RBj0jFgO+Xk0wPjP4UD6sBZi+/G6APpzPfD7h9j29Jtx1vtppT75LQxE+L/QGPwsYGL3r8ao8uHKOPvf4Z75cJHW+NN/PPUl4zr6r94O+V6UCv6XOnj6I+2q9wTgUPnruEj6B0kE8UsXEvaWe075vBTq7hPtavv/FUz5EuRU+tQc5vVtfn77GUrs+fcSYPu5QDL5RTDs+4GNdPjFThbxmfe2+7jN1vk5f3D1OPFG+PrQUPa1oaj6ECz29e2IKPW8LuT0L0EY9nLe8O38T9z0HMPa+hJ8/vg==" | null | 2790.0 | null | null | null | null | null | null | null | 0.15 | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | ada95115-275f-4229-aa00-f298a5ff931c | TCGA-XF-AAMT | null | 23 | released | 1.92 | Yes | 1.63 | 8.1 | 75 | -27397 | 90 | not hispanic or latino | female | white | Dead | 1931 | 2006 | 27397 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2680 | 0 | 800.0 | DDAC8877-7594-4939-B98F-0BAB7D3CDBB9 | TCGA-XF-AAMT-01A-11 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 65.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMT; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.63; rna integrity number: 8.1; age at index: 75; days to birth: -27397; days to death: 90; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1931; year of death: 2006; age at diagnosis: 27397; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 2680; days to sample procurement: 0; initial weight: 800.0; portion submitter id: TCGA-XF-AAMT-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 65.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 5th | null | null | null | 0.547945205479452 | 10.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 19da59a8-b67a-438d-900a-92a71e03bef3 | TCGA-XF-AAMW | null | 23 | released | 1.9 | Yes | 2.01 | 9.0 | 79 | -28903 | 253 | not hispanic or latino | female | white | Dead | 1927 | 2006 | 28903 | null | N0 | Stage IV | T2b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2682 | 0 | 640.0 | F763F16E-C76C-4A58-9096-8B19B9825C9B | TCGA-XF-AAMW-01A-11 | 30.0 | 70.0 | 0.0 | 0.0 | 10.0 | 30.0 | 60.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMW; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.01; rna integrity number: 9.0; age at index: 79; days to birth: -28903; days to death: 253; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1927; year of death: 2006; age at diagnosis: 28903; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2b; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2682; days to sample procurement: 0; initial weight: 640.0; portion submitter id: TCGA-XF-AAMW-01A-11; percent lymphocyte infiltration: 30.0; percent monocyte infiltration: 70.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | null | 5th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | edc290bf-9731-4f03-bc37-64542e78e8bb | TCGA-XF-AAMX | null | 23 | released | 1.89 | Yes | 1.84 | 9.7 | 87 | -31884 | 206 | not hispanic or latino | female | black or african american | Dead | 1919 | 2006 | 31884 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2730 | 0 | 1410.0 | 22526530-46B1-4DB8-A1EB-2D97AB18FD63 | TCGA-XF-AAMX-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 25.0 | 75.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMX; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.84; rna integrity number: 9.7; age at index: 87; days to birth: -31884; days to death: 206; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Dead; year of birth: 1919; year of death: 2006; age at diagnosis: 31884; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2730; days to sample procurement: 0; initial weight: 1410.0; portion submitter id: TCGA-XF-AAMX-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 9d2b19eb-bd61-490e-982b-fadf2c4aadf7 | TCGA-XF-AAMY | null | 23 | released | 1.86 | Yes | 2.01 | 8.9 | 78 | -28509 | null | not hispanic or latino | male | white | Alive | 1928 | null | 28509 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2006 | null | Not Reported | false | Not Reported | 2758 | 0 | 1090.0 | AEF3C925-7B93-42F8-921B-9A2D3912DE99 | TCGA-XF-AAMY-01A-11 | 4.0 | 1.0 | 0.0 | 3.0 | 0.0 | 25.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMY; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.01; rna integrity number: 8.9; age at index: 78; days to birth: -28509; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1928; age at diagnosis: 28509; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 3011.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2758; days to sample procurement: 0; initial weight: 1090.0; portion submitter id: TCGA-XF-AAMY-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 3011.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 5th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | ed36d054-53c4-465c-bd84-6ec5227097bf | TCGA-XF-AAMZ | null | 23 | released | 1.89 | Yes | 1.74 | 8.5 | 81 | -29667 | 1348 | not hispanic or latino | female | white | Dead | 1926 | 2010 | 29667 | null | N2 | Stage IV | T3a | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2557 | 0 | 370.0 | 45680E92-721E-4332-9E45-7F134D7AFCAE | TCGA-XF-AAMZ-01A-11 | 2.0 | 1.0 | 0.0 | 4.0 | 0.0 | 15.0 | 85.0 | 85.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAMZ; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.74; rna integrity number: 8.5; age at index: 81; days to birth: -29667; days to death: 1348; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1926; year of death: 2010; age at diagnosis: 29667; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2557; days to sample procurement: 0; initial weight: 370.0; portion submitter id: TCGA-XF-AAMZ-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | e7e95597-ef88-4442-8c01-8d633822e7b5 | TCGA-XF-AAN0 | null | 23 | released | 1.86 | Yes | 1.43 | 8.5 | 68 | -24877 | 1718 | not hispanic or latino | male | white | Dead | 1939 | 2011 | 24877 | null | N2 | Stage IV | T4a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2007 | null | Not Reported | false | Not Reported | 2551 | 0 | 690.0 | 0F0F3285-4798-4D8F-95D3-20AB4F0ED269 | TCGA-XF-AAN0-01A-11 | 2.0 | 1.0 | 0.0 | 4.0 | 0.0 | 15.0 | 85.0 | 85.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN0; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.43; rna integrity number: 8.5; age at index: 68; days to birth: -24877; days to death: 1718; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1939; year of death: 2011; age at diagnosis: 24877; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; alcohol history: Not Reported; cigarettes per day: 3.0684931506849313; pack years smoked: 56.0; is ffpe: false; composition: Not Reported; days to collection: 2551; days to sample procurement: 0; initial weight: 690.0; portion submitter id: TCGA-XF-AAN0-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 6th | null | null | null | 3.0684931506849313 | 56.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 5378f375-aa04-4eca-bc35-190b3efb52bc | TCGA-XF-AAN1 | true | 23 | released | 1.82 | Yes | 1.87 | 10.0 | 75 | -27687 | 941 | not hispanic or latino | female | not reported | Dead | 1931 | 2008 | 27687 | null | N0 | Stage III | T4a | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2006 | no | Not Reported | false | Not Reported | 2644 | 0 | 710.0 | 7BD47644-AADB-40AE-A5BA-997B74F6AD80 | TCGA-XF-AAN1-01A-31 | 7.0 | 0.0 | 4.0 | 0.0 | 0.0 | 18.0 | 78.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN1; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.87; rna integrity number: 10.0; age at index: 75; days to birth: -27687; days to death: 941; ethnicity: not hispanic or latino; gender: female; race: not reported; vital status: Dead; year of birth: 1931; year of death: 2008; age at diagnosis: 27687; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 2.5753424657534247; pack years smoked: 47.0; is ffpe: false; composition: Not Reported; days to collection: 2644; days to sample procurement: 0; initial weight: 710.0; portion submitter id: TCGA-XF-AAN1-01A-31; percent lymphocyte infiltration: 7.0; percent monocyte infiltration: 0.0; percent necrosis: 4.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 18.0; percent tumor cells: 78.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 6th | null | null | null | 2.5753424657534247 | 47.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 987e8157-fbea-40f3-aa01-0092d6cceb97 | TCGA-XF-AAN2 | true | 23 | released | 1.82 | Yes | 2.13 | 9.2 | 73 | -26720 | 1869 | not hispanic or latino | male | white | Dead | 1934 | 2012 | 26720 | null | N0 | Stage II | T2b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2505 | 0 | 280.0 | 00D2C4D3-B209-4B54-992D-54E8048415BA | TCGA-XF-AAN2-01A-11 | 2.0 | 1.0 | 20.0 | 4.0 | 0.0 | 15.0 | 65.0 | 65.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN2; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.13; rna integrity number: 9.2; age at index: 73; days to birth: -26720; days to death: 1869; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1934; year of death: 2012; age at diagnosis: 26720; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.095890410958904; pack years smoked: 20.0; is ffpe: false; composition: Not Reported; days to collection: 2505; days to sample procurement: 0; initial weight: 280.0; portion submitter id: TCGA-XF-AAN2-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 20.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | MX | 6th | null | null | null | 1.095890410958904 | 20.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 24ad2168-b25a-4de8-a021-dfe1c74fcc6e | TCGA-XF-AAN3 | null | 23 | released | 1.83 | Yes | 1.55 | 7.9 | 76 | -27909 | null | not hispanic or latino | male | white | Alive | 1931 | null | 27909 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2007 | null | Not Reported | false | Not Reported | 2445 | 0 | 590.0 | A0641D3F-1AB4-446B-B5AB-BB5882E82730 | TCGA-XF-AAN3-01A-11 | 2.0 | 1.0 | 0.0 | 4.0 | 0.0 | 25.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN3; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.55; rna integrity number: 7.9; age at index: 76; days to birth: -27909; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1931; age at diagnosis: 27909; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2625.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2445; days to sample procurement: 0; initial weight: 590.0; portion submitter id: TCGA-XF-AAN3-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 2625.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | b6c36037-56b1-4957-8df8-fda72b0d3c39 | TCGA-XF-AAN4 | null | 23 | released | 1.83 | Yes | 1.44 | 7.4 | 77 | -28302 | 823 | not hispanic or latino | female | white | Dead | 1930 | 2009 | 28302 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2457 | 0 | 900.0 | 4BE36D8A-9841-4CC7-9331-A2A14D5C2C30 | TCGA-XF-AAN4-01A-11 | 22.0 | 2.0 | 5.0 | 2.0 | 0.0 | 50.0 | 45.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN4; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.44; rna integrity number: 7.4; age at index: 77; days to birth: -28302; days to death: 823; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1930; year of death: 2009; age at diagnosis: 28302; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; composition: Not Reported; days to collection: 2457; days to sample procurement: 0; initial weight: 900.0; portion submitter id: TCGA-XF-AAN4-01A-11; percent lymphocyte infiltration: 22.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 45.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.36986301369863 | 25.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | c1591625-e794-4155-8ae4-b74d6264659f | TCGA-XF-AAN5 | null | 23 | released | 1.79 | Yes | 1.82 | 7.3 | 61 | -22411 | null | not hispanic or latino | female | white | Alive | 1947 | null | 22411 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2008 | null | Not Reported | false | Not Reported | 2172 | 0 | 350.0 | 43F485E6-346F-483A-826F-6960F00025C9 | TCGA-XF-AAN5-01A-11 | 10.0 | 2.0 | 15.0 | 2.0 | 0.0 | 18.0 | 67.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN5; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.82; rna integrity number: 7.3; age at index: 61; days to birth: -22411; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1947; age at diagnosis: 22411; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2293.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; is ffpe: false; composition: Not Reported; days to collection: 2172; days to sample procurement: 0; initial weight: 350.0; portion submitter id: TCGA-XF-AAN5-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 2.0; percent necrosis: 15.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 18.0; percent tumor cells: 67.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 2293.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.643835616438356 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 9d7fbdeb-ea3d-4e07-8527-23c5997d77cf | TCGA-XF-AAN7 | null | 23 | released | 1.86 | Yes | 1.91 | 10.0 | 60 | -21951 | 565 | not hispanic or latino | male | white | Dead | 1948 | 2009 | 21951 | null | N1 | Stage IV | T3a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2008 | null | Not Reported | false | Not Reported | 2087 | 0 | 1300.0 | B680364D-6FEC-45A5-95FC-1055E37DFCE2 | TCGA-XF-AAN7-01A-11 | 2.0 | 0.0 | 3.0 | 0.0 | 0.0 | 7.0 | 90.0 | 96.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN7; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.91; rna integrity number: 10.0; age at index: 60; days to birth: -21951; days to death: 565; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1948; year of death: 2009; age at diagnosis: 21951; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 2087; days to sample procurement: 0; initial weight: 1300.0; portion submitter id: TCGA-XF-AAN7-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 7.0; percent tumor cells: 90.0; percent tumor nuclei: 96.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 5th | null | null | null | 2.191780821917808 | 40.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | aa14e232-c6c6-4075-9d15-e1857373d233 | TCGA-XF-AAN8 | null | 23 | released | 1.8 | Yes | 1.27 | 7.1 | 74 | -27309 | 118 | not hispanic or latino | female | white | Dead | 1933 | 2007 | 27309 | null | N0 | Stage III | T3b | not reported | 0 | C67.4 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Posterior wall of bladder | Not Reported | Posterior wall of bladder | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2275 | 0 | 1220.0 | 07718E82-778A-4797-BBAD-4494AAE3CAA2 | TCGA-XF-AAN8-01A-11 | 10.0 | 0.0 | 10.0 | 3.0 | 0.0 | 75.0 | 15.0 | 85.0 | project id: TCGA-BLCA; case submitter id: TCGA-XF-AAN8; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.27; rna integrity number: 7.1; age at index: 74; days to birth: -27309; days to death: 118; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1933; year of death: 2007; age at diagnosis: 27309; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.4; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Posterior wall of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Posterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.287671232876712; pack years smoked: 60.0; is ffpe: false; composition: Not Reported; days to collection: 2275; days to sample procurement: 0; initial weight: 1220.0; portion submitter id: TCGA-XF-AAN8-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 75.0; percent tumor cells: 15.0; percent tumor nuclei: 85.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 3.287671232876712 | 60.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 95520295-90d3-4b4e-86b6-4bd856723315 | TCGA-YC-A89H | null | 23 | released | 1.87 | Yes | 2.06 | 8.3 | 78 | -28741 | null | not hispanic or latino | female | white | Alive | 1935 | null | 28741 | null | null | Stage II | null | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2013 | null | Not Reported | false | Not Reported | 205 | 0 | 380.0 | 0E633B83-3C48-4D53-B7BF-EFE0BDF73DED | TCGA-YC-A89H-01A-11 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-YC-A89H; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.06; rna integrity number: 8.3; age at index: 78; days to birth: -28741; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 28741; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic stage: Stage II; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 573.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; cigarettes per day: 1.726027397260274; pack years smoked: 31.5; is ffpe: false; composition: Not Reported; days to collection: 205; days to sample procurement: 0; initial weight: 380.0; portion submitter id: TCGA-YC-A89H-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 573.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | 1.726027397260274 | 31.5 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 97d6568c-0a89-4327-8988-71e81ee8dae6 | TCGA-YC-A8S6 | null | 23 | released | 1.85 | Yes | 1.81 | 8.2 | 71 | -26130 | null | not hispanic or latino | male | white | Alive | 1942 | null | 26130 | null | N0 | Stage II | T2a | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2013 | no | Not Reported | false | Not Reported | 21 | 0 | 220.0 | 9945C51F-169C-48D5-81FC-9BFEA1C276C6 | TCGA-YC-A8S6-01A-31 | 4.0 | 2.0 | 0.0 | 4.0 | 3.0 | 32.0 | 65.0 | 65.0 | project id: TCGA-BLCA; case submitter id: TCGA-YC-A8S6; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.81; rna integrity number: 8.2; age at index: 71; days to birth: -26130; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 26130; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 293.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 21; days to sample procurement: 0; initial weight: 220.0; portion submitter id: TCGA-YC-A8S6-01A-31; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 3.0; percent stromal cells: 32.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0; | [
1024
] | "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" | null | 293.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 6ee03f14-14ac-4cb9-bd23-b69704176301 | TCGA-YC-A9TC | null | 23 | released | 1.88 | Yes | 1.91 | 8.6 | 71 | -26283 | 20 | not hispanic or latino | male | white | Dead | 1942 | 2013 | 26283 | null | null | Stage IV | null | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2013 | null | Not Reported | false | Not Reported | 39 | 0 | 490.0 | DA4F1C21-0B25-452C-BBC4-B27ECE0216F5 | TCGA-YC-A9TC-01A-22 | 3.0 | 2.0 | 5.0 | 5.0 | 0.0 | 20.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-YC-A9TC; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.91; rna integrity number: 8.6; age at index: 71; days to birth: -26283; days to death: 20; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1942; year of death: 2013; age at diagnosis: 26283; ajcc clinical t: T2; ajcc pathologic m: M1; ajcc pathologic stage: Stage IV; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 39; days to sample procurement: 0; initial weight: 490.0; portion submitter id: TCGA-YC-A9TC-01A-22; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M1 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 661967e5-94b3-4f98-9402-6ab137893c16 | TCGA-YF-AA3L | null | 23 | released | 1.83 | Yes | 1.82 | 7.9 | 47 | -17268 | null | hispanic or latino | female | not reported | Alive | 1966 | null | 17268 | null | N0 | Stage II | T2b | not reported | 0 | C67.2 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Lateral wall of bladder | No | Lateral wall of bladder | Not Reported | 2013 | null | Not Reported | false | Not Reported | 88 | 0 | 80.0 | B30B0CE0-2C49-4970-A67A-1F777A4E00BB | TCGA-YF-AA3L-01A-11 | 2.0 | 1.0 | 0.0 | 3.0 | 0.0 | 20.0 | 80.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-YF-AA3L; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.82; rna integrity number: 7.9; age at index: 47; days to birth: -17268; ethnicity: hispanic or latino; gender: female; race: not reported; vital status: Alive; year of birth: 1966; age at diagnosis: 17268; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 364.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; cigarettes per day: 3.287671232876712; pack years smoked: 60.0; is ffpe: false; composition: Not Reported; days to collection: 88; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-YF-AA3L-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 364.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | 3.287671232876712 | 60.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 30ad8081-daa7-4e2b-96f8-07f5ad12e774 | TCGA-YF-AA3M | null | 23 | released | 1.87 | Yes | 2.38 | 9.8 | 57 | -21097 | null | hispanic or latino | male | not reported | Alive | 1956 | null | 21097 | null | NX | Stage II | T2a | not reported | 0 | C67.2 | not reported | 8120/3 | Transitional cell carcinoma | yes | Yes | not reported | Lateral wall of bladder | Not Reported | Lateral wall of bladder | Not Reported | 2013 | null | Not Reported | false | Not Reported | 133 | 0 | 360.0 | D0F09A8C-8431-4A41-B7A6-BE6E9621CC58 | TCGA-YF-AA3M-01A-11 | 3.0 | 1.0 | 0.0 | 5.0 | 0.0 | 25.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-YF-AA3M; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.38; rna integrity number: 9.8; age at index: 57; days to birth: -21097; ethnicity: hispanic or latino; gender: male; race: not reported; vital status: Alive; year of birth: 1956; age at diagnosis: 21097; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 415.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; cigarettes per day: 3.1780821917808217; pack years smoked: 58.0; is ffpe: false; composition: Not Reported; days to collection: 133; days to sample procurement: 0; initial weight: 360.0; portion submitter id: TCGA-YF-AA3M-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 415.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | 3.1780821917808217 | 58.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 5b39a0dc-8ab2-46c6-95c7-65df919ebc76 | TCGA-ZF-A9R0 | null | 23 | released | 1.88 | Yes | 1.46 | 7.8 | 82 | -30222 | 680 | not hispanic or latino | male | white | Dead | 1931 | null | 30222 | null | NX | Stage III | T3b | not reported | 0 | C67.4 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Posterior wall of bladder | No | Posterior wall of bladder | Not Reported | 2013 | no | Not Reported | false | Not Reported | 309 | 0 | 270.0 | A69288AE-85B5-4041-A601-A7ACDBCBBEB2 | TCGA-ZF-A9R0-01A-11 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9R0; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.46; rna integrity number: 7.8; age at index: 82; days to birth: -30222; days to death: 680; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1931; age at diagnosis: 30222; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 567.0; icd 10 code: C67.4; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Posterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Posterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.273972602739726; pack years smoked: 5.0; is ffpe: false; composition: Not Reported; days to collection: 309; days to sample procurement: 0; initial weight: 270.0; portion submitter id: TCGA-ZF-A9R0-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 70.0; | [
1024
] | "x+arvlwntj5oHkq+QGSzORTmHj6Ko+c+iHsavn6/LT7mXOW9MXwDvkqvzD48Gus88s9oPYKgPL70JFW+N3tTPlerZb3YVtk8bawrvv4UaT6i8Ai+RjTxPmLeSj6F4I69jOyXvs4Jr71WhI4+fwZ4PkrbyT0oMpI9ntPePWIRMz4u/Ii+tCGZvuC+U7osVN0+BGuDvhmsSL5IDhY+KbGrPCRe8D2GGKc+nDrmPXBSWb410uO+wDtOPaAT0juMWjy+9hNsPuzP0b1LIL+9ETblvWh4pL1sYZW+qu6SPdSSUb3Whby8iCqPvoJjxj52kUY/UEU2uXl+Sb2cxea9icTxPsQ+Jr708G0+CHSdvuYZnr6Cs4Q+nKNQvhJjDL4GGnk+unlzPqySkT5iWym+aTZSuxoxIr2mOak9FH4VvirV/j2hw5M9naUavoR+7z1w4hu+pM+GvlHEm76w+FS9tJqxvorYyz7MCLu+aN01PqCflj4Fv0I+QoVBvPilDbzKhJW9BsOCvOJGT74XUJg+nhfePZHp2z7iZjs8YMOAvTQrBL0gmuM9jGfGvdZZkj3sSae9FOpWvjN1JL4kTg0+nJ7iPiyP+zwYmII9NylBvebw7j3S7Do+Yd0NveCT6L7keB89BEwSPvEYMD/+wjy+nYGKvve0cTwjRku+dp78Prjkaz0WFA+/kleZvWb4Q76He4C+rGYIPRCBMT47/4u+1o6WPsjHfL9rkhe+dFmGvrCjED1qB7I84JaYPW5mAz6A6d8+sOI0vNpgwT5YJaG+2apAvkB4mL5ZAn4+bLySvkd/gD1266w9SEPkvuAM57pQyNy+BHqhPp3doLyLjbI9nWW0PrTAKLwCPwu8aUGiPXh+Az4mO5y+Y7ehvOqONz6r51G+lK45Puf0zbyKBx++GhOOvsjwej4vayy8X0dYPhs0M7wD+eW9nRDfPD19l72GBwE/HH+7vdr4DD/KYJK+DRAUPD7tfL2SG9W7oLEfvvNoLb8EXU09zIHjPeo6Qr5uk4c+1immPtwmiL1kesA96ACMvYJwDb53Dr+9HKQ9OxKQAr5hxuK+MBnovhIjC75t38E7PseiPmykVj2IKqy+/vdZvXCjJL6/KGC+unHwvmEdDj6ZUd0+x200PudTID3oHpG+ip/GvoBx2j3adW2+9xsJPvjCGr84/5U90s5IvgpRKL74jCG9vIIYvqgXq74ApwY/8BfiPHh8Ej6FaAq+CjiQvkUXkzxkIKy+/I4PvrxJhr1vWcy9Y182PgwjYj75IYA9dFV9PiBT/rwqE3m+4ljavLpZMz36mc49yr+avaZvuL54fgk++TVdPF6T4z1Tmie8hvm6PukWVL7UqrLAqmxVvdqXDD/YV0Y+OPVxvst/Zr75ozG+hPQ0PsdHkLuWDcq8vGqSPTytbb6/b689/DT0vO1vhz26CFy+OFVrPvAF2j0cthG+EBpLvXaLRD7PICs/0QMuvngiMz33j3c+BEvLva+OUz0sBMg9kP6GvONO2z3aGAY99D6hvviHDb6iG5a+noXHvhugVb0QDHq8AJ4wvldGqr0DEeW9QrimPbK2rj44NG8+xj5PPSgyqr2VbAQ9HRyuPiTPmD4xSbo+0KcjPhIbvj1OC7Q+0QfLvoCfPb5LRxE+9mm2PbDY3D1C5Tu+ayCwPcXbm77Z6vs8yrEYvmg24j1w0V07ZdqDvni3wT4kX3W+3tI8vuYoMj4Sj1Q9OmH2PnV7zL5TE+w9J7WLPnk2nD5oqyC+ATwyPigAMr45qpc9ZBYRPdvziz739LI9w2/jvYoRbD6Wg4498LilvfDRGL93Toy+F/skvi5mlb5SNts+H5hFPtwi3r1Q4Kc8nF3PPvwDNj7I3/c9uoudPidBbT4Fbjw+D6bHPjSLfj28vLO+1S80PJDCGz1aZmU+lU7WvU/yh763AZC8qr2PPcbQ171jEJY+r5u8PZalCb7geES+JnmbvVCTRz4CeNW9kneUPtfwZL4WSRy/QKTEvbCDjr48SsE9rbUFv0o9OT4LZYm9pookPohaKj+KvYO+G6u+O5oTt7zzWe8+lOP3vUiqHj43KIo+3jzlvTbzgT4ybkE+KHiLvnVsbD3gWBc+sNkwvjSeJ7+Qbvs8PWtsu/l38byLxY29TOIUvkj+1754iZs+8gqcPgrM4D14Vjo9/stlvgo3wj6PgIK+Gs0tvSIkL71GfR49P54DvnkG5T4GCTI8lCJxPpzXPz7T4Js9QAj8PSRxcb7ulHu8OC0Cv3pfPD3Wjja/plkoPlmh1L6VJQE/K8yIvljiqL2yU3K9+DECvsipuL6prY2+U5NqPdqo1r4odkQ+OPVjvl70Eb0IMa89br7bPUwP7D2QCIe84XOfvoZ+tj5eOKA/Uk+CPLIZfL3XioC+GMH9vr8BrTwhRIk87fesPk+u+Tzymbm+ml2gvs8TBb4GzqI+zoIBPhq2OT5pnBo+IYdSPTx17jvier89xiDYvqjAFL4ve8q+OgbsPQzuTr6PNhI9o6UTvLecBT4WsGc8sQAjvq4PGr7I+dK9ftoGvQp6nj4PzYc+1VAzPiWrtDwTCS4+kzO9vhW6czyUMoS+Ti1+Phtshb4WS4o+LwRKPpsAgj5CzX4+PiIEPjxKgT4dxIk+nKvWvNj59z30+CG+MPykPA8uQT7YmzC+G9SMPkj4/T24/cW+mpwAPTCIez7bZrk9nh0FPiZEs75vDzk99X9UPg0Gvr2gfJE9hnDGPWAT2j2Y4s29GFuHvThE5j2OA1e+JOIivQAdZ7qyBb89l5G6vkKMGL4FOQK+CLpmPPGGgT5xnui9y5NevX40O73g+aA+CKeNPbNF97ylRQ4/h1cOvtNG2r1ThFQ+IaaNvqwRZD5UHau8uGOMvsVuIz1f8cC98JG4PSbb5L3vCRA87MRgvqu1/D5N8le+pE+WPlJCp76w3JC9ifUHvjo6vDxOXsK+VRtsPrK2Mz1y/0++3G6sPkgsoz5LUwy/oHk3vlr0n72yUCS+GPSTPuKU772Wkbg+iDA0veEqST3GfU6+cjk8Ph9PNr4mezY+/glzvPhwhb1WPqY9i/82PfiXCj50lke/7PfGPVgCAb590nu+wDZFPnSbQr5fQZ6+NQChvV0F+r0po30+tgFcvuiuiD6iBZ+9vUPtPeteUb6RdOu9TSdHPMZrTj1GNCA+Aj+yvY989r0hWDi+Wnauvsbi2b1Evqe+tw5ZvkTg9T1OFjw+bsvGvcy2NL7dfJC+FRzIPljwoD3WQju+Eke6PsK0Bb9cQxc+vktvvvnJ1b5iGry+eiI8PsTRgj9+bta9VM6WPuyHdT11CK297juPvnQ0Tz66Z429oVuNPuxSdr5rx7W+qLzvu2pp4zyIx0s/oAfTvS9krb6Bsvs+4gp7PRyvGL4pAr89HSS1Pjcm270oV5Q+IxY1vv5dUT747KK9lANfPhIZzT6kSZs8pNUqvZH91LvmG6a+MjXHvpIdRb0Yway9FqkxvWiykb1cDYm+nB83PopJET6u6NW+4SybPjqVSj5y0mW+Ws5UvtZ/j759Q7m+YMsLvIRSnT0kvOi+ZKPPvqCKGj5T0DA+spy9Pt/g0D4ZaiM9p2QKvjXrmr7rhog+qlwZvv4+p77Lzpc97K4SvaBzJb7uW3C+PmcDPtSlMD4UMMS+ok0uPuUdur4KnlA++qbEPbepI743QDo+2QFOPj5O472sefm9pcICPUa84T0RrPu+gBcYviRhYL6MtFW+u/sNvmgYjr7k150+jZMmvYLPeT5Szm89DBQTv2pjuL3ePL2+gFOTPaA0fL5Om6g9nvTjvlHj1T3OatE+3DvzPrqiN75aLzG+/CBovlC3Xb63oss+9Y99Pq4hhb195da9LgiFPa+omz00PZa+/9RzPezO4T6oJ9a9DsQyPKgrND3M+N89P0IPvv7RBT6pvsy+KQ3fPf725r1hGic+dli6vsTa3jtWvkQ+Mmg7PnK0/D6M0Ko+Vs37vLJg7L76Hzm+GQLovcVGOj5uLFW9PbjAP1h8rD5qF9A+DX4mPuRpm74Ked8++kkQPwOmlj1TMwU+t7eMPr1/zD5scNG9LpmMPIEMKT/zLae+78nEvUMCsb9AeZO9/CNIPZT5GT9eZjc/YFhPvnbfvr4fHEG+ei8gvr+SFr7Z0MA98VkMP4QYM74wPzw+YNhFPrh+drwgkaQ+f6CCPmqaf75sEQw+d8iuvM5zc75uuYw8BbRwvV6nBT5iesm+0qQqvnZCKz6EtHC+tqaAPrqHqD7kjKG+eEqKvm/LCT7fZ4g9zPyavlzmEj84ByM7UV5uPkWhfD43eo2+itTkva05U77ilg2+oI5avliYer5Kb1k+sWF4vi6j1jwcRMI9xgWovqnyKz7zjiM+cYMqvYaHuT27qJg+kq9vvURTY77UYBe+umTFvR4sRD3w9ji+VyTQvoT8Iz91bws/KdWGPmid+L2gxTM9xCJsPrrfOT4TR6A9tjjovmiWCL5hFXU+kZa6vkyFWD3YeJg+aD+GO1xTbz3Y5J69BhHJPVSfOD523Oy9YN+CPnvyOb6Sarq9STy2vuSYhDzmMcW++cILPFaSpz1okbC+f4tHvDpSZr4cVpU+kB0MPrLGP761Gro9EM02vsmfmL4ihfU9Ld8NvWxlo76AVv05Guk5Pg0qFj66laG8LOkJPY/z6r0oXqg+XreyPkciQb4GAQM/I9yovQ4Ql71GjLu+8VWVvha+yb6dQLK+aYuAvr2kdb6uuwK+Agp8vVaWI754WGW9apbAPQYi3j4vAqS+ruBFPTWeKT1Gigq942k3PkbObr62vkO+vkp/PsS8eb1NUrY9dfM8PrJlDr4raKQ9MrN/vtdHuj10Atg+2t6ZvvWOST4ZYUY+nvUOPLoz2T4AEWA9vDbzvvECwT7gjbY9RiepvigDFr70sc29aD8cvTq5Az5pFJ49TsgRPm4byDyIJiA+FpQ3PlsMAz1m4EG+5neLvCy3wjufkEw9590FvfoCQL6E72a8uC6HPQYgDz9n/Do82mwsuuS27L0H70a+2fZePNEoQ75jLsC9JPLAvvc02r0iTYO+zLj7vC4qJz5KTU0+axRcv9Cnzr3ijse9aalgPuroDj7liRW8mj6YvjKM47zP4j8+6FWdvQqmgL67CHs+AQWKPhhl0r3Yy+q9XaWYPeg+bT0U+5a9M3VmPrNfjj4aFJm+nFZwPro1hz5mMKC9tOiPvsJiZb5wjGU98FsHP6BDwDpiKDs9DsF0PpAOWL7UQkC+l5zdPSIaw77e8GO+6fP/vtFxsD5KLUK96WkjPoxpDz7rfZI8KZHlvXo+3L4Qv9C8PKdVviIvFj5iTyU+xEEovTg9oL7PO8U++JmxPr1J8704pGg+RNtPPoDoO71CudO+6F9yvvYamT29lYe+xiXKO3w+WT4S95G9bL4zPXTRxj1E+FU9R74SvRF+5D3YOPe+pXc7vg==" | null | 567.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | 0.273972602739726 | 5.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | f1bd8305-5c3f-4c82-9e68-ba9cf4ecdf7b | TCGA-ZF-A9R1 | null | 23 | released | 1.83 | Yes | 1.48 | 8.0 | 81 | -29610 | null | not hispanic or latino | male | white | Alive | 1932 | null | 29610 | null | N1 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2013 | null | Not Reported | false | Not Reported | 317 | 0 | 150.0 | D0951273-E0D2-4B6F-8033-4745A2AAD74E | TCGA-ZF-A9R1-01A-11 | 2.0 | 1.0 | 0.0 | 3.0 | 0.0 | 30.0 | 70.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9R1; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.48; rna integrity number: 8.0; age at index: 81; days to birth: -29610; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1932; age at diagnosis: 29610; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 773.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 317; days to sample procurement: 0; initial weight: 150.0; portion submitter id: TCGA-ZF-A9R1-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 773.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T1 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | aeb08986-a802-43dd-a5b4-17f4ec018790 | TCGA-ZF-A9R2 | null | 23 | released | 1.86 | Yes | 2.1 | 9.4 | 75 | -27537 | null | not hispanic or latino | male | white | Alive | 1938 | null | 27537 | null | N0 | Stage II | T2b | not reported | 0 | C67.9 | not reported | 8130/3 | Papillary transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2013 | no | Not Reported | false | Not Reported | 307 | 0 | 240.0 | B5679648-237C-4F65-87BB-CD92D0C53393 | TCGA-ZF-A9R2-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9R2; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.1; rna integrity number: 9.4; age at index: 75; days to birth: -27537; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1938; age at diagnosis: 27537; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 642.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.1780821917808217; pack years smoked: 58.0; is ffpe: false; composition: Not Reported; days to collection: 307; days to sample procurement: 0; initial weight: 240.0; portion submitter id: TCGA-ZF-A9R2-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 642.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | 3.1780821917808217 | 58.0 | null | null | null | null | null | null | null | null | null | null | null | T1 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | ab77b411-4df2-4e3a-bfad-946e8bb1fa70 | TCGA-ZF-A9R3 | null | 23 | released | 1.65 | Yes | 1.67 | 9.5 | 53 | -19384 | 949 | not hispanic or latino | female | white | Dead | 1959 | null | 19384 | null | NX | Stage II | T2 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2012 | no | Not Reported | false | Not Reported | 499 | 0 | 90.0 | 1B5918AB-3C48-405C-BE7F-348E3907060C | TCGA-ZF-A9R3-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9R3; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.65; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.67; rna integrity number: 9.5; age at index: 53; days to birth: -19384; days to death: 949; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1959; age at diagnosis: 19384; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 734.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.5890410958904109; pack years smoked: 29.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 499; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-ZF-A9R3-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 734.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | 1.5890410958904109 | 29.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 371b5d70-9797-4dae-b523-247f5eaeb4ab | TCGA-ZF-A9R4 | null | 23 | released | 1.84 | Yes | 2.1 | 9.4 | 83 | -30398 | null | not hispanic or latino | male | white | Alive | 1929 | null | 30398 | null | NX | Stage II | T2 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2012 | no | Not Reported | false | Not Reported | 588 | 0 | 40.0 | 8E623BA9-F937-4DFC-97F5-7B8E5FE8498B | TCGA-ZF-A9R4-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9R4; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.1; rna integrity number: 9.4; age at index: 83; days to birth: -30398; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1929; age at diagnosis: 30398; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 921.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 588; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-ZF-A9R4-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 921.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | aaa55de1-8f53-4b56-ba0a-67cff909cf81 | TCGA-ZF-A9R5 | null | 23 | released | 1.73 | Yes | 1.88 | 8.4 | 59 | -21811 | null | not hispanic or latino | male | white | Alive | 1952 | null | 21811 | null | N0 | Stage III | T3 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2011 | no | Not Reported | false | Not Reported | 743 | 0 | 60.0 | 5871BCC6-E728-4DFD-B2F2-C5C1C2E43B4C | TCGA-ZF-A9R5-01A-12 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9R5; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.73; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.88; rna integrity number: 8.4; age at index: 59; days to birth: -21811; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 21811; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1090.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.780821917808219; pack years smoked: 69.0; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 743; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-ZF-A9R5-01A-12; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1090.0 | 20.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | 3.780821917808219 | 69.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | ce4e4549-befc-447f-9b79-ed46e302e6d7 | TCGA-ZF-A9R7 | true | 23 | released | 1.88 | Yes | 0.89 | 7.0 | 76 | -28063 | null | not hispanic or latino | female | white | Alive | 1935 | null | 28063 | null | NX | Stage II | null | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2011 | no | Not Reported | false | Not Reported | 910 | 0 | 50.0 | 4AC6F4EE-B501-4C35-B35A-576C03866311 | TCGA-ZF-A9R7-01A-11 | 3.0 | 0.0 | 0.0 | 0.0 | 20.0 | 0.0 | 80.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9R7; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.89; rna integrity number: 7.0; age at index: 76; days to birth: -28063; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 28063; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 665.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 910; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-ZF-A9R7-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 0.0; percent tumor cells: 80.0; percent tumor nuclei: 75.0; | [
1024
] | "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" | null | 665.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | ebad8bc9-f196-4f53-bfea-de38488eb4e1 | TCGA-ZF-A9R9 | null | 23 | released | 1.85 | Yes | 0.9 | 7.7 | 58 | -21491 | 864 | not hispanic or latino | male | white | Dead | 1952 | 2012 | 21491 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2010 | yes | Not Reported | false | Not Reported | 1239 | 0 | 140.0 | 164EE426-8661-404C-9E0F-4216A76253C8 | TCGA-ZF-A9R9-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 60.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9R9; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.9; rna integrity number: 7.7; age at index: 58; days to birth: -21491; days to death: 864; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1952; year of death: 2012; age at diagnosis: 21491; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 0.1643835616438356; pack years smoked: 3.0; is ffpe: false; composition: Not Reported; days to collection: 1239; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-ZF-A9R9-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 60.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | 0.1643835616438356 | 3.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 4ed34db5-ddb5-4efd-a49b-84bf26789aee | TCGA-ZF-A9RC | null | 23 | released | 1.86 | Yes | 1.31 | 7.0 | 77 | -28275 | null | not hispanic or latino | male | white | Alive | 1930 | null | 28275 | null | N0 | Stage III | T3a | not reported | 0 | C67.2 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Lateral wall of bladder | No | Lateral wall of bladder | Not Reported | 2007 | no | Not Reported | false | Not Reported | 2386 | 0 | 70.0 | B7DD19FB-FF13-44CB-88FF-B42A6E20962B | TCGA-ZF-A9RC-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 60.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9RC; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.31; rna integrity number: 7.0; age at index: 77; days to birth: -28275; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1930; age at diagnosis: 28275; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2868.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 2386; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-ZF-A9RC-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 60.0; | [
1024
] | "jVGmvqGDuz6ePUK+opaiOzEiJD6lCOA+5TkOvmGLLz4n0/e9NCECvm0E4j6zY608fpVHPb/hSb5SNFO+cnlVPuXU4ryBdh49eFU5vtbSXD75lg6+yIMCP+qdMD4+3Vi91NOfvgLSlr3ir5E+1IaAPoMfnD2rZ6s9Z1fePZUGNT5/dYW+RCGcvrIgmryf3NM+BZl9voFzNr4WEwE+NMsfvL2w7D3T6aw+Ba/mPX1iTr5I3eS+IN0rPayHiDy3pUG+539YPm0Kxr3ve6K9rM/hvQ/0lL1UGZm+ynWpPRcGk70IfvG8iH6Pvpjl0z4RakU/gZmYvKW987xj3P29yz72Pj1lHL4da20+pA6kvq5QmL546Hg+WAhQvqWBFr7SU4c+ErdrPhXckT4TcTe+zDHvvGYKU71BlMg9LT8Jvnsx8j1IPKI9h4kbvtij/D2bLii+8TOMvuHpmL7pEC+9Ppy/vk1e1D5/ELO+JSgyPl1imj7qKDw+7txEO1mVSjy1T5u9ZmgbvPCaQb5Xkps+SGq/PZqH3j6GpLI8Vot7vQpmIbzmDQQ+vLbmvX3osz3IVdq9XtVbvuNjPL45nw4+5qjgPnswszws+1s9ILNbvYW95j0kCjw+k0fGvPny9L7Pllo9yy4nPtpuKT8hvzi+YIeHvtpzFTwPxE2+BWX9PibGRT3Nxwy/dW6fvZxdM74mZoC+CIQmPfPLIz6ahZC+bL2nPtnfdb+mHwG+6WOLvqxRvDyy4Qs9DpiIPdyfFT7/Z/E+6fN2vCQWvj73+qy+KxVWvr1ykb5SzmY+tU6Pvj5ndD2Ly0Y9gnPmvoHxi7puZd2+wxenPq49BLueKFE9L72uPu47wrtIj6y8HfK2PcOl+T2TwZ6+Za5MvAPOOz7XamC+sF08PhcmorybIi6+wJ+SviikeD55Uqy8Je9vPuevZbzZRua9mQW/PMqRyb3wNPw+K/rQvXDlCD9fc5C+MgYsPLL2o70s+VG9sqokvl5sMr81Sfs8GvjJPbaYS74ykok+FsmqPi4nLr3kxOc98JeMvfxz2L28gqm9isTpOqcQ9b0B/N6+kJf0vsqe5b0cjno8zgaiPuZciz2iBbO+2AlzvdxfMr7n81u+0rvzvj4RCz4aFN8+kuo7PnihID1yD5e+tD3UvvIKrz3udnO+0ZASPiDbGL9FuY49HF82vmP3Pr4Fica8VWUdvsfuq77umAE/sIsEPUnU9T1NJiO+krKHvuLWID15Dba+po8cvmvpr72xHu69164oPs74Yj4e/Uk98mh1PvICS72ffne+RbCcvOoP3DwQG9I9uEZ1vYl8pL7A0vc9D8o8OlxQ1D0qLyO9bx/GPlflZr5kOLPAuZFivTYUBT+VQlc+MxhuvptQdL7DVzq+YWdLPi8rajzIHi28R7K0PWVwdL40ULQ9JkK2vEOQUT0IDmK+IZNwPj6brz0CCAm+q8x2vaXaXT4x+yo/QT0lvkwxHT1QIYE+sVjWvfrlDT0uauM93/W3vA9t6j252ok8Hf+avjNHGL71gJe+YZbMvpwvlr1+0dm8so4ovgiKhb1M7ve9bklaPVaUrD6mjnM+4IIRPbOp/b2PGRY9NlisPm+wnz41+bo+rFskPn2nrz1vEbw+6Q/VvpkSXL5Ahhw+TlWmPQ+s+D2l6km+GHelPazoib4JTTw9hLc6vsNDAD4wEjE7ksSPvptywD7X8G2+1g5BvnILNj7M8w49RkLwPoacyb7PP+E9fgOOPjFGmz4N3h2+2YhJPh5+Sr6FB7E94NgZPW/Pjz7FVcQ9SJH6vQgeQD5sbJA9ggS3vfl8E79W6pm+CxcWvuRclb61rds+mRxEPreK3L1nwVQ9TTbCPpaYRj6RAew9CFSbPpIldT5heVc+YLDBPjk9tj3mdrW+mPc1OywrIj1MLXQ+yhydvV/zhb60m4e8RyA8PTPb0L0gB6Q+rofCPY/J773AZBu+DZ+XvexbSz6eeeG9QAmZPn3gdL4KuBq/U/jpvQWljr7UINM9ftgEv5t3JT5IC5i9KQ80PijnJD9cvIK+mHnzPF4CCb1AVe0+U3v+veo8Kz5mi44+icjzvSrYYj7SfWI+WIWUvqdshj0pgBY+P4E6vq7FJr+HkQ09f9xRvB4tGr0YTHa9vX4Ovviq3r7aFZU+dg+YPrkr4T1uRkk9kzNrvjMkuD4BFW++NiAJvRxSCb3M+848Er77vZw86D7Jxgo9kjhqPotLOD4mB4U9dkUXPoF1br4pnwa9Qe8Av8ftjT1iMDe/VsM/PngPyr57vfw+5oSWvrrLtr0CZiG9EdYCvo6TxL7hyYO+F6yLPS201b6Cn0k+hJZuvqmJBr34kMQ9JCKIPbjc1j35mmW9G0Cdvh/qrj7VyqA/qUw4PE9MbL0zSXC+X7f+vo6YHjefqiQ9bfClPmcRXTwKrsW+VC+avl4o1r3zoKg+oBwRPhhsNj7+OyY+lOeGPVrQ8TxVJQA+EOvlvm/yJr40E8K+YC3FPUFLTr4P0Gg9opQxvDlbCT5xkNc7swE0vkPGDr7Yy7W9C/YDvfrRmD7TgIg+gpVDPsBg2zocIzg+ArrDvmj0zDsrJ4K+k79xPpM9hr5Os44+Ci5SPhfMhT4ePXY+lIQTPgQIhz4X/5M+FwJTvew65j0gdRy+fWJTPUB8VT4Ydz2+FkaVPkHe6D1zoLm+ZiZRPQLPfT5P+r490inpPebar77t2Bk9WytLPsFgz73T8I09WgrZPVcT8T2FEYm9LRkBvYkH0D1UID++WtgcvX1SgLsKtMQ9M5W6vnoyDr491he+ON57PKZ3dD5yZdC97sYivfzcH717ppc+EdBAPV6KhbvSSQ4/dFj0vbEh/L3rWk4++fyRvoPyZT50gam88eWPvjScqjw9iOO92jO+PZzXpb1O0DY8+I1svmrV9T4fPGC+mQSXPkeSo77CBjy9zK/wvZVZFz0hu8O+W85nPjM7MD0J+1W+Q7qhPtjpnj5sAg6/JpQ/vp+Qu70fWiq+uoGSPncw9L3NsLE+wcMMvR+dMT3prVi+AXUpPp9COr7BRSs+Zka/vIW2q71iHr898WUrPZxh7z1aEEq/iNK+PVcn4r2izXq+hEQ5Pk5oO75/VpS+Mc/Uvay38b2nG3Y+TkdVvq7/iD6Qjp+9ugfPPRtkQL6MLOa93JHfO+mDVj1iCCA+tOa4vdBNyb2sFDa+30ajvkKO+703dp++14A5viqODD6IXEY+Q33wvW9BLb5fAJa+cBHJPufQRz2KWza+K828Pt7/A7+VVSM+TLJ3vvbR1b4mCrS+4hA8PnQQgz9Htt29M9uIPiXbjT0Wgrq9y7qWvnzTOT6O3mS9ARmQPnRLcL52pLi+FB4NPIVbDj29Ekk/ZDG0vX0Job5Umvg+kx1yPaxfJb4s3Jg9SfqyPuT91r0rX5U+Y98+vvgTLj4idIu9jlhiPodk1z6MPAk80GUXvbOFDzz2gJu+FqXNvmRDSr3ClNC93FoNvQ6plL31IYu+H2hGPlOEED5t0c2+a2yjPjy5OT6ECmm+YTtkvpWRer6Njr6+1XGGO7+5oz1Q6um+2SfOvirOFD4lBy4+F0LAPrwYxj5ZJos8XaEVvq1CnL4B6nQ+MwwhvkXskL5MuHI9WuOBvPERPb7WIVS+sYcYPgVAKT5BgMO+Qac6PtM0r75qz0s+HPixPVqC/72a40E+uadaPi3F/71K4ue9lbAGPfKivj3uqvq+IMkKvjjbU76edXC+JOr5vbtLhr4Qs6M+yc79vEnjdj5tGEU9j4URv84rl71HUbq+s15SPT2mhr4zmKU92errvlyD4z3Y09A+wALoPrYRXL4h4i2+cox6vgmbab7fSdk+EFZ4PkA8jL0De8y9dN1wPUnkkj3siJW+CNaRPRVG2z4Sc+29H7TJO14JGj1H1PE9X4jivfG/Fj7zEeq++4DSPThevb35PEY+6VW4vk7nMzyelkU+Kt0bPkQgAz+fJqk+MM6tvL4f9r6S4ye+rj+3vfmMHD693CK9s6zAP3Brqj5kFtU+yO8zPnh3mb6O3OA+R2sTP6S7lT3s8Rc++TGRPjFCzz651bW9E7ilPFvHKD/2mKu+cSHPvTbzsL8ibTW9vvOAPXRsGj9nzDg/N6Y0vquOyL4+u0q+NGEwvjRiG76pbOU9YqIMP7GHQr7VPjg+dftNPglKCL3luK8+yUN3PoR6d76qQxQ+doExva3Lfr6to/I8rZslvU9qCj6dSbC+fzkevlfzOT6sGYO+b+tvPqUKqT4236G+ReeQvqQpAT6t7Z8913aavndSEz9qLA48Yu55PhNmiz49OJe+cvTjvV/gUb6SqAe+v4JdvuCdgb41zEg+FAiIvj6YzTwh98g9AhSrvj8OOT4AhzM+9URrvYe8xz3Y26E+l12AvRZKY749viG+hzXIvXRReT2KBk++gzfVvq1eJz9b6w4/IbWFPhItE74t8ls9mbZwPoSUJz6YsFQ9Wz3qvrpC772y24I+waOxvh3OFj3RHqE+FjqBvGMKgD1xaYi9+CbDPdEuJj4Ud/W9ZvCDPhSuS75JAqS95iS4vkY/6zxItMS+NX1XvKfTfD1Mf7a+LxaHvDjdZ769iaY+Epn+PbKNXb5iTtY9B3cYvpWxk76fSA8+JlYfvbFLpr7gfoU708NJPicvKD73SwK8cyhOPY05CL5Z4p0+YAmrPkpXSL7D9QI/wumOvSXlqr0vsbW+COWkvhnwvr4N8be+xwSCvrQCd750twG+Cvd3vdxhLr6qTEq9w4fFPcc34T5w0aK+bIYGPSrUgTzKu5i8JTgxPq2Dcr6D5De+k0R7PnKhgb3CxLk9ecwiPsNbEb5agXY9eH9ZviGe1D0TWto+6MyevrzSRT5rXEI+72Cbu8GEzj4S/Zo8i37zvkDRyD54Gq09fGKnvmLoFr7VZfa9QFpLvby++z0oIqg9HhYRPn14uDxGixk+cns8PgXnPj2hiDu+YhAdvbl1cD21z5Y9wCYqvdpbNr4zl768bWYtPb98CD9Tl388FUCdvGviHr7FFUK+Yx0uPaeGK74Dl/y9PzPBvk4f0b3JS4S+QvPhvFDcOT7aoVI+WmdWv3C98b0xO8W9rrtdPrCRDT7fxru8HNWMvh0ANrzPYjA+RJaUvfjviL4o0GE+YkKaPiR9wL1vPwC+EpOoPe3FeT0SZbC9PdB6PtEOkD7QSpe+UKh3PuUHij6Hdl290a6LvnvXWb7L+IY9gnwHP7RwxrsAgi08kgyGPlOOW77qcki+z6PsPdDSx76rQFm+huoEv1u1sz7d9YC9uyoLPiFsFz5AA+Q82aruvTPFzL47zGq9NDJXvh8HIT5t5jA+NP07vQbcor66vMI+opu2Pk+29r1HAmQ+LpRyPo29i7xP1dO+yI9Vvs8Smj38g36+XeUCPNJhdT6aZZK9MGZbPAGq1T2Tlmw90N60vCoYBz7faP++toFBvg==" | null | 2868.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | f57122dd-a6f1-484d-b08a-cb1194de2f9d | TCGA-ZF-A9RD | null | 23 | released | 1.89 | Yes | 1.83 | 7.7 | 75 | -27496 | 408 | not hispanic or latino | female | white | Dead | 1933 | 2009 | 27496 | null | N2 | Stage IV | T3a | not reported | 0 | C67.4 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Posterior wall of bladder | No | Posterior wall of bladder | Not Reported | 2008 | no | Not Reported | false | Not Reported | 2074 | 0 | 220.0 | 6B721B6B-AD81-422E-8390-D615EA75EF64 | TCGA-ZF-A9RD-01A-11 | 5.0 | 0.0 | 0.0 | 0.0 | 40.0 | 0.0 | 60.0 | 60.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9RD; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.83; rna integrity number: 7.7; age at index: 75; days to birth: -27496; days to death: 408; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1933; year of death: 2009; age at diagnosis: 27496; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.4; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Posterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Posterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 2074; days to sample procurement: 0; initial weight: 220.0; portion submitter id: TCGA-ZF-A9RD-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 40.0; percent stromal cells: 0.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 0.547945205479452 | 10.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 284e175c-3229-4fee-a627-a49eac538e3a | TCGA-ZF-A9RE | null | 23 | released | 1.86 | Yes | 2.03 | 8.8 | 78 | -28622 | 106 | not hispanic or latino | female | white | Dead | 1932 | 2010 | 28622 | null | null | Stage II | null | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2010 | null | Not Reported | false | Not Reported | 1364 | 0 | 30.0 | 9AF70357-D696-4AEB-B338-7A711A39DAE5 | TCGA-ZF-A9RE-01A-11 | 8.0 | 0.0 | 10.0 | 2.0 | 0.0 | 35.0 | 55.0 | 85.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9RE; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.03; rna integrity number: 8.8; age at index: 78; days to birth: -28622; days to death: 106; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1932; year of death: 2010; age at diagnosis: 28622; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic stage: Stage II; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1364; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-ZF-A9RE-01A-11; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 55.0; percent tumor nuclei: 85.0; | [
1024
] | "3yGsvhwqsT4Y9V6+Q/MEPXZTJT4c0tU+q2wdvkftKz7jX+a98gYQvvRN3j76yis85uVJPRjnV75tp2W+5F9jPihIEb23DTk9yYYavk6aZD4AGhO+lBQCPxM1MT65h4W9dcGUvpOU0L3NF5E+4W2APgcRnT0hbJ89VuvnPSCiQD7qS46+QL2mvljRKbyJgts+aTFmvjJ4M743PBc+seb2OohA4z1xAZk+vYkHPvfeU76Okdq+R0uSPYf8xLyfYj++IX9oPnwNDr7xaru9YQ6uvePQjL3gppm+VP6pPd9jWb3+Wc27VbGJvrOhyD6ViD8/lte8O89bTb1UmAK+4ZnyPqRHLb6ICXo+z76ivlF1iL7JuXs+7pA3vqTdC77maHc+rpaMPn0roD7qEDq+scLfus/WFr0hxtM9lrQPvnh4BT6CIq49nhALvqxkCT7fKTq+H7KCvuOskb7GUxK9xBbTvibk0z6jLa6+H304PhYplj4eaUw+L3nVOz7rdTze+qi9TzDCvIw8Sb4U5Y8+92SbPZpH2T6cgwo9NiOEvURfEbwHxwA+HzgBvijvjD1x8MS97DNQvsvPGL7xRRM+QOnZPuJN4TsR/EI9UoQhvX3K1T2TnUc+FFx/vV6u777IFmU90zExPnl9KD9Zbza+vQmMvqlU7LtPT1G+Bl33Plqlqz28Mge/B8lkvYS3Ob60gYq+Xjk3PVZ9Mj5a846+oXSePr6ZdL9f3hS+JrSGvhQkNj0mcMA8QCixPX2wAz6aTeA+4IN7vLZW0T6fdZ++QE06vgdxjr4EOHs+SIyJvkKwFz1cYQk9alj9vmRegrxJn+O+uVC8Pt3xTL3PqrI8MfigPqT8h7x18u689rmpPcBtAD6DQay+ABjau+dENj44pGC+NccnPo7lMr1Lkze+fDuIvhqXbj7CSMy8veGNPnMGQ73Nfea9AbNUPUiEmL35IvU+wdvYve/HCD/fhJW+/sDEOxbcKL2tuRa9Ri0kvpi8L7/uKBQ9AAitPYJbRb4GhIc+2kavPp9foL1yAMM9y9agvXGSGr7nxpK9NR/CvLFV8L1GXNq+S37/vgdSCb6U7e+7l+ehPs4fiz1NMKm+f+CVvW/8I74s7jy+6D7rvrU5Hz5u2tk+MeFhPmHstDyAEZi+kmDBvhxr2D2k3k++ddb5PfwXFL8Zk4c9yOVEvhFjIb60+4S8110Jvur0sr6/TwA/UmiwPNpXxD0unQq+cN+Hvv2cED1P8qm+YTQbvhRYnL2W27G9KQ8/Pu+tWT5xSX095D6APiMZaL0x4lG+urpQvQAuCz1sSA8+1zWWvdYrqb6ixso95JuQu/wR4D0KZwO9dFu9PrxZdL78cbTAC+CUvZTSCT9xx0Y+LHtlvlw5e758Nzy+C1Q8Pj50oztuuMS8n5fNPayveb5NxrQ9fgq0u0telz2P91m+7g1VPgsa2z32hwS+1ouUvZ9zWD6UNSU/+rMzviGNEz25IGk+tNEAvrwNND0DygM+Vg7EvLcC2z3WuRg9MX2RvqBZ7L3gio++LKjQvtr/YL2WWVS9tFImvrGhUb2PYLW9vxSHPWjyrz66SXU+ODiTPT7p9r0R+AY9Kmm0PupQhj7NHrU+SxccPqrWmT3197M+AffRvrXkSb7xThE+PvOgPWpACD4Ylje+hiCYPSD6pb48zQ09i71VvihIAj5GIO880raDvt29vj5srka++YIjvl1KMj7NAdE8Uv/2PizguL68Hf09joSLPhpelD51sie+EspgPgy5WL45m6g9kyqdPKm/gT6Md709Ghr+vWjVXj4HnKo9dmibvRegFr9twoO+JTIKvgKziL6jO+M+4upKPkR4uL3uMCE9Ai3UPgkDOD7hzOQ9hL2mPgLyiD5zrFo+6/C7PmhMpD1gBr2+3bw6Oyz4nzum51w+nl3Vva11kr7IaIW87zIIPdFHxb2NiJ0+fPmcPdLiuL2ekDW+hH6Rvb/NRj7xRQ++AIScPjHubr7Gihi/ixfovegGkr75da89PWoAv7OCST4sFJ693b0sPnUxJz9aRoq+skAGPeZv17yJnvE+JJYKvlPAMj7RyZM+nRzmvW6vez45KDs+6yuMvnZikz2udAM+35M3vhUoJr9kWQg9koCHu+hHY7wqpXq97YgFviwW3r7z2pE+xtqePhFmpT2+iU497NWAvvc1rT5Ay2e+zIBuvS4pN723cPk8/bobvtJ93j7rRr48BhJLPgAHOD6PYVo9KtYGPg8UZr5R5jW8MQv5vpY7fT322DS/Nw08Pp2fyL4LVvg+hBCFvst7ub3ufmK9OZ8RvgaWur7KUYy+vAaJPffY2r74UlU+mOBkvsmDHbwLKsM9Wq7EPRIC/T36H4q9qe6MvkqKpz4qHJ0/oKznPCQair138Xa+nL/7vhHbBbxADLs8EfSgPrxSXzwRMsS+E/CbvsOe5b2dl6s+AS35PZrBDz6a6xs+l7QkPQcDKTw1OJs9Em7lvj0KEr6WZbu+/PrZPYixNr4lwYA8apB2vN9YHz7B/Nm7yWA7vsftGL586uK9+W4svTI4lT4sJX0+VsgoPtfqjTzMnjA+kfTPvgY/m7wqcWm+s+VWPnk6jL5PvIE+VbhZPnqIhj68Ens+wMkPPtL3eD6HYYQ+2FBhvXrB3T2uhg++mLRhPSOzWT4upDi+rLWaPj070j1Hm8G+cmw4PBTlgz5zErY9zfLYPZFspL4mHmw9+vRRPpe86b2n+7Q9o/nTPR50/T0mib+9BBuYvccC4z3C0Du+vD3mvL4ihrzcNK49783BvhWWJr6XvSS+b9ayPOTfjD78urG902lUvSHj2Lzhspw+XZCXPUAH0ryohBI/aGHjvdI12r1ARlU+94l7vmoSXz7RDuI8ls2Lvl7mvTyhrA6+PsXHPVQ7ub1sSFW82JF5voSC9D7z4F2+asqVPs3frr6nZU29QxH9vYTMnTtCJs6+nfOCPo9LLD1P5kG+9/2rPmaZlz7ZEgm/hjUMvgIXn70WKTC+AzOIPsuN7r3LELk+fwz3vN1mZjvfhmS++OgiPlf2VL7KbUE+wML7OoCfqr2ZgKE9+loIPVhZFD6kFkW/Ne3QPRYb+b3iJoO+LD07PixkSL780pu+gWTnvW4k4r1wtYE+1qBKvlybhj5AZ5+92snyPeF1QL7AFhu+W8yDPArGCT0SGxU+XdGqvQ/t2L0PA0W+qrCpviao9r2fApa+UTc5vnPxDj4oJ0s++YX8vSQjLb4hhIu+vMrIPgDXED1W/jq+Ti29PlGvA7+u+R8+X0t4vtQ81b55yLS+yV5IPtYohD+U9LS9ceWDPq6GsjwjC5q93x6Svt3zKz7Vr4C9Dy2LPrRsib4EaLK+HIWZPI8lszqArU4/GmG9va2pm77I/wI/At+wPbOpM77zubM9VoDBPtbI771u95A+fT5Vvr7tOT6n+eG9DNtkPnaizT7ucDy8tvNEvY1MQbs8Q6K+xvHIvo8GgL2Eu7e9sVslvePYY71cDYS+2IJNPhaQLT6r0dK+zfagPmeLPj5uGHu+qFppvmpTer68urC+83V+PAfc2D1YUuC+ycTLvkOSMD5Unz0+h9a2PqPKwT6NWzI9MUkivgm2pr4cW3g+VFowvmzfjr4RA4s9zgxZvLahQb4u/VG+0zQAPu73NT6EF7a+2gMkPjyQsb5z4GY+3xXHPWxhHL5uYSg+cblFPhrA7L3sude9J40jPTMBqD2xhvW+QBcUvmShQL4UZ3K+nzcivgXYi76Tv50+OIUvvXZWbT7hElg9ozQSv7Ofkr3Dnb6+/LpNPTitir5Hn7I9hJngvrlK8z1J6tQ+ajLrPgS0cr70yzi+AvZzvooiXL4VjcE+6j9fPv5xWL3PMeS9qm97Pfnjvj1qapK+y0KTPbeJ4T7B3s296kobPDFNOT361uY92J3Svf1aGj7qZ9i+3rPjPa6H7b164Ts+zTe9vmo2rzxk+20+b+g2PglhAj+jm7o++rFmvB2Z5r498zW+qG/uvYcaGD4za629wG2/P9xkoz4dktI+j5k3PnUfj77GsuQ++SQPP+C+kj0pODE+cEOCPv6W0z5YfJO9kt9YPDdnKD+NAqu+zVqyvV3Cr79hOSa9nWkuPafzFD8xSDc/TxdOvmrsvr7c7ES+5DA5vsx/C76ZhAQ+gg0MP4IuPL6MxEw+ytRCPo0VIb2aLKc+QbZxPj40ab6fhRU+Rz0CvUGhhL6WkxY9H3ktvS5Ryj33gcK+bB0zvk2/Nj5PaYi+LKp0PpJXpz7CqJ6+re+Cvlp45z0YK3I9cmeZvl31DD/RLD68D3N0PgYtez43NJC+FOvKveHSVb6Prgq+y7ZmvlSajb6peFA+HAFyvo1PqjzjOBc+w1qnvqKeNT5hHC4+vM4mvQn57z1oYq4+hFmYvTi0YL6RYhO+7OfovT+AbT3Hwhy+AmbSvo1EJT9oQw4/wd+ePopYC74SSjA93MZiPuizND5ycIg9MZrnvp0VC75oFHo+8dK2vqOLOT00uI8+ANjDup/Ddz1nMYG9YleqPdhpQT5vu9O9CBpwPhHxNb6GLp+9KjWzvmEM0DwpLM6+NjamvMFenz1Ag7S+SQGau/ehfb4AA6I+mjD3PaOPSr4J6tM9SbguvhQ0mb5aXeg9g0W3vC0Apb6uzS+8oyUiPs8PKT7zX/C8ZHqHPRi97r2Z/54+wE2jPlJTSL6SdQQ/y7KlvcITsL065bC+XF6Xvkc71L73UKy+PlB4vjhgdL5ja+O9lP9LvV9pKL5vJy+9WKWwPQlE5j5jf5y+OlLHPIpS3jyEl728gPswPuDMcb4aljC+KPh2Pr4ilb3odr89vIw6PtGsAb40Xiw9FJk5vp+7mT2sP+c+S36VvgZBOj4zqkE+WkawPAeJ0j42li09lsXqvnWp0D7M34g9XcuxvvppHb78Rvm9TuBHvX1NIT6Erbo9QngRPgBP9Dx/ihk+wtxDPuJcIT3j/1G+D/BwvCG2ubzfTLU9QJz3vE2DI77PmXi8qNthPapjBT/jlYA8wmiEu8NK9b14yDy+GrQJPSqDR761kPe9Oi+pvsgts70dR3O+bqPfvEjlHT7fZj4+luZYvzn3Er4/Y6G9IDM2PuoBFD5Zszi865SIvi3vwLzHAF4+uc+svVmnjL7uCEk+rbmTPkoh6r2sBN29/JO5PTw9Wj2yw5e9IHtsPu5Jiz5AO56+mpFgPh0shz7fTiu9NSlzvuRNd77SeUk9wMQMP7kqvryVZXU8/5mNPhYBXL7TzjO+b0LFPSrhzb5HUHq+Vsj7vjEAqz4S0y68IdYqPqBmFj7LrkE8jgPsvQtwyb4XrAO9Ha10vio2Kz5uVDk+wOIwvWFHq77p3r4+H7CuPv1g6r29slk+tM1jPr1NmLxrddq+NE5RvlZtAD5cyFi+vAcLPS+5bT53dJa9UBcDPfFu6D2aiTg96seNvCPz+D3/5ve+aE5Avg==" | null | null | 30.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | fa05f7f6-50e9-4878-a834-f655c0877394 | TCGA-ZF-A9RF | null | 23 | released | 1.86 | Yes | 1.5 | 8.5 | 74 | -27281 | null | not hispanic or latino | male | white | Alive | 1935 | null | 27281 | null | NX | Stage II | T1 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2009 | no | Not Reported | false | Not Reported | 1536 | 0 | 80.0 | CBA9E3B1-AD28-4E0B-B851-D70ACAED921A | TCGA-ZF-A9RF-01A-11 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9RF; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.5; rna integrity number: 8.5; age at index: 74; days to birth: -27281; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1935; age at diagnosis: 27281; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1949.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 2.8493150684931505; pack years smoked: 52.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1536; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-ZF-A9RF-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1949.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 6th | null | null | null | 2.8493150684931505 | 52.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 1eb0adbf-dbe8-4736-97f6-2dc4ee30e943 | TCGA-ZF-A9RG | null | 23 | released | 1.89 | Yes | 1.49 | 7.0 | 70 | -25656 | null | not hispanic or latino | female | white | Alive | 1940 | null | 25656 | null | N0 | Stage III | T3b | not reported | 0 | C67.2 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Lateral wall of bladder | No | Lateral wall of bladder | Not Reported | 2010 | yes | Not Reported | false | Not Reported | 1421 | 0 | 250.0 | FAA3F68D-0FB9-44E4-AFEF-7DC1662BE783 | TCGA-ZF-A9RG-01A-21 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 30.0 | 70.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9RG; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.49; rna integrity number: 7.0; age at index: 70; days to birth: -25656; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 25656; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1786.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1421; days to sample procurement: 0; initial weight: 250.0; portion submitter id: TCGA-ZF-A9RG-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | 1786.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 386f51e4-d03a-4606-bf2e-6168f2122c5f | TCGA-ZF-A9RL | null | 23 | released | 1.86 | Yes | 1.52 | 8.7 | 61 | -22480 | null | not hispanic or latino | male | white | Alive | 1946 | null | 22480 | null | null | Stage II | null | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2007 | null | Not Reported | false | Not Reported | 2221 | 0 | 10.0 | EC382266-E28D-4F67-B363-84425688F82F | TCGA-ZF-A9RL-01A-11 | 3.0 | 0.0 | 15.0 | 1.0 | 0.0 | 15.0 | 70.0 | 95.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9RL; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.52; rna integrity number: 8.7; age at index: 61; days to birth: -22480; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 22480; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic stage: Stage II; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2703.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2007; alcohol history: Not Reported; cigarettes per day: 2.0821917808219177; pack years smoked: 38.0; is ffpe: false; weight: 10.0; composition: Not Reported; days to collection: 2221; days to sample procurement: 0; initial weight: 10.0; portion submitter id: TCGA-ZF-A9RL-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 70.0; percent tumor nuclei: 95.0; | [
1024
] | "pOamvl4grT76r1O+QSTRPDIAIT6jJto+V4kmvl4PSj4yP/m9JIX2vXO7xz5Tof08L5JkPYa5OL6qWUy+m0ZsPtMTNr2isnc80cg1vrKVWD5x/BG+30r1PrqlQD6XYIS9KMaVvsEdp70Le5A+klF9Piw+qj3o6iA9/OoGPq8jMT7Vzoe+BQeYvomqtrx+CdM+nI5vvqgFNr7/hh0+Lk3LPCy2Az6boag+rC/sPexuZb5jO+C+ATtPPVgkxTnagly+ylFsPo1n8L14erW9OUzgvebytb1yVpi+f0GNPVrdoL1ejdy8piZ1vicFwT6taDs/laHoO+2zML35jPa90UzjPrZ9E74jiYg+SVeXvgFplr7UVoA+1HJCvsAu5b3sAoY+SNSEPqAkjj7cxC2+SpaIO7CuNL3Vpt89mIIivqcXAD5XPrE95dIOvvTW6z0jbyu+aaWBvqLmj76Rbhu9gYDIvrc7zT6LMae+6O4vPsV3jz7rjzM+BXWhuhaltLvpN6e9xqwtOZMILb7WF5k+rQvEPU8N2j7gH8M8t/BOvZIJpjvLi/M9WCkEvmnGwj3GwOK9xsZqvhcBIr6XVA4+QfjaPjZ1q7r38J89FusqvXErvD287EM+QezCvEKR7b6PrNs8yXslPoXHJz/XaCq+54iDvrofBTzlXU6+xuv1Ph+QVD0iDgu/g4oCvReAPr5BnoS+DFm6PB+MIT51I4C+L+uXPtCod7+2AR6+ZjeJvgWaDT0Oa6g8P8TCPWY35D3Nudo+N8x2vDvCyD7v+Za+4MVEvqFTh75PoIc+JdWGvsbhgj1WeX49AozrvmCfy7tHf+G+J06yPlF5A71tT4I8AxuaPmJLyDsXBx+8HLfoPTAbwz2qx6u+dKzHvFvXEz4csVu+lhYbPmsKVr0BeB++PjSXvrHzgD4iR6S86L2JPvscHr17Ufa9KSIJPecxh72CJvs+P7TRvUkjDD9CpZK+UqQnPZgJRr2RmNK8P8A0vqS2ML8ABDg9453BPbeSRb6FsYM+gdi4Pommmb2cvsQ9q3i2vQLJDr56Nqq9aJEhvFdoAr60EeO+4OjzvieiFb570em76uqpPmQnYj3LQ7G+D2KWvXkvKL5yyUG+Kxn2vtX6Gz4gQs8+yKliPiJChTwIGZm+DTjKvmnAoj1tnEm+ENsEPvu7FL+FzII9n7suvlMjIb5396y8rQwLvgLtr75HAwg/fBySO37EvT0NbfC9UhaIvq+dPDzo+LK+FtQcvmrps70pA+O9m+cyPoarWT4nOYI954aBPiXZ5bzRCXS+oLgwvTvsYz0kiAk+yG+JvXsJr75CUwg+0A2IOifp3D2JKiI7tySvPuTNaL5d6rTACAxLvZpGAT8atVA+BHxxvkrZar5Hcji+OlgsPtOyJ7ttYmi9rbGZPYRbbL7dmZQ9ewmivGk3hT0PcEi+uURVPvi72j3vY+29E+SLvdnqND7/siQ/iG49vhSvPbqXd3A+H+btvdaX9jwjiQ8+KOyxvKP37z172zU8D0CavjkT+r2+OpK+mpnEvtrMl73Upye8zIs6vpY9cb20uaS9x/aAPXyPoD7DR2k+Igg7PQkh0r2TRY48pry3PtQ/lz5OUbM+m0UUPgzLrT0PasE+PjnOvi+4Q76SaR0+oOa3PTSrIT5wRD2+OqiZPRUhlb7UECA9Bu41vkS/6D36a5w8xPZ+vvtPuD6MpF6+1Zkdvue1Mj6rYnM8glf3PrwOx77kmg4+qyiQPvTgmT4jPSq+JJZIPirETb6bXac9FJNsPQh6iD4ImKc93I30vWP0Vj5lLcg9qK3FvT5REL+hapi+BU8bvlIJjb66Nds+BSxUPrcH973Kmjo9Dm3QPpxmSD4s+tU9kuibPozVgj5lFkg+hcW9PnMroD3mFrG+vdEsO82PcjyfLXo+APy1vXVrgL6F9Mq7CHhGPVEg0r3THZQ+Ng23PROYw738RSq+LMjDvZItXD6ggfu9HLmUPqt/ab4QxB6/sj3svV5zhr5SX5g9i6v+vo5HOj4EZqq98aAoPuzFIT+jLY++L1UFPfFbFb0fB/A+fsQAvse/Mj6dxpY+/A3mvSq3dz5QblI+WJqJvnQAPz0JMv09we0zvnnRIL88MS499YkTO51/5bzVy5i9QQwKvvwN0L49PJM+ulGWPjQ+zT13H1A9YUd1vqa9sj5G2Vq+RL/7vMVliLw6IRU9nBzjvXKO3z7lnxM9v2dYPoUyJj5DulQ9Ul7+Pbo1YL4AB4k7AeYFv4swYz1kSTu/14pXPhGA0b4uJvw+jGmPvuupsr2YBTe9nggRvs6OuL59Xo++YZ8/Pfp32b5NhV4+vfFTvkq8C72oU5I9eePMPRnckT1XPVG9GVeZvloJsj63Lpw/2sUTPIXwZL0pwYO+PygAv2VGgrwh2009dZOePuW1xjyiys2+mbejvpaAAb7VW64+BnILPphBIj53rS0++QRfPVi4z7tgQaI9DHfavqmmCb6Gl76+HJXUPScDLr6pNLI8M5TFvMFhBD4JT2y88JI5vjxXML5tOd69HF+yvAjqlD7Z3Is+t8IYPnbSDT3mGDc+d6/KvuXaY7zWs3q+m/NrPmcEg76knoA+w6RzPtEOkj4yJmw+yB4JPkLRfj7z54Y+39DpvC904z2dLAu+k21xPXzxTj4g5Cq+tYKTPm+kGD5b4Mi+1arVPJEKaT5Ka6o9l9PkPX1xqL4WkCk9GDhYPscmwL3ksJk9nX7LPSSoAj6TEs+9TTqJvTTvyD1z202+lidlvYOoRbw3nNc9w8/DvvTbL77R3Cq+TG8YPdGGiz5ig/a9gUjsvNl9Pb2/3ZM+SnSSPeldTb1MARE/yGoWvrGu1L3RVEY+HYd/voPQYD7JLz88H5KNvqVbCD1Brti9Vee5PVRu0b2TfEA6NCFqvkh68z6HpFe+YP2SPqKOo746umC9vCkAvupGijw5Pci+5wZkPjnBgjyhzWO+53OiPk/okz6dHwi/5GQpvlynrb12CSS+FeaIPpuc1r136Ko+wgsTvdW9PT2/q2S+nCMyPn1DUL7NLzQ+hp0nvPdiSb1IB6M9VfcXO5obAj6aVkS/BNSuPQOC3b1Oj4G+NPNRPrLlV75dppW+r8qvvXow2r0LQII+Lz1lviG9gj5q2MS9s9S/PTi8X746XwO+tnGaujuYWD2QjRw+czWavU9v470ZKkC+4VKivlcJ6b1EsZW+Nv08vsiO+z12rUQ+f1bPvYsAJL7bkHO+/3a6PrMkGj0+pzC+JL/MPpPeA7/TFCM+pdiGvhzvx76E1K2+FBg8PtOhgz8SY8C9paKQPks9pD3p+3S9kmSJvqalPz6w5Uu9GV1/Pnqyf74IlLK+75uyO6Au7DsD6Uc/dZTuvdDsnr5/B/E+QwHRPSmhHr5b7YM9U9/CPuA5x71OwpY+UuJZvjtBTD7gVKO9tgVRPgVDxz6iWPW7i6ILvWnEBDuquq++/GLBvlV7073VBI+9ewMcvZbdPb3L13G+aoNGPtmmDj7glcy+eaGkPkc3ND6c9m2+0WdbvmaPjr74Zba+6gSCOwAU3D00fNK+BmbIvg9GQT6pjic+sXe5PrievT4Dwwc9Zn8JvujDnL6kHHA+U0svvloooL7RHpw9dGZFvD7DGb6oqm++PdQTPgtCKj5k67W+aNEpPosisL6hSVQ+6QXoPY+bGL5cuzI+dAVDPuVcAr59m7i9Dkn2PENPxj3ydum+lw/xvWpHV75rNHW+jfgjvjIpjr5yvZ0+MwBEvdGbXj4+/m89FM4VvxXulL0y+bK+cW0rPQv6j74A0Kc96qrjvlq35z1wONQ+kCbiPkbrXr7Dpza+F8prvk1cVb7bqsc+i7tVPpyuWL2LNum96EWiPRmo3D0aoJO+qRGYPQFe3D7nGYu9PhvxPC44bT1uNuE96XvfvRwQBT5TJtW+SvW3Pdno9b0mEDw+eo23vqV9IT1/rTo+cpEiPrVOAj9WuLA+D8kVvQ4a5L7Ssye+sIfpvfIMLD6alL69Avy8P7yMnz5n5cM+/1c2PoMSkL7LI/A+ZTILP+NvgT2zEgc+pVKRPp541j5ddrS9KHlePBNZIT82d6e+ae+6vYhlrb+giD+9mbaTPZj3GD+/MTI/CVVWvjxxwr7ZEl6+spUYvnz5Bb5aa/49V9sHP74mLL51zk0+Uqw+Pgat4bwMNqI+fAR/PtgGf76H8g8+JPEfvRy+dL7Cpgo9OdZavTeR4j35LMO+pFAZvpNwOj46X4C+S+1zPnelpz4FC5y+U4eGvj9O/T1Dwo89aG2ivuE/DD+Foka8B29pPjSmgD7AsJa+Xk2tvZPgTL4alPW9wUROvlrdbL5cwWU+JG10vmQn/DwX1NY9Cxymvl9fOT5RLxg+COAbvf2M9T3zvaI+rjEjvSLEXr75Sg6+w8XCvWrViT0U9Ry+qhfTvtWbHT9rrAU/baqKPgYMEL5PE4U92tZuPmJWHz5ivYY9UJnjvuUoGb5uAXg+tA+wvs0NWD1U/os+qiXROitdIT3h0569P4JvPevzMT6r3te9H8d3PgDFR77K+Ki92tSuvsuKbzxLh82+wJDYvG3JYT1PJb++/m+Ku5JndL7MwqQ+3LUOPgYzU76uFZw9gU4rvrJhir6zkQA+k7YFvbgJrL4pmxM7kIUjPjb+PT7K3iq9kGYjPTvN1705Gqw+FoWoPnP/HL7mfgU/o+mYvfh7271wLK++QTSWvtumx761fKu+jYN+vq0bbL4fWOa9Oxtmvah9Ib5ESE29NQ64PXW54T7SCqC+iOPtPN9n8DyDvuO75Vs2PicVZ75xUC2+6YmCPjyVjb3vcXo9ciEtPuzMBb4DNF891jFHvougjD2met8+Qi2Mvjz/ST51Ji8+bkTuu9EX2D7m7PY8WFrsvozNzD6WC8A9yTmqvhK/Kr5kJum9cm4zvWR9Bj4oR5Y9suMUPndjojwTYg4+a8Q7PhA6MD35KEq+r0qXu6/ReTy9wc09FezevDh/M75pyQK90pE/PTJqAz9EjHO8F9bTvAV26L2pcCm+Cf5NPQtsN75Tz+i9uHe2vl/Szr0CnXC+r9xovZiqID5RmS4+ptJXv6i3GL6h27a93IhKPmLJAj78z1+8taiDvuFPTLzkcFE+ND/DvXOTir59kXg+U2ObPlVJ1b09RNe9plipPQeNnz3IzJm9YRx5Pqk4kD4dwY6+Zm1hPubmhj6ue3u9fUyDvqAbVb69PWo9BfgPPyVk0LuKq8c8j42EPoy/Ur5eBy6+AyPJPTBY1b5umWC+/vwFv04KvD6PnEq9rCowPgnCHj6W5K47k0bOvSI80b7zY2e8b0Zkvp3BMD60QDs+DF7svENPlr4V9sM+OFeiPjjh0L1r6lE+rLdsPg1gDL1Mlt2+s6BevlL29z2JeFm++vvZPGCRbj4pf4u9ZMVAPQVPnz29VTw9/DIPvHi8+T0bH+++fMpPvg==" | null | 2703.0 | 10.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 2.0821917808219177 | 38.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 7d71945a-b81a-405c-bb17-cec9b1d7592c | TCGA-ZF-A9RM | null | 23 | released | 1.86 | Yes | 1.76 | 9.1 | 70 | -25642 | null | not hispanic or latino | male | white | Alive | 1940 | null | 25642 | null | N0 | Stage II | T0 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2010 | no | Not Reported | false | Not Reported | 1133 | 0 | 230.0 | F5403E2C-C4B0-4F82-A4E8-E210017FC34B | TCGA-ZF-A9RM-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 95.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9RM; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.76; rna integrity number: 9.1; age at index: 70; days to birth: -25642; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 25642; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T0; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1455.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.4383561643835616; pack years smoked: 8.0; is ffpe: false; composition: Not Reported; days to collection: 1133; days to sample procurement: 0; initial weight: 230.0; portion submitter id: TCGA-ZF-A9RM-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | 1455.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | 0.4383561643835616 | 8.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 73db40ce-2ba7-4a56-aef2-b78d2c744be1 | TCGA-ZF-A9RN | null | 23 | released | 1.9 | Yes | 2.2 | 9.2 | 67 | -24795 | 615 | not hispanic or latino | female | white | Dead | 1943 | 2011 | 24795 | null | NX | Stage III | T3b | not reported | 0 | C67.4 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Posterior wall of bladder | No | Posterior wall of bladder | Not Reported | 2010 | null | Not Reported | false | Not Reported | 1184 | 0 | 260.0 | BA6EAB50-FDB2-4E63-AD3E-E60236ABA7F7 | TCGA-ZF-A9RN-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 15.0 | 85.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-A9RN; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.2; rna integrity number: 9.2; age at index: 67; days to birth: -24795; days to death: 615; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1943; year of death: 2011; age at diagnosis: 24795; ajcc clinical t: T3b; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.4; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Posterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Posterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1184; days to sample procurement: 0; initial weight: 260.0; portion submitter id: TCGA-ZF-A9RN-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3b | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | c692e696-37fe-4fc1-90eb-8e34a91a98fc | TCGA-ZF-AA4N | null | 23 | released | 1.85 | Yes | 1.74 | 7.6 | 74 | -27056 | 88 | not hispanic or latino | male | white | Dead | 1937 | 2011 | 27056 | null | null | Stage II | null | not reported | 0 | C67.9 | not reported | 8010/3 | Carcinoma, NOS | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2011 | no | Not Reported | false | Not Reported | 919 | 0 | 220.0 | 2330755B-EBE4-46DA-ABAB-A240CD849F36 | TCGA-ZF-AA4N-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA4N; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.85; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.74; rna integrity number: 7.6; age at index: 74; days to birth: -27056; days to death: 88; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1937; year of death: 2011; age at diagnosis: 27056; ajcc clinical t: T2; ajcc pathologic stage: Stage II; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8010/3; primary diagnosis: Carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 919; days to sample procurement: 0; initial weight: 220.0; portion submitter id: TCGA-ZF-AA4N-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 70.0; | [
1024
] | "VJ2zvkyrrT6P/Wa+sS4kPUK1ID6lV+Q+UuEUvj6PKj68h9K9iJUavr9Y7D6TyXw8bfQKPebxS75PsnS+TNdVPipiN71g7dk8dtQsvtXRYD450f+9kOMCP6wJNT4voIW90PSRvn1xD77HcpQ+xEV4PiYE5D1Tf7o9EyZdPclhSz71JYu+lYarvt25dTsGGuI+oB2BvtDpSb6ynDc+QUPku9bU3T2yiZE+U0ElPiNSYr6Z3N++W00fPaiSM70dBTm+eQFwPqXADb5z3MW9I3i5vQYKsL0uqaO+S8+APYbtYr3J9QI7XWOFvpnyyT7VzEY/lVHpNqrvO72negG+LDb6PjcwPL5yTnY+pXahviqfkb6lIYE+4dQ6vh2vD77Hk2o+gKuLPmSioT4n4jm+4jHgu5bfRL18J/09eDv8vT0aAj45kaI9hSsMvr0OGj6NYyq+4kSDvv6djr4Z3IW9vhPPvrE+2j49eK++Eb8gPnuDoD79bUk+fef9OlrsK7tlFKi9SqbQvF/KZ74tmJg+jHrBPRdB3j5+cAw8xe8MvSUZKL0zFCg+c1v/vbotij31mMO9zDZevo3jDr5TFBY+Ys7nPtmCWTzCdQo9y5plvP7Axz3sZ0g+ftp0ve8o977Hthg9c1cfPkmFLz+Y0ja+DnqJvu3Uizxvq0u+dIH2PtTQzT3PMwC/0Ty7vUwzW77ctZC+OaFMPUeEQz5xXou+KcGjPiZLf79EwQ2+gIaPvjVtZz3ytsE8spmTPXTY8D1WBeU+u4wrvBBc2D6LGai+BUsuvvtLgr7mBXY+NYKUvmqcED1XFjo9Iqj6vmB+Fby2vNG+GGuuPpj/Dr1nDQ09Ms+YPlzr07wuDAy9ayu7PTOtAz4iSay+IKcBvfzeMT6G8IK++PI7PpBED73xkTu+RYCGvrD/gD5ETru8QfGMPt59P72fWOW9bHzrPGnZhb1oePc+2XQQvlyCCz8lzaS+MvF8uk8rtLwCNCg7RX8cvrB6Nr+kh1c9BVibPSG9SL4iZXw+cv+wPu7dxb3U9cI9q+zGvTUgGr7Oloq90F07vLSwz70fL9++5q8Iv5JD+r3JobC7zO+gPutBbj0LOLO+YWytvbllML4QAE++qcvwvrrdKD6qdtM+k2FQPnEpmzwfq46+qM7Fvt9TDD6KMmq+FwEDPm2aHb+FTYA9rg47vlsFRb7QDhY80HYBviB1tL5BDQE/XyWaPBRpnD2KuRO+E1qbvmtpMz3iE6S+kCgIvkJdg70AkNO97/EsPiacXj6VyE89E0N2Pni+ML3flTe+klMcvfJXKz0BqRU+p3OVvWmevr7OJ8g9xdawO+E01D11hCW8SffBPsLxRb66DLPATY6ZvecOFj+CIUg+L9hRvvXxir6AV02+yi85Ps/omLrzKBa9u2TfPfzgbr67iaI9nwqiuombUj0GY2i+HuxePuz77T1Jtgi+3ZuxvcJkYz4ZQCk/OcVEvtabEz2Ua4Q+z2rnvcqnzzymx/o959+lvGsW/T1N7PE8o4eWvj/o67066I2+i3vavh42p72+Aja9iIkYvlKvVb0WM5m9ynGIPeFUsD6tyGQ+9GqYPbsl0725LFQ9YTWvPuf3ij7EXcY+hKcgPlBNmD1SsbU+XPjXvmjDa7525hM+fz/BPdh+/T3LIUS++sGePZdUnr7mfiY9nXFLvrOEAz6LJ6I8j591vgLvsj7exFy+jqQsvjUdRD6rkCs8dB35Prkwzb5FsPc9XROEPoDyhj7vmT2+QJ1wPt67V75C+649/HggPWbIej6i6qk9RK0EvmhmaT5Q26491jegvV/XIr8cfnC+2OgevlDyk76GBts+/IAfPiWtzL1RxNw82rrZPn6WNT71fgQ+4XClPjzEjD7/CVw+y8jEPklQkD2uBqi+yZhrvKTQSjxlLX4+fh7pvfo/mL6WyhW8HCY4PaECv734dKQ+qnetPW7o17320Dq+f4DRvbZCVD6NVAG+DOqTPotddb55fyG/Bqryva3Om75WtaM9pAAIv3RTTj6jrYu9KZoRPorSLD+fo4q+q2T7PGF1hrzWl+U+4+MNvnbuJz5vk4w+fzPWvVaBYj7AKUY++fOBvoXdbj3X2Ok9ETdFvgpLI78ZJgs90qYZuliNKbw151297aIGvixz5b4ITJU+44eVPm7TkD3CsYU9MtlnviAIuT4r3oG+A0w+vYUcNb0bKEi7+UoMvgP84j4jYt08sRBNPgtBNj6tq888kEr6PSTmb76I87g79tr9vqhmQT1LwjS/wSszPgtD1b6XgPU+SoaOvhtcer0zSmu97kckvhPNwb6RlZK+YuZDPXYK1b4QImA+Q8tovtJ4PrzNr+E9gdbHPSA5Aj7YQ4a9qCyNvsuhsT7Jsp4/TjDkPJKLfb3i4mO+zfz3vujt/Tu5cPk6Qqm0Pny/xjwX/sC++0KTvskq/b3tS6k+V/rWPcgrCj4J5P091oJlPSUCFLyxfrw92U3OvsKQ7b1LVrm+aT/WPQLLS75G6fs72sNjuwwGND7AYUI7XvNEvniJJ767sdK9a9cnvYkvlT4RvII+/mwPPm+q7DzimCY+GuPOvu1SCL1pQHm+M/RtPu79mb7/lYU+1hxbPpgthj7HQXo+UlkIPo3GeT6tAHI+XF86veh11T1U5ha+FPzRPNSXYT6m2xS+MQGoPgEE+D1Rsr++IsEzPJWxhj5rF809k93jPQusob6JrIo9BxA+Prea1L2/L9A9Htz0PdtVBj4wbsW9Vs+DvVCnAz6wv16+tZCRvFWfMr0UzL099HLHvqnEE756HCm+UbDXO+ZLhT4IDqO9bTaEvfzENbzQOJ0+iO58PdGrEbwLZRE//+bgvWi95r2TCUw+4byJvhTcYD5GeTo9Gf2Xvtv5pDwzQQe+fGHxPQVJsb02LOK8PHd/vlW//z57ymq+RZWZPgFIvL720WG9CQryvbrCCTzjJMO+HQKLPvV8Mz3/5ki+gQW2PhccnD4gzQm/x/sLvrEKsb12ski+zqmaPjEnw72J+7s+4z9FvQKSrjxU62C+bYYuPqIwVr7aX0Q+O3mhPHK/ur220GA9DY+SPYHXKT68X0S/sssHPr+9CL4/9Iy+8NNIPigvQL5SfqG+TxfdvY8m0b2XW4o+QKFMvmMthT7Ip6i9ezoIPrCTT75ELC++kHpUPLGojzzRoRI+HgGZvZVF0b1YTUi+E/i1vnQGIL6YUpm+S0sqvlu4Cj45nFk+1GYQvuf0Mr5TD5m+OxzOPmI+ZD3Z/kW+RwDCPkbkC7/OhC0+IDyCvk8z3L4Dbb2+QipTPnuUgj8UDLG99jCRPlzllTxa7IO9cZONvr+zGT7xUYG9rkmTPhRLh77ehsW+A5ysPJtHhDzQd1M/fG5NvVkUpb6e9go/zL6VPV7zN77nvdQ9I9K9PtXL9b1K8JY+ClZHvupmTz4RIr69K8NjPvsO3D5SSjO8lYeIvRR5MzxkmKG+haG+vtPNXL3k9bW98flbvaQug731nJW+t5U0PncsET4FE8e+n8GmPtZ1Qj6bVXe+SlhsvmOyeL7/26++IEEXO96nrz178ua+M5vrvrKKJT4t5Ds+JqW6PjvZxD5uVCc9wQ0XvsNPpb7gxnQ+o+Idvpwenb6FL089pLoBvQ9+Or7koE++eqz3PWpRTD5UfcC+OR0MPpq1t76qIG8+p8TAPZCuML6lnjU+F3xTPpZV3b3hrMu9MKc2PTMktD0pdAK/4gYLvq1/Sr5gj2K+HWQ9vqbmgb41rpc+vWBZvY8XdD7wojw9Z70Rv7rCyL1A0cG+j3tjPTJgjr4Ow7M9x8bgvpMw3j30EM0+x2P9Ph4rY77vFDe+K2qBvsziZb6Yxck+1eN+PuqyBb0vCdS99EqiPb6Vdj32AKK+n2K2PQgG2j4SeNK9DAUHO+y2NT1ksu49visIvkXrID4pocS+MeO3Pdmk5730GUE+yWrAvpWBpTxJsWQ+2ig1PkZUCT/ANcY+uvYrve2/4b6PkSq+RDjtvcK4ID6gkJm9DqXGP3b5sT5ejcQ+cWArPtq3nL5LbfI+1WsTP6OPiD3tEBo+qTJ5Puugzz6wn6G9GRiTPFhYKD9jPJ++5WnHvVU7tb8ZygC9O5pxPRSAGD9JCkA/b7ZMvomzzb5AqUK+0uY3vkskDr5Llvs9hfkGP0qfPr7cR0I+y4xZPr3CAL0GkaQ+dTBoPtVZcb6aHQw+hI9kvexZg75LguY8MEpAvSp66D2R6s2+O6Q6vvLKTT7eL32+dJJ9Pn85sj5PjJq+R5mEvnS7GT4OBqQ9Un2Uvq4dDD93NdS7lbt3Pi+ybz43j5S+MtnIvT3oe76U9w++wy9dvnPlhL7cIU0+1U6CvtmEOj2+JOo9kaufvrb5Dj6g2CY+QCM3vbH09j1jAK8+TZClvQZpRb6XaBu+HdHqvZ5ZUjxF9wS+HZLOvgqNJz9fyBU/m4qKPtTp7b06MyI96M91Po0xUj5blZo9MP7dvvRkDL75I4M+Rtitvmz0ez1ZQ5w+ne8XvJG3uT13/Yu9UDLhPVeaNj4cWbO95QONPpUJKr44ytm9boupvlQhwDyfnd++pMShO+SWnD2B/aa+l9mlvKWhdL5gn60+8C/wPfkHUL4QRQY+C6NBvib6lr6r/Nw9dEw5vbOfnr76bEq83aY8Phg+Iz7eLAi98eB1PUEg0r0ypZ8+K2enPrWSUL72TgY/Un+lvZh6ar2fnrO+ev2RvoRX0757FrO+eOKHvhq4c756bge++OztvNjENr5rtlu82JalPZev5T60RKa+ThrDPLIxRT30Ue+6UGpHPnvuXr4pZze+iZmAPgd+j711ILI9TZFAPpMZG75jsQ89Dm0wvjSksT3b0uo+UJSNvtE0QD56j1M+6FggPTwt5j4qj2Y9TDfovpOyzT7weqc9aVexvlu4Gb4nDQe+224evaDtFT4vZL09KFPuPSYEqjz0qic+LdBBPkTWED3FGim+Q1yOvG3feTzU5rg9V7UKvdPrM771O127rKaPPd7pDT/63C05zyRLO6x20r1Xg1a+uT4svFstUb70zb69yNStvmWA3b2DUVK+o0k1va7yHD4daD0+xIBiv9uNJ75ea6e9dTA+PmBmBz7Q8pk8ib+FvkXXCbx+Pko+e7m6vaJgib56qEE+Z+edPnrkxr0IXPG9vMXbPZNKiD33Cbe9SAp2Pikajj6avpS+Sx5iPtD5hj75kyO9DvqCvlv7dL7xCSY9yi8SP6Z51bwb4DE8NSCPPnF1Ub7R60C+v3/EPcLBvL4dhIO+ELH5vssJpz5OnrK8pek3Ps4MCj5N1GE8k/wgvheQ0L6wEfG8q+xtvg4wJT4D0lk+Ll5ivW0BoL55A8M+qFK4PrsDHL7yqGA+yDZcPhqvvrzdNNe+LkhFvkty8D2TzH2+PqsSPLPiaD7LdcK9Vft9PRcXFT5zR7E8C032vO0Gzz39hey+DylSvg==" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | null | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | b36e3b5f-8904-4722-adae-b00812efec65 | TCGA-ZF-AA4R | null | 23 | released | 1.82 | Yes | 1.31 | 7.4 | 67 | -24537 | 1036 | not hispanic or latino | male | white | Dead | 1941 | 2010 | 24537 | null | N1 | Stage IV | T3a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2008 | null | Not Reported | false | Not Reported | 1834 | 0 | 60.0 | 6E9D0F98-3697-46E7-96E6-1CDAAE63DFC5 | TCGA-ZF-AA4R-01A-11 | 2.0 | 1.0 | 0.0 | 3.0 | 0.0 | 25.0 | 75.0 | 75.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA4R; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.31; rna integrity number: 7.4; age at index: 67; days to birth: -24537; days to death: 1036; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1941; year of death: 2010; age at diagnosis: 24537; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1834; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-ZF-AA4R-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0; | [
1024
] | "lRWzvng+sT7z016+GPjcPMslID57ZOk+LpMivlxNMj7pd++9/3gNvvEm1z4+6d462OYiPSZRSL6z0Wa+C1RcPvJCgL2pd0c9LIk0vlZXZj79Rf+9IYYIPz/KMT4paWW9AnWfvqBp173YAJk+OuyCPoX3wj22Prs9KH/BPf1iVz5PrZW+QE+jvlkYLLx0f+U+0dd8vvR2TL51ZSY+WiYnvKQU8D24M6M+r5ESPn5pYL5Xpee+v0RrPbUp5bwhpE2+WTVvPq22Cr77GKS9IGfHveyxlr3o1J++cuiaPaA9i71xpJG8zC2Lvqkezj7FREY/y2dvvKcIzrzJiNO9DSsDP3kUL74UbXY+FnGnvtd4lb5Uc4M+saJTvhmcFL5FyHA+cKCIPt5bnj4BijO+axWxvBHJc72wROE9ca0NvvjACT5QP5I96FgjvmM88T04ejC+4JOGvrfWlr69djS9szrGvlNo1D4tF7G+/iczPn+fmj5iX1Y+gKK9O9waFzwLfcq9PPIWvelDWb4Ga5Y+P2u5PT1r4T6RxY26aw1NvdgDC7ulLBw+7yzfvfAxiT1Dv8K9S69VvvuUNL58ghs+5xfkPteIjDwgVvw8nuFxvSR+7T1n+j8+yJRSvcRY+L6nUbM8EYgUPmvxMT+sZlS+0I2JvnuAGrwWM1i+AisBP02Okz3qzQ6/hfqdvTElN760lYy+THkxPQ8kJz6LApW+DnOmPo+Oer8NIQe+r5aRvsF9Zj3GeBg9vXWmPco+GT7IsfM+Sq/fvEGC0j7EIam+/bFDvh0Xib7apYA+is6PvqLngD0EPYQ9YnD8vr7jBLs1wOe+eFK1Pomy8bwSBC89j8GiPvaFtrtF88m8C+GwPZ2sBT45H6O+1gluvAERTj5np1y+1aszPsb9zLwOzzC+nJiRvveegD6dLV68+pOIPhXIF70YVfG9pooPPcNLQL3hLfo+QYXSvcFDBz+4Y5a+9Cg6PCbJUr18aKO8FW4cvhrNM78RUAg9e9WgPSxDQ74zLIM+cACjPpRHoL3gvvw9ME6jvWE1DL7B0Lm97TixOxtVAL7SJ+q+gz8CvzdDDr7+AM+7EWiaPmP0gz1ho7O+ld6mvbFGJ772222+mb3vvn20Kz6NStg+VO47PjDlAD3zN5m+v67GvpkL4T3L4Wa+GZsKPkQbHL8RGJk9g3FMvi00Mb6Z3Na7W8D+vWaNtb4srf4+b/QCPYhA3z28LiG+ZQKWvjHpJD1aVrK+h7D7vZ0Qsr2s3M694KgyPsrdWT7ydow9W3SEPreYQL0lNnG+rj9Kva0YRz0DQQY+6EVhvcpNsL79m/09kX2SvB541z26w8q82YbMPpnMZb5r97LABpCBvXI1ED+pflQ+GdhTvpn1g768AEe+CCtGPtVcU7ys+TW9M8HYPU0hb746jcE93Fg2vH6Glz2Wi1S+3FFnPg0x3T2vjAK+OYVyvYITSD68vS4/I0ZOvvTKPT3HxXw+7XzlvVP5Qz1lAQI+05bCvOsHsT0ZYOE8D/2UvqgdDr56o56+bGbSvomNib3HaSy9eXkrvi2+Lr2g4+C9fa+CPUE8qD6yqHs+DZ05PXjfz70i0WA9cea3Pg0KmD4PzLk+wVEZPvSsrT3la8Y+wxXfvpUOXb73cB0+lhGyPTlH5j1fR0K+JdafPaxumb7hhPE8jBRgvruuCj7w67A7hsSKvtJUxD5W+12+m9EevsbPTD4E4x49Fj/6PhPEyb4PHQQ++gSIPi/gnT6l2CS+rsRvPvDocb4oeOA9cdYzPT5jiz6aoqM9lOPxve++UD7zc8s8eXCnvS7QI79OK5m+2k8Bvhtvmb7g0N8+s0JBPvi3vL3P3hY9rQ7TPifDUD6JleA9rH+pPhulhj6FQUE+JuvSPtIjvz3oSLO+2YPDu31EED06/YU+ngLIvcXllr4dWo28svtbPXTLu71qEp4+deOoPd+58L0I9Ca+qbKZvbLyUD45P9i9lBiUPsoXfr6jgxu/wPXkvTSEnL5UNtc9H+UFv1UYQT5uW5y9mLYtPsCaKz8iYoe+8DNUPQedX7ygPu8+/6sFvsCZLT5s2JU+/GrGvRXKaT4nv1Q+73WQvjJOgD1kPvI9D7hDvjEZI78LhyQ9PpGavEmY17xg3n+9YroUvgeU4r4RHpU+yVumPuS6wj2v4XM90GKDvqK9vz5fhn++VQSHvU9n47wLhHw8RsHovcb15D7W6pg8j+FPPqXpKD6ez2s9x2gQPmgleb5wF9q7eAMGv8O4dz1V3T6/3/wpPiqf1750T/w+kjOJviGfo718hIa9y5sFvnYuxL5Dr4++qjxCPRbd177xFlk+a0pzvgG07byukwo+4Hm2PbgwDz5pUjq9GO2YvgIYrj4sH6M/Lta+PEPWob07VGy+O9UBv1JOGryrT7E8t6u0PpAs7DydoMi+ObOavhZh1L2+a6Q+/VoMPps4FD6zFhU+9GY+PZNxyTt8xuI9VDrgvrKE/r0Oasm+ic75PYnuRL7NdrY8S1uqvFy0Gj6Uu7K7wuQ/vuUIDr7A66G93lpHvSZamT5z34I+vQgiPvF3VzynjkE+AnDPvqRpsryK0HO+v8RpPoIllr6if40+OyRbPiYChT70tnU+5mr+Pancfz7fCIo+VhVLvWKR1z2+BA++cHtAPRFEQD5RZS2+KhOjPhzW6j3eF8K+QF0gPaNXiD7H8KE9IbHlPfS8s77/WIc9LE9RPnUE5L1gPwE+u9HuPZE+8D0gqa69ad5VvYRxyz0pJme+EA/lvC33BryKlbI9t/zPvqVPGr6uixS+00g4PNdedT5NdMG9hpVEvTAoUr3MWZs+DvpiPVT7ubuAuhI/q4oHvv7E271IOFM+mp2JvlEWaD5e5807SNiYvnz6LD1dABK+XF4KPo8/vb0NuKE6kIhxvha0/z6TYlW+twWYPphnsr5wqIK9h1QEvsxieTzN98e+aNV8Pl/LaD334j2+e5WxPominD5GbQu/sT4Zvp5t3L3najm+g0KQPhgj4b300bw+JCsMvSyXKD2ecm2+d7ozPl4CRr4OIDs+EW7nPBnDo72zOqg96OZqPQWrJD7/ykS/FTPYPdtx/r0AxGi+pfM+PhG9RL4UraK+2DvWvdGou70S0IE+96Byvuxuej4u05y9FwnuPZqrTb79viK+Kf6/PHtvNT3YcyA+vLPNvUVezb1XvFa+g36rvg+uAb50tpu+MRZEvgRc8j0evFc+txsAvp9MJL7+GI6+0fniPucfDj0Th0y+6b2+PoW1Br/OaCY+fWGAvlSl3r4eSb6+A3pNPllVgT9WFJu9eoKSPvFdXj1SY1W9DlqQvpUtKj6aSpe9qFOLPv7XgL4/GLq+pJ4LPFK8gzyUe1c/sEnWvf+Mpr6GqgE/7td7PVufJb5SM7c9p9i9PmMa9r0XtY4+6/BevokjUz5qutW93vFzPsLy0z5zaZs8XMk4vUSzR7xlfqK+TbrUvgYmg72RrdC9VzEpvVaUkL3D0Iu+8j82Pod6Hj6ws9G+uteqPhq5Pj7EsWu+nZlzvsPugr4murG+0R8pOrN15T2LMuy+BWnUvhmKHD7xbCs+2uq1Pp73xz5Oryk9viYQvsQwnL5+FX4+zsQYvpDInb6k/Yo9ixADvVKaOb66a0++e0wHPpUZPj41CMG+4NYaPt9cvr4K8nc+NEe5PcRtG75rsio+fe5SPuPVwb2ZQNO9zwHcPNSyxD13kfW+9vQQvozjWb6KAHK+JugRvhMwkL5Kl6s+728OvU0Ifz71bYM9Lj4Uv4X8kr3Pw8++zp2RPex8hb42F8I9QT7ovv01zj3/wNw+tMnwPkRdYL48Mh++VtJ5vsY7a77VUdE+JxF2Pr+IR73kzvy98hKVPTjc3T3M8aK++MKgPZnP5D754cu9q9qku2sRRT0vK9o9worMvTG4Ej7ENtK+p4WbPU2V1L0+4T8+jaC3vl6/AT0E7FM+FLYuPh4cCz+QqrY+cSKFvIUL6b6p1y6+bU3avfV6Jj7TIX+9GVvCP54bpT4mz88+NHo1Pni2nb5/LtU+R3YRPzFmrz37RiI+Fl2LPkZ12T4kF5W9k3EWO6R5KD8IlrC+danRvcCCtb+p7sS8KW4RPSWHFT/thjo/sxBIvoNmvL5qVFe+LrBMvnH6Ir55Hco9I5oOP+UpO76dnzo+SotbPpjAOr097Kk+vV1/Pmdrer6iGi4+4y38vGGTh77Ripg85RpFvVZn0T2F3My+82NGvot0Mz56nIS+6C17PmH9rT4OwKK++PGBvh2vFT6aipw9WbmbvrIwDj9D2qC7OpltPqNhhT4M/qe+kqDZvZOJY74hnBy+7b9ivnNXjL5Qs0A+utiHvgziQj3GDwQ+zAavvm7uMD6ZuC8+jNE5vb7//j3Vpaw+pUScvTgqUb6DmRy+51novf3oFD2BuUS+18rivhEkJT8mPBQ/iPyePkdoB77vbFY9G0V7PuccQj6HFYQ9277rvteFC76GEY4+9pGuvu+BUj11up4+DsLbugJcmz1E3Le91X3HPZhnND4ifva9cEmGPs3jRb7vl4+9f2C9vuyZ5Dx1Pc++JSrHux0ssT0wd7m+HQP4u/M3fL4FXKY+10zlPb5XUb5qUK49YoIovnmLnr5Qggg+k/E9vVjCs741gMO7ymo8Pv7OLj7GYnO8WxqDPfrb7L0RxKs+stStPhhaWr4nugg/pGWpveWUqL2IAsS+LwWSvsUN2b7n4rK+VVWKvs4Adb4vRRC+nIMfvX+5KL4kByu9SUabPX/G4j6ceqa+OuGVPKe7Bj3z2ge9ehIoPuZyZL7JpDW+94pyPnhbjL3X+d89E7s5Pl7ZEL6ccIY9VxtVvlguxD1uc+g+HeqcvvxkOD6/PUU+QHw1PHIB3j4vzD09mdDzvmL4xT4BYbQ9QmqpvlHhHL69NA++zz9gvb/dGj40oLs9j2QAPnYKtTyqwSg+pPNEPqzJRj1Q0Dq+H3XXvFqLKj1FXK09gt3JvOYqL74acbO8D0BfPekkDz+BBO4848gGPKlk170L8DG+sniuPIWDOb7HUL69D2a6vhnC5b3Z3H6+ym0ivaDlQT4QT0k+5C5cv5llDb67Dd+9yrFaPjbMDD7N5pW8nayKvpFEBL2lXT8+LfSYvaN8h774jlY+6WubPqBq2r0/5/O9WqPoPWYLlj3FD3C9xDVzPr/djD7QpIi+X6d7PswYjD5R2HO9L/qCvh9UcL4ewT091tALP4sEH7zbX4k8XnmQPgbXYL6Wf0C+RNLoPcAwwb6hB3W+8cjyvmYmqT7OyTW9FA4nPiV/GT44lxc9huLjvRtDzr6Xuee82Y19vnRcKT71X0U+9gOMvSnbqb4zaMA+BG+4Poi0+70VeV8+MvJxPmyv0LyHDdm+LAdSvqk32T0/mHS+ABALvG4fdD4X7Lu9B/tlPTB9BT4U4hE9OWz9OzPiBT6SvvG+zplFvg==" | null | null | 30.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 1859a4c5-78bc-4b1a-a26e-3d2b4cb221c2 | TCGA-ZF-AA4T | null | 23 | released | 1.76 | Yes | 2.1 | 8.1 | 65 | -23974 | 599 | not hispanic or latino | male | white | Dead | 1943 | 2009 | 23974 | null | N2 | Stage IV | T4 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2008 | not reported | Not Reported | false | Not Reported | 1834 | 0 | 160.0 | 9BB5D705-F2CF-4BD3-8E55-7F8BCB2A0DE5 | TCGA-ZF-AA4T-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 85.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA4T; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.76; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.1; rna integrity number: 8.1; age at index: 65; days to birth: -23974; days to death: 599; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1943; year of death: 2009; age at diagnosis: 23974; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1834; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-ZF-AA4T-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 585dfb25-5013-4ae1-a26b-5fed08e6cdb3 | TCGA-ZF-AA4U | null | 23 | released | 1.87 | Yes | 2.03 | 9.9 | 70 | -25682 | 262 | not hispanic or latino | male | white | Dead | 1938 | 2008 | 25682 | null | NX | Stage III | T4a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2008 | no | Not Reported | false | Not Reported | 1842 | 0 | 90.0 | 72EA5495-3D5D-4547-B2BE-54C138294216 | TCGA-ZF-AA4U-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 98.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA4U; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.03; rna integrity number: 9.9; age at index: 70; days to birth: -25682; days to death: 262; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1938; year of death: 2008; age at diagnosis: 25682; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage III; ajcc pathologic t: T4a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1842; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-ZF-AA4U-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 98.0; | [
1024
] | "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" | null | null | 30.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 1.36986301369863 | 25.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | ccd65bc8-82ef-453e-b4bc-a005cc2262d5 | TCGA-ZF-AA4V | null | 23 | released | 1.87 | Yes | 1.91 | 9.3 | 66 | -24448 | null | not hispanic or latino | male | white | Alive | 1942 | null | 24448 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2008 | null | Not Reported | false | Not Reported | 1850 | 0 | 290.0 | 52B54951-E580-49D6-BBB5-4F2329A271B0 | TCGA-ZF-AA4V-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 85.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA4V; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.91; rna integrity number: 9.3; age at index: 66; days to birth: -24448; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 24448; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1806.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; cigarettes per day: 1.5342465753424657; pack years smoked: 28.0; is ffpe: false; composition: Not Reported; days to collection: 1850; days to sample procurement: 0; initial weight: 290.0; portion submitter id: TCGA-ZF-AA4V-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0; | [
1024
] | "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" | null | 1806.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 6th | null | null | null | 1.5342465753424657 | 28.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 63443198-4fcf-40bd-befb-4a6920d29ca4 | TCGA-ZF-AA4W | null | 23 | released | 1.86 | Yes | 1.82 | 7.0 | 56 | -20611 | null | not hispanic or latino | male | white | Alive | 1953 | null | 20611 | null | N0 | Stage III | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2009 | null | Not Reported | false | Not Reported | 1742 | 0 | 200.0 | CEDD5865-4B14-4F0C-9BBD-CBE89E68C2C3 | TCGA-ZF-AA4W-01A-12 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 50.0 | 50.0 | 60.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA4W; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.82; rna integrity number: 7.0; age at index: 56; days to birth: -20611; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 20611; ajcc clinical t: T3; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1830.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1742; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-ZF-AA4W-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; | [
1024
] | "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" | null | 1830.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T3 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | e6f7bf6c-92b1-4795-94fc-b189d0c7877f | TCGA-ZF-AA4X | null | 23 | released | 1.83 | Yes | 1.82 | 8.0 | 56 | -20579 | null | not hispanic or latino | male | white | Alive | 1953 | null | 20579 | null | NX | Stage II | T2 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2009 | yes | Not Reported | false | Not Reported | 1603 | 0 | 60.0 | 56AEE38E-1301-436B-91CE-BCDB523A56E5 | TCGA-ZF-AA4X-01A-11 | 0.0 | 0.0 | 20.0 | 0.0 | 0.0 | 10.0 | 70.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA4X; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.82; rna integrity number: 8.0; age at index: 56; days to birth: -20579; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 20579; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2044.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1603; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-ZF-AA4X-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 20.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 70.0; percent tumor nuclei: 90.0; | [
1024
] | "3D6lvoZ/uD6frFK+vZ1+PEd/Jz62DeA+K+8YvvQ+Lz7eyNi9S9EVvnaR1T6FLXg8pHkfPawTSb6+Eli+Q8hVPmuqx7z3cjY9cyErvu4DTT5dZgi+0QoAP6TtRz6jVGi9ci6hvklRt73UiZg+q3x8PhmccD3NB6092EXlPfsaQz54V5K+6fuevhvZrrxbjtY+lVt1viNnNb6XZgE+7Kq0O9rl3T2jz6w+n3/6PVe6RL60Vd++xxpuPSVGgTySU06+iZxkPg3Uv70h/K+9d6ngvdm8mL11f56+RDWjPdpIgr3wFtm8P86JvuGo4D6inkI/yniSuw9e3zoboOm9uLPzPpW2H75vi3E+0HWpvnmgkb61rX0+UQE7vlRdCr7Ak4I+ACaEPsXHlj49d0O+8vCqvAcLjL04L849tdAPvmtM+D1HZao92egpvtCwAT5Ywia+aImUvki/lr4s7zy9zmnDvtVn0D5LWae+zYUjPtQwlz61pkI+asUePPg5azyLlsO9Pm0qvDfGVb5qoJY+HyfOPWED3D4Wn5M8nAWIvabvDDy6jhM+OhnevSjcwj35Brq9+8pavjxnL75ErRM+JwLePpZHVzw0v0k9sC9ovU9X+T1LjCY+gQmPvGMx9L5a8yA9H58tPgRyKj+Y+EK+pY6Evlzb1bt+902+8CsAPzV2aT2SRwm/EWO+vYiBLL7tbX++mjR7PclPJz4mV4i+OxCXPt7hd7/5ewG+CBiJvly0Dj1PWdk8dKitPXamAD6Pneo+W10FvW+bzD4ZWKi+qmlMvim5jL6coHc+dGyKvmT6Xz2HmkA9l7DnvvzLs7u0ceW+kJKrPlIp7bytHio9MtylPtuYZLz0nFC8k4/dPRoD7j1TVZm+EoffvECxRz7qr16+j7IgPsSM1bzFoRi+YOGKvlKpdz6tbzO9/qV9PjIjpry3zum9RnxRPfxNXb0muQA/gdbivX6OBj8INJK+57PFPOVNQL1mhVa98+oWvsD8NL/u5K08qRTDPTyfN754ZYI+M7CnPs6Gfr1OItU9XM+lvajz+r2CedK9TXpFvLmuCL5zzui+BfPrvmAxCb65yNW6WFyrPhVUcz1ezK2+UY2qvbSfNL7Nul++VnX8vm3mHz7KiNM+mIZEPr99pDyiPJG+wh3VvnhOgD39cl++MIoTPpVGGL/FNa49rf4uvmYLMb4E5oO86joVvkOeqb7qjwE/rGFtPBYh8D0WAhu+hViJvko0Nz0hvbK+VSMdvp4itr2X1tm9aI02Po5yaT7tqVc93J92PnCQN70X+IG+WlAgvUYiJj3fLgc+mw2FvTaGpb7udfo9VGlouwGJ8D0O9aS8KVvEPmWHWL7xR7PAgcJAvfMdBz+sLVY+tiF1vgyIaL4zwCy+/4tIPlqlPLtb4xi9ySDWPTTuc77E/r096WtmvOYydz0wNEO+/qFgPuZdsD1DZAO+m92NvfSOZT6iyik/fywyvr3mGz2L1n8+2X3bvYN16Dw+xgU+cMDxvCTavT2SpBY857GXvtVcFL7MA5a+nwfPvgzdlb1jg2G9vGYovmqkX71jrLW9h1JkPZLXpz5kfnk+XUhQPboZ670irmE9RJuoPkYsnz7dQbg+/t0yPnT4uj0hCcA+YajSvoFHVL70yB4+aDWmPXl29j1rfEe+IZWkPU9/mL4wpkQ9r4s9vvz/Bj4lb6y7kuOLvnijzT6xdnK+4yUwvh09PT71wiQ9qzbtPr7bwr79luo920qVPvdSmj79ryy+N9lCPsYkUb6pftY9qnshPb9phj4R1b490jvivYJ9Sz7x1JU9a961vXS2E79/25O+XmEWvsQFk7416t8+hTJDPqGV2r3fjGE9GAjHPrE/Rj4g4Ak+obOiPpJqez7ATFU+fTu6PkhMbj3/T7G+/WOxu3To+zx/aHI+NovMveb6gr7ErBS8x9k9PaxN2b35/KI+yXmbPdW8A75k4ha+1RKXvRwXTD7KFdS9DVGRPq4Fbb745hy/Ppb9vfT+hb6seeU9xwIFv7E0Qj773Ke9d2MbPphqIj/Hi4m+a1Q3Pb3eIr1J8vA+vTkKvvToMD4q4JQ+wS4FvjIzYz7IgFQ+EtuXvizBkj0MJRA+ad5HvtenJb9Kog09daHZu7ee+Lx6pnu9OToIvqbR2L7z8Y8+E7uaPq343T1N0NE8KNpyvlNxvj5/S4C+QJ/bvO9KCL1n/vE8VtTjvewh5T6JiBA9yKJlPp1rMj6wDDs94+8EPsu6W77lanm7VMUFv/vMqT1rkTi/1fdbPnYS0L59YfQ+Zm+Mvim8vb1fuUK9YMkBvhz7vL5/OYi+yCROPdFK0L4cjFY+mqpwvtccmbxVzNc9P6+TPbbV4j0NOF69l5WQvunRqj6RZp0/4YRwPAhMbb3s92y+TkMDvymDzjjBYlw9qguqPpl8Ljx08cK+cxyhvtbz6L022aY+BHbnPXrCJz7d5gc+JFVHPdQuDTzfatc9yTHrvnxnLr6yq8W+DamtPV7vNb57FRI9C1mAvCwhAD6gokw80uMxviGgIL48ksu9qhAmvTjnmj6x8YU+dS4mPrVaET2csDc+LfbKvgFTBTs5WHG+MrxjPvKyjL54IoY+sn9fPq0ejT4hOFM+ku4UPuYygz49cY0+B4snvXnbwz30rwy+xUQqPaGjQD584i++G/KePr05BT4cL8i+8Q9uPVzahT6ibJ09L8vFPTzpp74NZEY9aAVVPjhj370ZHKE9iazJPf3qyD31z5S960sfvS9B1z01Hki+pjsPvewo47wt0rY9aDe9vpxeFb7HUym+/cSFPCmXdD6y68e98XYtvbFOnrwFSI4+BFlaPaQOfLxv/BE/VVr6vTUVDb7aIUY+SZ+KvukDWT5Ce207siuLvhRHHj22m/O9MNvDPQEnr72yNYm7XhdxvoTb7D6vRWO+ocKZPm6Iqb4t1h29QRH1vfcPhjwFvcO+HSldPp/pLz1DflS+udykPmBbmD5vTQu/nXUsvpa0sr1lPSq+hVOJPiRUyr1kQK4+5zcFvXptczwpg2S+OogePuO1Rb6VZTE+dZmRvFQOnr2lGa89EkoBPZg6Az6CtUq/l6m2PWFWxb0i6Hy+OYw3PryqPb4cL5K+c7nwvSssBr73/Yg+6zpdvpgFgD5k18y9UirdPZ0bTr5cywG+Fv2PvOH6LD0PRAQ+hujEvRbx0r2Oszy+mPGXvlj44L188Ju+yUE5viH1Ej5pKk8+WxgHvliGKr6ebIu+5mjTPtiNqjwc0DS+FJG6Po0RAr/57ik+AeuFvhnR1768LbC+x11VPgijgz8878m90geKPm1cXD387Lu9f0ubvnWLQT7Ayk+9w8iDPk46cb6EKbS++VURPBefpTs8BU0/EG/Kvcscmb7so/Y+PmWTPdbDGL4iv4w90x3DPoc29r3Ha5o+RIdWvnIrPz6Iybe9YllePg/OzT6piRG8YXc/vaFBlLvD7Jy+SFjRvu7egL3KWuK9wHRGvdizmL0ATIi+sO80PujzET4o4ci+4TmuPu/QMz6W2GW+nGdmvuh4gb5OgMC+O9VePJw73z0QLeK+XqTFvnfZHT4ZDyA+4eiyPvdMyT6mUr88qRwPvv8qob70ToE+C1gnvoZYm74pLlI9AT2humD7Hr7jYVm+aVYZPoPENz6KN7a+YBEhPrWgrL5AOlo+oL7IPeRJB77d9Dw+Yq9ZPqD09L1+3u+9nFUDPbrppT1x6fi+H0AVvg/YWL6HO1++eC72vZO/ir4Piqw+k4wFvfqjbT58vpE91LQQvwCoir1apMW+nU1ePdZMj75vKdI9FYztvrJV7j1NzdU+RwPlPpwUZb7KKje+CAh1vrhmaL4ubs8+EJNmPjmMk73ygvm9n1k4PQGmtj00/5i+WnKVPaP72z7oJrm9Z26UO9MUOT19G9s9NjzhvXYlGD7JkeO+FXjIPez0q714Rk8+hMm1vsPfzjzuy00+vvQOPmw2BT8O7aw+IfOzvO+u677b6CC+cqbHvfdIKj4mLnO9vdW+P4EToD4c2sY+c84wPgdMlL4uL+Y+TvQVP72UtD3qNTA+edOPPoqo3j4+pra9w5W6uzS/Jj9l8Kq+M9zCvX1hrr8Efh+9H31KPchGFj8Uhzo/51FKvsc8u76fCUu++UE4vk13Hb5Y6t89k9YPPxHZUL6acD0+smtTPusHQb0WH6g+Q0J7PgYGgb5VZRE+XMMrveNYgb6TjN08hP8BvaQ87D2PXLa+fTwfvhV7MT7SbX2+PPd1PoNOrz5xtaO+L6aOvjwsAT6aE8c9QumaviIeDT+r2cI7uJh0Poilgz7jPJW+afzevXRbXb5icg2+E3Bkvl8qg74WfVw+YFx+vnyKJz0QK+E9Jd2kvuEAQz7MZDA+GdZcvXnLxz03BaM+Jhd2vSnhZ74bgha+GmbUvZHieD08YEu+H0fOvhijJD+BGBM/1RyLPkZQHr46N009AsxqPq9UJj4+tjU9CUPnvn1s5r0+AX8+Z9m2vnDkDj1eOZs+ykjEvEq+lz10ZYe9K6e8PTVOJT5rLgG+6/GBPsMHRr6jAI+9AhTEvuOqrDxO/sO+/S8+vNmOjT2ktLC+0LNBu9UIeL60jKk+BaXqPcX1Xr52gMI988cvvkjUjr54Ego+Ip0xvUyOq76dJi48ZXJDPiKpMT53a8u8C892PZOuAr4/E6k+TTOpPpvfLb48LQI/TqCNven6rb3qMbC+POudvlVbw77aa7W+//iCvoxEdb6qh/q97Egavd1ALb41iuC89PCaPRjz6j6E16C+tNASPaVnIjyvAlK8pEgwPoWwX75+5S++dCB9PumShr3I+Y09wM41PohWHr7Rths9FQpMvrcWpj1TEeU+256avqXhLD7JdzM+njO8O+Pt2z7WwrQ8ozbwvq7Nzj5aDHw9+CmlvhB/Jb4MkPe9WtMevd0sED6jErs9hmQVPg4TkzwWcg4+tZhBPlXWIz3hjEq+gE8EvWFQGz0s73I9X30WvZpUL75kQQK9hG0fPaIhCT/39ss8gXYtvHTrAb6ejjm+BDtKPbOfOb6jVc29IuK/viI7y70a+4K+wk9Mvb7HJz5IIE0+dUtav5hc4L1fpse9eilcPgIKHD7SjI28UsqJvr3kgbwONT8+8q6mvYfEeL54Zlo+l+6XPp4FrL2Iku+9LVG8PfyrVT2NmKe9kL91Poyckz7IFo6+GM9tPpBdhD5LGze9KlyDvt+WVb43Qmo9wGcMPzodIbz2lYA8WPiGPpY3Rr7mbkO+0SjYPTvW076kKl++VNr/vusNpT5o1Zm9SoArPkjIHD687C48+DjqvZpPyr74cSu9yf5eviUiKz4w6jU+fyorvWOqpb4mA8E+aGWwPjcmAb65NWE+a7R1PiN4N7xyc9u+4Glavg2Xtz2VwHG+6GLUOw4Oez7dPHe9KXQMPcU/tz1OMoY9A3nVu+hNBT5Ik/a+821Nvg==" | null | 2044.0 | 30.0 | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 1029514b-a32c-4c43-a440-a5ba2709f717 | TCGA-ZF-AA51 | null | 23 | released | 1.9 | Yes | 1.28 | 7.0 | 69 | -25484 | null | not hispanic or latino | female | white | Alive | 1940 | null | 25484 | null | NX | Stage II | T2 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2009 | null | Not Reported | false | Not Reported | 1479 | 0 | 130.0 | F2059BDD-0218-47A9-BBA8-BFE95D1CD55E | TCGA-ZF-AA51-01A-21 | 90.0 | 10.0 | 10.0 | 0.0 | 0.0 | 30.0 | 60.0 | 70.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA51; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.28; rna integrity number: 7.0; age at index: 69; days to birth: -25484; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1940; age at diagnosis: 25484; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1714.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2009; alcohol history: Not Reported; cigarettes per day: 2.0821917808219177; pack years smoked: 38.0; is ffpe: false; composition: Not Reported; days to collection: 1479; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-ZF-AA51-01A-21; percent lymphocyte infiltration: 90.0; percent monocyte infiltration: 10.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 70.0; | [
1024
] | "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" | null | 1714.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 6th | null | null | null | 2.0821917808219177 | 38.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 6c5f09f0-2019-4440-8554-e8912bce5e98 | TCGA-ZF-AA52 | null | 23 | released | 1.86 | Yes | 1.3 | 7.0 | 70 | -25579 | 1077 | not hispanic or latino | male | white | Dead | 1939 | 2011 | 25579 | null | NX | Stage III | T3a | not reported | 0 | C67.4 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Posterior wall of bladder | No | Posterior wall of bladder | Not Reported | 2009 | no | Not Reported | false | Not Reported | 1543 | 0 | 130.0 | 85DADBA7-A561-4282-B405-9906A8D3678E | TCGA-ZF-AA52-01A-12 | 0.0 | 0.0 | 10.0 | 0.0 | 0.0 | 20.0 | 70.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA52; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.0; age at index: 70; days to birth: -25579; days to death: 1077; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1939; year of death: 2011; age at diagnosis: 25579; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage III; ajcc pathologic t: T3a; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.4; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Posterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Posterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.1095890410958904; pack years smoked: 2.0; is ffpe: false; composition: Not Reported; days to collection: 1543; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-ZF-AA52-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | 0.1095890410958904 | 2.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 92c6856a-b26f-4512-bbb1-8a8aff4636ab | TCGA-ZF-AA53 | null | 23 | released | 1.83 | Yes | 1.84 | 7.9 | 60 | -22035 | null | not hispanic or latino | male | white | Alive | 1950 | null | 22035 | null | NX | Stage II | T2 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | yes | No | not reported | Bladder, NOS | Not Reported | Bladder, NOS | Not Reported | 2010 | null | Not Reported | false | Not Reported | 1434 | 0 | 270.0 | 07A1F163-55AF-4D64-AFD9-DE8DFF7CB2C6 | TCGA-ZF-AA53-01A-11 | 30.0 | 2.0 | 20.0 | 3.0 | 0.0 | 45.0 | 35.0 | 60.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA53; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; concentration: 0.15; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.84; rna integrity number: 7.9; age at index: 60; days to birth: -22035; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1950; age at diagnosis: 22035; ajcc clinical t: T2a; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1761.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1434; days to sample procurement: 0; initial weight: 270.0; portion submitter id: TCGA-ZF-AA53-01A-11; percent lymphocyte infiltration: 30.0; percent monocyte infiltration: 2.0; percent necrosis: 20.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 45.0; percent tumor cells: 35.0; percent tumor nuclei: 60.0; | [
1024
] | "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" | null | 1761.0 | null | null | null | null | null | null | null | 0.15 | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2a | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | bca645ae-a0c9-4005-b672-85d8920b6afb | TCGA-ZF-AA54 | null | 23 | released | 1.9 | Yes | 1.52 | 7.4 | 71 | -26128 | 590 | not hispanic or latino | male | white | Dead | 1938 | 2010 | 26128 | null | NX | Stage III | T3 | not reported | 0 | C67.2 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Lateral wall of bladder | No | Lateral wall of bladder | Not Reported | 2009 | not reported | Not Reported | false | Not Reported | 1472 | 0 | 180.0 | 6B1A202D-C715-4495-9F28-0235F69BF983 | TCGA-ZF-AA54-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 90.0 | 95.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA54; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.52; rna integrity number: 7.4; age at index: 71; days to birth: -26128; days to death: 590; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1938; year of death: 2010; age at diagnosis: 26128; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: No; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1472; days to sample procurement: 0; initial weight: 180.0; portion submitter id: TCGA-ZF-AA54-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 6th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | eb30ae33-2076-475d-aac9-804a8f1119a0 | TCGA-ZF-AA56 | null | 23 | released | 1.88 | Yes | 1.9 | 8.8 | 79 | -28937 | 259 | not hispanic or latino | female | white | Dead | 1931 | 2010 | 28937 | null | N0 | Stage III | T4a | not reported | 0 | C67.4 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Posterior wall of bladder | No | Posterior wall of bladder | Not Reported | 2010 | no | Not Reported | false | Not Reported | 1344 | null | 230.0 | 835DF5D1-5F61-4C7A-860B-265F1209DDC9 | TCGA-ZF-AA56-01A-31 | 7.0 | 0.0 | 3.0 | 0.0 | 0.0 | 0.0 | 97.0 | 65.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA56; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.9; rna integrity number: 8.8; age at index: 79; days to birth: -28937; days to death: 259; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1931; year of death: 2010; age at diagnosis: 28937; ajcc clinical t: T2a; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.4; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Posterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Posterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1344; initial weight: 230.0; sample id: 72f50bb3-c7a3-49b5-8262-185eb830e17e; sample submitter id: TCGA-ZF-AA56-01A; portion id: 6fccecfd-cc8c-49b1-9f4b-af6498adfa4f; portion submitter id: TCGA-ZF-AA56-01A-31; slide id: 8e33d817-e4ee-4cdd-bed9-1be0916acbaa; slide submitter id: TCGA-ZF-AA56-01A-03-TS3; percent lymphocyte infiltration: 7.0; percent monocyte infiltration: 0.0; percent necrosis: 3.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 97.0; percent tumor nuclei: 65.0; section location: TOP; | [
1024
] | "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" | null | null | null | 72f50bb3-c7a3-49b5-8262-185eb830e17e | TCGA-ZF-AA56-01A | 6fccecfd-cc8c-49b1-9f4b-af6498adfa4f | 8e33d817-e4ee-4cdd-bed9-1be0916acbaa | TCGA-ZF-AA56-01A-03-TS3 | TOP | 0.16 | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | T2a | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 0da6502c-058d-47f5-9996-8aa1d511d7e4 | TCGA-ZF-AA58 | null | 23 | released | 1.77 | Yes | 1.48 | 7.4 | 61 | -22549 | null | not hispanic or latino | female | white | Alive | 1949 | null | 22549 | null | N2 | Stage IV | T3a | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2010 | null | Not Reported | false | Not Reported | 1252 | 0 | 220.0 | 31EED29A-65A9-4DB1-8E78-799A927D59F3 | TCGA-ZF-AA58-01A-12 | 0.0 | 0.0 | 10.0 | 0.0 | 0.0 | 20.0 | 70.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA58; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.77; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.48; rna integrity number: 7.4; age at index: 61; days to birth: -22549; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 22549; ajcc clinical t: T2; ajcc pathologic m: MX; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1649.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2010; alcohol history: Not Reported; cigarettes per day: 2.136986301369863; pack years smoked: 39.0; is ffpe: false; composition: Not Reported; days to collection: 1252; days to sample procurement: 0; initial weight: 220.0; portion submitter id: TCGA-ZF-AA58-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | 1649.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | MX | 7th | null | null | null | 2.136986301369863 | 39.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 04477379-6c51-45d9-b9b9-d05d53b53945 | TCGA-ZF-AA5H | null | 23 | released | 1.89 | Yes | 1.57 | 7.6 | 60 | -22122 | null | not hispanic or latino | female | white | Alive | 1952 | null | 22122 | null | N2 | Stage IV | T3b | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2012 | null | Not Reported | false | Not Reported | 437 | 0 | 40.0 | 34430EB2-DC78-41EC-A4BD-9452B1B01C92 | TCGA-ZF-AA5H-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 20.0 | 80.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA5H; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.57; rna integrity number: 7.6; age at index: 60; days to birth: -22122; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 22122; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 897.0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; cigarettes per day: 0.4383561643835616; pack years smoked: 8.0; is ffpe: false; composition: Not Reported; days to collection: 437; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-ZF-AA5H-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | 897.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | 0.4383561643835616 | 8.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | f78cb4fa-5548-40f8-b71b-663dde47f539 | TCGA-ZF-AA5N | null | 23 | released | 1.88 | Yes | 1.94 | 8.7 | 62 | -22741 | 168 | not hispanic or latino | female | white | Dead | 1951 | 2013 | 22741 | null | NX | Stage IV | T2 | not reported | 0 | C67.9 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Bladder, NOS | No | Bladder, NOS | Not Reported | 2013 | null | Not Reported | false | Not Reported | 29 | 0 | 60.0 | C115F113-1A42-4DB6-A6AA-7717C6DE227C | TCGA-ZF-AA5N-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 20.0 | 70.0 | 80.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA5N; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.94; rna integrity number: 8.7; age at index: 62; days to birth: -22741; days to death: 168; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1951; year of death: 2013; age at diagnosis: 22741; ajcc clinical t: T2; ajcc pathologic m: M1; ajcc pathologic n: NX; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C67.9; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Bladder, NOS; synchronous malignancy: No; tissue or organ of origin: Bladder, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; cigarettes per day: 0.547945205479452; pack years smoked: 10.0; is ffpe: false; composition: Not Reported; days to collection: 29; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-ZF-AA5N-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 80.0; | [
1024
] | "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" | null | null | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M1 | 7th | null | null | null | 0.547945205479452 | 10.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-BLCA | 24d56331-4bca-4ab8-9fb7-a95a30b4c8fe | TCGA-ZF-AA5P | null | 23 | released | 1.89 | Yes | 1.33 | 7.1 | 65 | -23971 | null | not hispanic or latino | male | white | Alive | 1948 | null | 23971 | null | N2 | Stage IV | T2b | not reported | 0 | C67.4 | not reported | 8120/3 | Transitional cell carcinoma | no | No | not reported | Posterior wall of bladder | No | Posterior wall of bladder | Not Reported | 2013 | no | Not Reported | false | Not Reported | 85 | 0 | 160.0 | BB68912E-1368-47BF-BC76-0C1C8532E6BF | TCGA-ZF-AA5P-01A-11 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 25.0 | 75.0 | 90.0 | project id: TCGA-BLCA; case submitter id: TCGA-ZF-AA5P; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.89; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.33; rna integrity number: 7.1; age at index: 65; days to birth: -23971; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1948; age at diagnosis: 23971; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 372.0; icd 10 code: C67.4; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Posterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Posterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 3.3972602739726026; pack years smoked: 62.0; is ffpe: false; composition: Not Reported; days to collection: 85; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-ZF-AA5P-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 90.0; | [
1024
] | "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" | null | 372.0 | null | null | null | null | null | null | null | null | null | null | null | false | false | false | false | false | false | false | null | null | null | M0 | 7th | null | null | null | 3.3972602739726026 | 62.0 | null | null | null | null | null | null | null | null | null | null | null | T2 | null | null | null | null | null | null | null | null | null | null | null | null | null |
TCGA-DLBC | a43e5f0e-a21f-48d8-97e0-084d413680b7 | TCGA-FA-8693 | true | null | released | null | null | null | null | 75 | -27468 | null | not hispanic or latino | male | white | Alive | 1937 | null | 27468 | null | null | null | null | not reported | 0 | C83.3 | not reported | 9680/3 | Malignant lymphoma, large B-cell, diffuse, NOS | no | No | not reported | Stomach, NOS | No | Stomach, NOS | Not Reported | 2012 | null | Not Reported | false | null | null | 0 | null | 977683b9-1cad-4033-9825-7dbb84b171e1 | TCGA-FA-8693-01A-11 | 90.0 | 0.0 | 0.0 | 5.0 | 10.0 | 0.0 | 90.0 | 80.0 | project id: TCGA-DLBC; case submitter id: TCGA-FA-8693; selected normal wgs: true; state: released; age at index: 75; days to birth: -27468; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1937; age at diagnosis: 27468; ann arbor b symptoms: No; ann arbor clinical stage: Stage I; ann arbor extranodal involvement: Yes; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 132.0; icd 10 code: C83.3; last known disease status: not reported; morphology: 9680/3; primary diagnosis: Malignant lymphoma, large B-cell, diffuse, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Stomach, NOS; synchronous malignancy: No; tissue or organ of origin: Stomach, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 36.0; days to sample procurement: 0; intermediate dimension: 1.5; longest dimension: 2.8; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-FA-8693-01A-11; percent lymphocyte infiltration: 90.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 10.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 80.0; | [
1024
] | "iaZ4voPbuj5aPz2+sax+PVojND5kRcA+vWJgvXiVrT0stz69k9EIvruCuz596lY94TKAO0p/Mb6OCTu+nY5lPkzUxr3wSi49bXcmvs2G1D15GtW9sYr1PqLFRj5tfKq9L6Nevrt+370O0I4+BuhgPuAw9j2f5Ow8aXoUPsswBD50xIO+rIibvrkUtbyX05U+J6FUvm8mJr7+DAY+D9rmvCfixD3eep8+lfwVPsRMnb5aO86+T/JpPZ2A4L2AsQS+OZ4tPsRJqr1Sj/O9tHB4vcvlFL5v15u+uQR4PZwVnbyJIIe71jVDvhgmtj7TDTo/7AmRvUpjqr3vRz6+dhziPpiXBb7pFJQ+2ZeNvpfRK749uX0+v1v6vYgHI75Txmk+ASNUPjX3nj6m4Sy+7CCOvVqnDrsNyeU99546vo8Yxj3sliw9xKMCvsteiz15n0k6u3OqvkZ4a76K4Ru8H8rdvq5yxT6M7tS+j4j/PfvOXj5yAYQ+bRXdPBk1cLwaq1q8shCjvYJrnL5Hz5Y+ezX8PQ58zj5+8yo9yihJvW1h5zz4PPA9Co41vrH3Iz6g8Aq+aYSIvudhFL0QXT8+qiLiPm65Cz1PRNM9sn4HveU9Jj39W00+ngdDvP8F1r5Lj6E8l6YqPgSkCj/nGvO9FwGIvtSoID2QFTG+6W7qPonc8j0oufi++f37u3rdK777NIO+REKHPSBnBT7EAIe+nd2PPo25a78A3EG+2N52vpaA1DwUbM68l99zPoryKj1Q6sY+KuCQvZupwD4Pq7y+lWsvvjW0b746YJ4+etpVviZaRj31um49J+bRvp8OwL0H8sq+ERRXPpwysLtaTKi8ZZyQPtzppj1KWFi9yp7mPSc8DD6nToy+xPwKvaw77j3ueT2+DLnPPcMGaL0S/0a+b4i0vqQlhT4Ujmi9fzSkPm1gj70cxpa9UayXO07RXr7YugA/t8ghvso/Cj+nDoi+0IyuvBJZhD0L+H+98FL9velOKb9M68Q9ieL9PYkyor2744I+VmGxPoVXmr12OgK9Z+OuvYz4071P/5K9OVFQvOQyi72QBxC//w39vkpKY76D4Ae9zhyJPjQ0JT1dNba+U2r+veWKF74SN/C9r8v1vlFRTz7kb8g+ImuxPgHNOD3N5gS+0rXIvkXBDz1mF06+4223PadmDL8LBs67CECxvULmaL6xOG492czdvSu0z75gkRM/ycVTvBs87T1zUqK9xGtcvlfgYz3Rc6K+of/cvZudZ736qxa+D5vxPZftYj5OfKQ9Dig/PpM/zTsC1Xa+JGxFvQwLTzztWt49oXIfvSxtqb4q+Ik9Yxm0PGymAD7gEf28DOiHPoJAjb7UBLzAAyBNPUTcCz+8OOw9awtBvvoTLL6wxVi+lZUfPlMzFDyYY8C9ZysMPN5iNb4dGpc9C5EZvd7zLT2a7gS+6QCqPtfxET7l1N69vqUounsVQD5M9Ss/AcbmvTeptLy6S04+rbTWveOsHLqoM0w+gDnXO3eDJz4n1cY8FAxqviddNL7zrVm+5CvhvgjcDr5rQKk7ixUdvp3crL2BeJK95NHTPKZulz4/Nm4+tuFnPagVJr6Habg8nMaQPoJHqD4g7Jo+ZXjRPQ/PFz7CQpk+tJPDvmWigr69w4U90CUTPmaRlD0kHEa+/OGBPWrByL7co/m6vR4evgL6Hz7579s9eKiFvgaL2z6eHYm+mRQSvudehD0oc/+8lcDNPj0XqL4W3XY+9v2UPr0zbj7aK1e+/3xhPoe/h72VCQQ+YpD5Pe12aj7zVN081mMXvsmfMj5R2RQ+OORkvV/qD7+vu4y+H54Kvv+ChL7CftQ+TExZPs7dDL7ZavA7ZJutPg++8j28xnY9gmSEPg/YYj5me3U+7neTPpYq0T3EE4i+X3kcPZWvRjxFaZ8+e66vvVTMO74Pw/M8PIBLPfUxxb11p3c+wFR+PP6+3r2LFnO+0yXSvbsiSD4rXu+9iqGEPrhSLb5pHyS/3tkFvhT3ab64HR0+UXL1vgKALz7bph+98U+cPQbJID/QPE6+cuWAPQN+Qb3zPtU+ka0IvsDiCD4+TZA+HUiOvQ+mRj5jL2U+aS2CvgGrXD3NSys++LRFvtn8AL9YTo67DxaEO9p95LzOAIC9TcUXvjWP+r4n8mE+r7mAPhnaRT0a0/49xX9kvlL1zD7anwy+LswGvJe4YL2XH3M9jpMQvvt8yz7c+uk77i9UPrF+jz6PlOs8rkraPTyBf768tKg8HO7hvpJMxz22BjK/UahhPjox0b4K8PM+/MCXvghhS7wfRLa95zJSvsQItr4Bw5K+k/f2PBiipr76mww+o7dnvhiw5r3U+ms913VjPS4o/j3a64O9xMI5vuY6iT6GTJE/SfZ1PUr2k737roW+En7dvofQZT0IvsA8AZPKPoxQf7yaMZu+86Stvr75E74ACp0+FVYDPq8c9D27kaE9wSInPUZelLy7hi09eUKwvtnUFL4khLK+rvQPPn93YL5dvRo9+szvPOnE1j3ufr+8sNFLvqqZDL7HIOO9mSCevQjciD6n+JI+haaKPSb6ZT1uPRU+t53cvjJh8Tzxj1y+05eZPkJcrr4SXDE+LNtaPh7xfz5kC38+dQXSPT4bGT6ARkU+nuvevbiHejzqv+O9tM2pPeKEIz6TrQy+sdffPiFhtD2D+5m+Kr4OvVTeYD58/JY95eSyPaO3pL51HYo9rX5UPsayO76r8os98dQPvWiIvT2TLtm9xM6oveDtAz7xXhe+aZ/fvCndpr0KvhQ+SGqvvuPgM77Cfwu+av0BPa/2XD6E9Hi9EBuBvUpGbz1HCZc+H37APVP2F7yCl+8+WGM8vsdGmb0sp1s+AVmCvv8dcD5TFw09LGWBvqOJjLtDwpu9RhDGPVD64r0YPJO8DaZLvuCl+D5TKmO+BuaOPpxpwL5Xric9RhQ4vh4JUz0II2y+U2dTPvDWSTzp1Cy+egKQPhbkgD4Sqhi/fYIEvnU5GL5Ttlm+wq+WPpyajDrxXJs+80ItvQtglDwPp4e+k2yUPuzwdL5rlzo+ztlSPZQ7J71RIdM9zFcDviNyij29mk2/n56CPeAw9L2mBG++MLA8Pm08FL4UPH6+Xoa4vZz5Lb4iuYw+0N4bvo3Pfz47GTK+PMKlPUMa9r2JlJe9AsaUPIyjo7xKKSk+rlIgPQ+pAb4SHgu+4sqkvtmsIL6cAWq+XSaHvgNA+D3QGD8+kGwIvhIGKb4Ey4e+RQC3PkxyNbyEpCu+5cLnPpq+Dr/bYjM+Z81jvlFNr74wG5i+VtymPqfwhz8ywAy9gJeUPolSoDwrq7m8JDiSvu4JcD4Vnty93plkPrbNiL5RTdm+CzqGPeyr4DuANT8/TC8jvMnYwb4zof8+v2H/Pfj5O77noiE91o+GPr9oIL7/Vmc+U2hHvuLsNj6h1By+tdo0Pil1uj6QHNq9uGR3vej4nj3s6KG+fYGnviDSSL3uRc+9U9UWvUBlXbwL+jW+EcpYPo5dfj5Yc7u+5SunPg8qUj4kM02+nXRHvuLRFr4dVsO+H4C9PON3BT3mhLq+U7O3vvU9Jj4H3h0+CbiePoYZsD52Qyi9PnvPvR5Jr779zSk+1ZE1vtpTrL7hT8Q9tmSlvSsOK75BmDa+trHXPbKdIT5wOYu+3/oMPluYjL5DODo+becfPtnl2r1bpLg9wWncPTmLQ76nyBW+Aic/vI31oD383eu+5isfvsy51L2dIIq+qrImvjcnpr6K64w+reVdvEgpVT7Ellw9y1rvvnktLr3s28W+qKi+PMvkhb6oDrU94C7RvgtbvT2UUdU+1n/bPjjYGb6HQR++tNhdvtpzhL7ZaqQ+dlp6PpP/FL0GVPi9mx03PeW1hj2U05O+QC25PWCb2T5hfem9SfAcPJz5RT1lZM09/Uk0vnTq/T0W/8y+oMkgPkY0Dr76UHY+vrecvsipn7zLmyU+dO3yPSsT5D7LF9c+AfCPPDXwm77saOu9F5VKvUnkXT4MN/q9Zr62P/Ep0D7PDdA+HrkuPljLoL4lzwE/+tEXP9X0Sj019hM+uCZfPjWIvz4IOG670I7ROzWKBD8VgIG+C6FTvb3Qqb90ml29M/k8vMUKED//WSw/WjL3vTUnrL6i5V6+QlwrvmKM+72E6mA9JKEDP29sLb6gDjo+BjxiPpynijzZcVc+DCNBPga8F7536/s9UmPUvTpEir5gjgE9y1kVvQ/Skz3b+H++Fq4DvhnVfj48zIC+InCpPg5a6j6CzmS+5qShvhsNtj0vd6M9/82xvhmE/D6oeL28AYpfPl8LMz5msXW+yB2ZvbEmW74i0Ly9A3A3vkIidr5pA0A+wsRpvj9wAjxiEw+9ZTCIvkIu0D1hqqE9asMMvVmrET4DC5A+cuEVu8tJk76T0hO+6j/+vacy4D3Csca9XnK3vtyOHT8mevE+FtKHPsS7Hb6yKim9JSwlPjDXwz1M63w9Z26mvh3nRL68OoE+8WmVvnwBxLvg1I8+v1qWPAQi2jwLZty9WlbgPUWzBz6g5Oq9ICZCPuSFI76azQ6+t8elvhsV0Tvcm7G+MBkwvov6Wj3Lb5C+UynnPF5EaL4Drpw+SWTlPXZ+LL5rDS0+xsVdvhziY76kfuQ996QIPNSeiL6C3DG8QQj1PQFIzz2gmMW9NOKUPRAopb0ByYE+ham0PvqhIr57efg+eeTPvfXf6DsKvKa+7vKbvuB72L7qSr++FJtFvt23XL786Ra9UwwMPMUTSL1h2rY85vD9PVE19D4nX4C+GSJVPToYL73PB4095zEAPmQ4KL7+tFa+GM2HPgJ9O72m4rM9+8xGPtURNL7hX9C8hfMvvgMevj3HHOw+jbSUvlm5kj0ipRM+o2RrPPz12D5Be8g9aRLHvsZx1z4rk7o9Q+Ohvi7yQr6Acpm9caVBvKVerj3Zsvg8vO4ePl+Jfju2nV097cUmPgs+Jj0ej42+83cEvWnNpzxxiR0+tozjPHHBEb6USB+97+ERPT7nAz9UXIK8IBuQOpMqMr00xlW+q0qEPR0Vgr6ORT29RafIvoWnsr2qgfS9BsQivppf8T1YC0I+WpY/v/1zWL5STzi9QeNnPlqf/z21Kla8UWJjvk9jPr0MVJM+Q01Rvqbfc76CDGM+O0x8PtgWzL1FUTS+EWSWPcQ1mz2Axyq+XBMnPkSHVj5YN0K+fBd2PslWgT4cmq+7PV14vkOIcb6VIHc9U9bsPhLJgb11cTY9+qOIPu4SA769AmG+DvzzPXeY0b5yuYa+hS0Lv4DLlD5fdlo8nlE8PnlwbT4/RFY9dLNjvcKvsr4W6fE98z52vjw6Qz6c3l0+5ZqGPQaqgL5OjWA+oWOfPsN6Rr7Io1U+0qiYPjJ3qj0Bk+O+GBqWvlObBz5Kpii+fCdfvRK9qj7FQ6u9ouyvPcOEwT0jEp287YJ4Pc98MT5wl/O+xoUTvg==" | null | 132.0 | 36.0 | null | null | null | null | null | null | null | null | No | null | null | null | null | null | null | null | null | null | null | null | null | null | 1.5 | 2.8 | 0.5 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | No | Stage I | Yes | null | null | null | null | null | null | null | null | null | null |
TCGA-DLBC | 1843c82e-7a35-474f-9f79-c0a9af9aa09c | TCGA-FA-A4BB | true | 23 | released | 1.77 | null | null | null | 67 | -24590 | null | not hispanic or latino | male | white | Alive | 1945 | null | 24590 | null | null | null | null | not reported | 0 | C83.3 | not reported | 9680/3 | Malignant lymphoma, large B-cell, diffuse, NOS | no | No | not reported | Lymph nodes of axilla or arm | No | Lymph nodes of axilla or arm | Not Reported | 2012 | null | Not Reported | false | null | 97 | 0 | 1430.0 | 05B34041-D414-4215-9A66-2B7E4D09F4D5 | TCGA-FA-A4BB-01A-11 | 3.0 | 2.0 | 0.0 | 0.0 | 3.0 | 2.0 | 95.0 | 95.0 | project id: TCGA-DLBC; case submitter id: TCGA-FA-A4BB; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.77; age at index: 67; days to birth: -24590; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1945; age at diagnosis: 24590; ann arbor b symptoms: Yes; ann arbor clinical stage: Stage IV; ann arbor extranodal involvement: Yes; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 132.0; icd 10 code: C83.3; last known disease status: not reported; morphology: 9680/3; primary diagnosis: Malignant lymphoma, large B-cell, diffuse, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lymph nodes of axilla or arm; synchronous malignancy: No; tissue or organ of origin: Lymph nodes of axilla or arm; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; days to collection: 97; days to sample procurement: 0; initial weight: 1430.0; portion submitter id: TCGA-FA-A4BB-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 3.0; percent stromal cells: 2.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | 132.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | Yes | Stage IV | Yes | null | null | null | null | null | null | null | null | null | null |
TCGA-DLBC | a5b188f0-a6d3-4d4a-b04f-36d47ec05338 | TCGA-FA-A4XK | true | 23 | released | 1.82 | null | null | null | 40 | -14723 | 708 | not hispanic or latino | male | asian | Dead | 1972 | null | 14723 | null | null | null | null | not reported | 0 | C83.3 | not reported | 9680/3 | Malignant lymphoma, large B-cell, diffuse, NOS | no | No | not reported | Jejunum | No | Jejunum | Not Reported | 2012 | no | Not Reported | false | null | 140 | 0 | 1370.0 | 05EFF049-BF35-4D89-8968-5442C5FF375A | TCGA-FA-A4XK-01A-11 | 3.0 | 1.0 | 0.0 | 0.0 | 3.0 | 2.0 | 95.0 | 95.0 | project id: TCGA-DLBC; case submitter id: TCGA-FA-A4XK; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.82; age at index: 40; days to birth: -14723; days to death: 708; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Dead; year of birth: 1972; age at diagnosis: 14723; ann arbor b symptoms: No; ann arbor clinical stage: Stage II; ann arbor extranodal involvement: Yes; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 456.0; icd 10 code: C83.3; last known disease status: not reported; morphology: 9680/3; primary diagnosis: Malignant lymphoma, large B-cell, diffuse, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Jejunum; synchronous malignancy: No; tissue or organ of origin: Jejunum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; days to collection: 140; days to sample procurement: 0; initial weight: 1370.0; portion submitter id: TCGA-FA-A4XK-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 3.0; percent stromal cells: 2.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0; | [
1024
] | "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" | null | 456.0 | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | null | No | Stage II | Yes | null | null | null | null | null | null | null | null | null | null |
Subsets and Splits
WSI Data with Clinical Details
Combines detailed whole slide image (WSI) data with clinical information, providing insights into patient demographics and vital status related to their diagnostic case.
WSI Data with Clinical Details
The query joins WSI data with clinical data but simply returns the merged dataset with no additional filtering or aggregation, providing limited insight.
WSI and Pathology Report Data
The query retrieves detailed file information for whole-slide images and associated pathology reports, providing basic linking between the two datasets by PatientID.